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Abstract 
Investigation of regulatory functions of microRNAs in skin and hair follicle 
development and cycling  
Majid Ali ALAM 
Keywords: skin, hair follicle, microRNA, miR-214, gene expression 
 
miRNAs are important post-transcriptional regulators of gene expression which 
play vital roles in the arrays of physiological processes, including skin and hair 
follicle (HF) development. In this study, the role for miR-214 in the skin and HF 
development and their postnatal physiological regeneration was investigated. 
miR-214 exhibits discrete expression patterns in the epidermis and HF in 
developing and postnatal skin, and is highly expressed in the epithelial stem 
cells and their lineage-committed progenies. The effects of miR-214 on HF 
morphogenesis and cycle progression were evaluated by using doxycycline-
inducible miR-214 transgenic mice (K14-rtTA/TRE-miR-214). Keratinocyte 
specific miR-214 overexpression during skin embryogenesis resulted in the 
partial inhibition of HF induction and formation of the HF reduced in size 
producing thinner hair. Overexpression of miR-214 in telogen skin caused 
retardation of the anagen progression and HF growth. Inhibitory effects of miR-
214 on HF development and cycling were associated with supressed activity of 
stem cells, reduced proliferation in the hair matrix, and altered differentiation. 
miR-214 induced complex changes in gene expression programs in 
keratinocytes, including inhibition of cyclins and cyclin-dependent kinases and 
several essential components of Wnt, Edar, Shh and Bmp signalling pathways, 
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whereas E-catenin acts as a novel conserved miR-214 target. Indeed, the 
inhibitory effects of miR-214 on HF development were rescued by 
intracutaneous delivery of pharmacological Wnt activator.  
Thus, this study demonstrated that by targeting E-catenin and, therefore, 
interfering with Wnt signalling activity miR-214 may act as one of the upstream 
effectors of the signalling cascades which govern HF morphogenesis and 
cycling. 
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1.0 INTRODUCTION 
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1.1 Structure and Functions of Skin 
The skin has long captivated scientists dating back to the beginning of the 19th 
century. Studies carried out by Hermann Rein first demonstrated the presence 
of a barrier between the stratum corneum and viable epidermis based on the 
physiological behaviour of isolated human skin (Menon et al., 2012; Rein, 
1924). In recent years the structure and biochemistry of skin has been greatly 
elucidated, revealing how the skin is a multifaceted organ (Blanpain and Fuchs, 
2009; Fuchs, 2007; Tobin, 2006). 
The largest organ of the body (~15% of total body weight in adult humans) 
(Healy, 2005) the skin provides an indispensable barrier. It carries out a variety 
of complex roles required for the body to survive and function properly.  It acts 
as the first line of defence against the environment, providing a physical barrier 
preventing dehydration, entry of microbes, mechanical and chemical stress. In 
addition, the skin can regenerate after injury, participates in immune responses 
and through its pigment producing melanocytes, it protects against harmful 
ultra-violet radiation (Costin and Hearing, 2007; Proksch et al., 2008; Slominski 
and Wortsman, 2000; Tobin, 2006). The skin is considered to have two distinct 
layers, the epidermis and dermis with an underlying connective tissue the 
subdermis. The epidermis is the outermost constituent of the skin, consisting of 
a stratified, multilayered epithelium between 75 and 100μm thick and up to 
600μm thick on the palms and soles (Tobin, 2006).  
Underneath the epidermis is the dermis, which is a two to four-mm thick layer of 
connective tissue and fibroblasts that accommodate the neural, vascular, 
lymphatic and secretory apparatus of the skin. Separating the two layers is the 
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basement membrane, a highly specialised layer of extracellular matrix (Fuchs 
and Raghavan, 2002; Tsuruta et al., 2011). 
The two main types of human skin are glabrous, non-hairy skin and hair bearing 
skin. Glabrous skin which is found on the palms and soles is characterised by a 
thick epidermis and lack of hair follicles and sebaceous glands. 
The skin houses several appendages which include the pilosebaceous unit 
consisting of the hair follicle and sebaceous gland, mammary glands, nails and 
teeth (Figure 1.1) (Eckert et al., 2013; Fuchs, 2007).  
 
Figure 1.1 The skin and its 
appendages. The skin 
consists of the epidermis and 
dermis, separated by a 
basement membrane. The 
epidermis is stratified 
sqaumous epithelia generally 
consisting of four layers. Also 
shown is a cross-section the 
hair follicle, the sebaceous 
glands and sweat glands. BL, basal layer; SL, spinous layer; Gl, granular layer; 
SC, stratum corneum. Adapted from Fuchs and Raghavan 2002 
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1.2 Epidermis 
The epidermis is stratified epithelium that originates from a single layer of 
ectodermal cells that are specified to the epidermal lineage. In mouse 
epidermis, a single layer of epidermal cells forms and persists from embryonic 
day 9.5 (E9.5) to embryonic day 12 (E12) when keratinocytes begin to stratify 
and form the multiple layers of the epidermis (Eckert et al., 1997). As the skin 
becomes populated by mesenchymal cells, signals transmitted instruct the 
stratification of the epidermis and initiate the positioning of down growths that 
mark the induction of hair follicle morphogenesis (Blanpain and Fuchs, 2006; 
Blanpain and Fuchs, 2009; Koster and Roop, 2007). 
In humans, at approximately three weeks of embryonic life, the epidermis 
consists of no more than a single layer of undifferentiated cells. At four weeks 
the epidermis begins to stratify. The ectoderm initially gives rise to the periderm, 
a superficial layer of cells that is a purely embryonic structure. This forms a 
transient covering for the epidermis, which is ultimately lost as the epidermis 
keratinises beneath it. As epidermal differentiation and stratification progress, 
cells of the periderm are sloughed off into the amniotic fluid and contribute to 
the vernix caseosa that covers the foetal skin (McGrath et al., 2010). 
The epidermis is composed of epithelial cells that differ from each other both 
structurally and functionally. The epidermis generally consists of 4 layers, which 
are the basal, spinosum, granular layers and the outermost stratum corneum 
(Figure 1.2). There is an additional layer, the stratum lucidum in the palms and 
soles. It contains no blood vessels and varies in thickness from less than 
0.1mm on the eyelids to approximately 1mm on the palms and soles. The main 
cell type that makes up the epidermis is the keratinocyte, which make up 
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approximately 95% of the epidermal cellular content. One of the main functions 
of the keratinocyte is to synthesise the keratin protein, which forms the 
intermediate filament system in epithelial cells, and are connected by protein 
bridges call desmosomes (Kolarsick P. A. J., 2011; Proksch et al., 2008; Tobin, 
2006) 
 
1.2.1 Basal Layer 
The innermost layer of the epidermis above the dermis is the basal layer. 
Rapidly proliferating keratinocytes within the basal layer continually renew the 
epidermis throughout a lifetime. Basal cells within the interfollicular epidermis 
represent a unique population of stem cells and transiently amplifying (TA) 
progenitor cells that can produce daughter cells or initiate a program of terminal 
differentiation, generating the suprabasal layers of the epidermis (Alonso and 
Fuchs, 2003; Fuchs and Horsley, 2008). Cell in the basal layer are polarised 
with their lower surface anchored to the basement membrane by integrins such 
as α6 and β4 (Margadant et al., 2010) These integrins play an important role in 
organising hemidesmosomes, which anchor the basal keratinocytes to the 
basement membrane (Tsuruta et al., 2011). Cells in the basal layer are 
characterised by expression of keratin 5 (K5) and keratin 14 (K14). As basal 
cells divide and migrate up to form the suprabasal layers there is a down-
regulation of K5 and K14 expression and an increase in expression of keratins 1 
(K1) and 10 (K10) (Blanpain and Fuchs, 2006). 
 
In addition, two different cell types are present in the basal layer; Merkel cells 
and melanocytes. Merkel cells function as mechanoreceptors and transmit 
tactile sensation. They are neuroendocrine cells concentrated in touch-sensitive 
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areas of glabrous, hairy skin and some mucosa (Lumpkin and Caterina, 2007; 
Polakovicova et al., 2011). Initially Merkel cells were thought to originate from 
neural crest cells; however lineage tracing experiments using epidermal and 
neural crest specific promoters showed that Merkel cells actually arise from 
epidermal cells (Morrison et al., 2009; Van Keymeulen et al., 2009).  
 
Melanocytes are pigment producing cells derived from the neural crest. 
Melanocytes are responsible for producing the pigment melanin and transferring 
it to keratinocytes. Melanin-containing granules known as melanosomes, which 
are membrane-bound organelles, is where melanin production predominantly 
occurs. Melanosomes protect the epidermis by transferring melanin through 
their dendrites to keratinocytes, where they produce supranuclear melanin caps 
that reduce damage caused by harmful UV radiation (Costin and Hearing, 2007; 
Lin and Fisher, 2007; Tobin, 2006).  
 
1.2.2 Spinosum Layer 
As basal cells reproduce and mature, they move towards the outer layer of skin, 
initially forming the stratum spinosum (‘spiny’ layer). The stratum spinosum 
contains between 8-10 sheets of irregular polyhedral keratinocytes with some 
limited capacity for cell division. As cells enter the spinous layer they switch off 
the expression of K5 and K14 and switch expression to K1 and K10, forming a 
robust intermediate filament network interlinked with desmosomes (Blanpain 
and Fuchs, 2009; Fuchs and Green, 1980).The upper most cells of the spinous 
layer consist of additional structural proteins such as involucrin and loricrin 
(Baroni et al., 2012). Also found in the spiny layer are Langerhans cells, which 
are immunologically active cells, derived from the bone marrow. They are 
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crucial for the immune barrier of the skin, acting as antigen-presenting cells and 
play a vital role in immunological reactions such as allergic contact dermatitis 
(Baroni et al., 2012; Moll et al., 2008). Langerhans cells are characterised by 
the presence of cytoplasmic organelles named Birbeck granules (Romani et al., 
2012). Birbeck granules contain langerin, a pattern recognition receptor which 
allows Langerhans cells to detect and respond to pathogens (Valladeau et al., 
2000; van der Vlist and Geijtenbeek, 2010) 
 
1.2.3 Granulosum Layer  
The granular layer consists of 3-5 sheets of non-dividing keratinocytes. Keratins 
1 and 10 which are initially synthesised in the stratum spinosum become the 
predominant keratins in the granular layer (Fuchs, 1990). It contains flattened, 
polyhedral non-dividing keratinocytes that produce granules of a protein called 
keratohyaline. The keratohyaline granules represent a mixture of smaller 
proteins containing keratohyaline and filaggrin (Matoltsy and Matoltsy, 1970). 
The lamellated granules are specialised secretory granules, which contain lipids 
and their extracellular processing enzymes. The granules increase in number 
and size and as the cell nuclei breakdown, their cell membrane increasingly 
becomes impermeable. These cells flatten as dividing cells underneath them 
progressively push them toward the skin surface (Costin and Hearing, 2007; 
Tobin, 2006). 
 
1.2.4 Stratum Corneum 
The stratum corneum is the outermost layer of the epidermis consisting of 15-30 
sheets of keratinocytes, which are terminally differentiated (non-viable) but 
biochemically-active cells called corneocytes. The corneocytes are connected 
8 
 
by corneo-desmosomes and embedded in a lipid-rich matrix containing 
specialised proteins and lipids (Elias, 2005; Lee et al., 2006; Menon et al., 2012; 
Tobin, 2006). Keratinocytes of the stratum corneum release lysosomal enzymes 
that degrade organelles leading to the formation of a tightly cross-linked 
squamous layer completing the cutaneous layer. The final stages of 
keratinocyte differentiation are linked to dramatic changes in the structure of 
keratins, leading to the transformation of these cells into flat and anucleated 
corneocytes, surrounded by a cell envelope. The terminal differentiation of 
basal layer cells leads to the formation of anucleated cells which form the 
epidermal barrier until they are shed and are replaced by the inner cells 
migrating upward. This occurs continually throughout a lifetime with cells 
migrating upwards in a synchronised manner. This program of migration and 
shedding occurs every two weeks in human epidermis, with each transit 
amplifying basal cell dividing three to six times before differentiating (Alonso 
and Fuchs, 2003). During the latter stages of differentiation, keratins are 
organised into condensed arrays. Filaggrin, a matrix protein, aggregates keratin 
filaments into tight bundles, which promotes the flattening of keratinocytes, 
which is characteristic of corneocytes in the stratum corneum (Menon et al., 
2012; Proksch et al., 2008). Over time, these cells slough off and are replaced 
by underlying differentiating keratinocytes (Proksch et al., 2008). 
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Figure 1.2. Illustration of the epidermis. The epidermis generally consists of 
four layers based on the characteristics of the keratinocytes of each layer. The 
basal layer is a monolayer of mitotically active cells that gives rise to the 
suprabasal layers. The stratum spinosum (spinous layer) lies above the basal 
layer and consists of several stratified layers. The stratum granulosum 
(granular) layer consists of three to four flattened layers of anucleated cells. 
Keratinocytes in this layer express proteins such as filaggrin and loricrin, which 
aggregate to form keratohyalin granules. In addition, lipids are produced and 
stored in lamellar bodies. The outermost layer is the stratum corneum, a 
cornified layer consisting of 15-30 sheets of terminally differentiated 
keratinocytes called corneocytes. The epidermis is separated from the 
underlying dermis by the basement membrane (lamina basale). Adapted from 
Lippens et al 2009. 
 
1.2.5 Dermis 
Underneath the epidermis is the dermis, a 2 to 4mm thick layer of connective 
tissue and fibroblasts that accommodate the neural, vascular, lymphatic and 
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secretory apparatus of the skin (Costin and Hearing, 2007; Sorrell and Caplan, 
2004; Tobin, 2006). The main cell type of the dermis is the fibroblast, a 
migratory cell that synthesises and organises the extracellular matrix (Chang et 
al., 2002; Costin and Hearing, 2007). The superficial papillary layer of the 
dermis is arranged into ridge-like structures, containing microvascular and 
neural components that maintain the epidermis (Sorrell and Caplan, 2004). The 
reticular layer of the dermis extends from the papillary layer to the deeper 
vascular plexus and makes up approximately 80% of the thickness of the 
dermis (Sorrell and Caplan, 2004). Collagen is the major constituent and 
provides the skin with great tensile strength and tissue integrity, whereas elastin 
maintains elasticity and resiliency. The dermis also accommodates 
multifunctional cells of the immune system such as mast cells, Langerhans cells 
and macrophages (McGrath and Uitto, 2010; Tobin, 2006). 
 
Mast cells are specialised secretory cells originating from bone marrow. They 
are present in the papillary dermis and also in subcutaneous fat. The 
characteristic feature of mast cells is the presence of dense cytoplasmic 
granules that contain histamine, heparin, serine proteases and cytokines 
(Kolarsick P. A. J., 2011). They can be identified by their characteristic cell 
surface markers such as CD1a antigen and MHC class II antigens (Mizumoto 
and Takashima, 2004). Mast cells function as an immune response, releasing 
inflammatory mediators such as histamine to protect the body from pathogens 
(Kolarsick P. A. J., 2011; Prussin and Metcalfe, 2006). 
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1.2.6 Skin Appendages 
The skin contains appendages such as nails, hair follicles and a number of 
glands which includes sweat, sebaceous and mammary glands. Although fully 
formed skin appendages differ greatly in their shape, number, functions and 
regenerative capacity, they are extraordinarily similar in the early stages of their 
development at both the morphogenetic and molecular levels (Mikkola, 2007; 
Mikkola and Millar, 2006). The development of skin appendages involves 
reciprocal and sequential interactions between the ectodermal epithelium and 
the mesenchyme (Jahoda et al., 1996; Oliver and Jahoda, 1988). The 
appendages of the skin can originate from either the ectoderm and mesoderm 
(hair and mammary gland) or the neural crest (tooth, vibrissae and cranial hair). 
The epithelial-mesenchymal interactions are mediated by a number of signalling 
pathways which includes: Wnt, bone morphogenetic proteins (BMPs), sonic 
hedgehog (Shh), ectodysplasin (EDA),  fibroblast growth factors (FGFs) and 
transforming growth factor-β (TGF-β) families and their downstream 
transcription factors that are required for the development of these skin 
appendages (Fuchs, 2009; Mikkola, 2007). The molecular signals of growth and 
transcription factors are widely conserved across many species as well as 
across distinct appendages (Fuchs, 2009; Mikkola, 2007; Mikkola and Millar, 
2006). 
 
1.3 The Hair Follicle 
The hair follicle is a dynamic mini-organ found in mammals. Humans possess 
over two million hair follicles, with approximately two percent located on the 
scalp. The significance of hair has long been associated with health, culture and 
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identity dating back to the days of ancient Egypt, to modern day society with 
hair products and services now a multi-billion pound industry. Although human 
hair plays an important role in life, its physiological importance is inversely 
related to the psychological impact it has, however disorders such as alopecia 
and hirsutism cause great psychological distress to those affected  (Blume-
Peytavi and Hahn, 2008; Cotsarelis, 2012; Krause and Foitzik, 2006; Vogt et al., 
2008). The main function of the hair follicle is to produce the visible hair 
shaft/fibre. The skin of mammals is covered in hair except the glabrous skin of 
the lips, palms and soles. The visibility of hair is clear in the majority of 
mammals, however for humans, hair growth is extremely reduced in most areas 
with small vellus hairs making them virtually invisible to the human eye 
(Botchkareva, 2009; Stenn and Paus, 2001).  In mammals, the hair follicles 
encompass several functions, which includes protection (thermoregulation, 
camouflage, protection against UV) and adaptation to seasonal changes 
(shedding, social and sexual communication) (Stenn and Paus, 2001; Wu et al., 
2008).  
1.3.1 Hair Follicle Anatomy 
The hair follicle is one of the most complex and highly organised mini-organs of 
the human body. Composed of several distinct layers, it is one of many 
appendages residing in the skin and is the only mammalian organ that 
possesses the extraordinary capability to self-renew throughout a lifetime 
(Figure 1.3). This capability of self-renewal is based on epithelial-mesenchymal 
interactions that control the activity of several stem cell populations within this 
mini-organ. The hair follicle plays a role in many aspects of mammalian biology 
including organogenesis, cell-cell interactions, tissue growth, regeneration and 
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aging (Botchkarev and Paus, 2003; Jahoda et al., 2001; Krause and Foitzik, 
2006; Stenn and Paus, 2001). 
The mature hair follicle is a highly organised, cylindrical structure, separated 
from the dermis by the dermal sheath.  At the centre of the follicle is the hair 
shaft, which is surrounded by the inner root sheath, the companion layer and 
the outer root sheath (Langbein et al., 2004; Schneider et al., 2009). The hair 
follicle can be divided into three regions: the infundibulum, isthmus and inferior 
segment. The infundibulum and isthmus of the hair follicle are known as the 
‘permanent’ upper region, whereas the lower inferior segment is known as the 
‘cycling’ region, which is continuously remodelled in each hair cycle.  The 
infundibulum region of the hair follicle extends from the surface of the skin to the 
sebaceous gland duct opening to the hair canal. The region between the 
sebaceous gland duct opening and the arrector pili muscle site is known as the 
isthmus. The inferior segment extends from the bulge to the base of the hair 
follicle bulb (Figure 1.3) (Paus and Foitzik, 2004; Schneider et al., 2009). The 
hair bulb can be divided into two parts, with the lower consisting of actively 
proliferating keratinocytes and the upper portion containing differentiating 
keratinocytes. The boundary at which these regions are divided is referred to as 
the ‘critical line of Auber’ (Auber, 1956; Aubin-Houzelstein, 2012) .  
14 
 
 
 
Figure 1.3. Hair Follicle Morphology. (A) Image of longitudinal section of 
human anagen scalp follicle (B) Magnified image of the isthmus. Dashed box 
indicates approximate location of the bulge (C) Magnified image of the hair bulb 
portion (D) Schematic drawing illustrating the concentric layers of the ORS, IRS 
and hair shaft in the bulb. IRS is made up of four layers: Companion layer, 
Henle’s layer, Huxle’s layer and the inner root sheath cuticle. Cells of the 
companion layer are tightly bound to Henle’s layer, but to the ORS allowing the 
companion layer to function as a slippage plane between the stationary ORS 
and the upwards moving IRS. Further inwards the IRS cuticle is composed of 
scales that interlock with the scales of the hair shaft cuticle, anchoring the shaft 
in the follicle, allowing both layers to jointly move during hair follicle growth.  SG, 
sebaceous gland; APM, arrector pili muscle; DP, dermal papilla; CTS, 
connective tissue sheath; BM, basal membrane; M, matrix; IRS, inner root 
sheath; ORS, outer root sheath; HS, hair shaft. Adapted from Schneider et al 
2009. 
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1.3.2 Hair Shaft 
The hair shaft or fibre is the visible product generated by the hair follicle and is 
formed by keratin proteins. The hair shaft of terminal hair follicles consists of 
three layers: an outer cuticle, central cortex and a medulla. The cortex is the 
main structure of the shaft, forming the bulk and strength of the hair shaft and is 
made up of long keratinised cells, which are formed into long fibres (Harkey, 
1993) . The hair shaft cuticle covers the hair and is formed by layers, which 
interlock with opposing layers of the inner root sheath, allowing the hair shaft 
and the inner root sheath to move upwards together (Rogers, 2004). During hair 
shaft growth, cortical cells emerging from the proliferative keratinocytes rapidly 
undergo a differentiation program and begin to synthesise large amounts of 
hair-specific keratin proteins. Some of these hair specific proteins include four 
type I keratins which are K25, K26, K27 and K28 and four type II keratins which 
are K71, K72, K73 and K74 (Langbein and Schweizer, 2005).  
Several transcription factors have been identified to be crucial for hair shaft 
differentiation. For example the homeobox C13 (Hoxc13) gene is expressed 
primarily in the upper bulb region in hair follicles of all hair types in mice 
(Godwin and Capecchi, 1998) and also in human hair follicles (Jave-Suarez et 
al., 2002). The expression of Hoxc13 is initiated at the early stages of hair 
follicle differentiation, during both hair follicle morphogenesis and the anagen 
phase during the hair cycle and its expression continues in the proximal-most 
region of catagen follicles during regression (Shang et al., 2002). In anagen 
follicles, the Hoxc13 expression domain encompasses distinct subpopulations 
of cells primarily in the matrix and the three cylindrical layers of the 
differentiating hair shaft, including cuticle, cortex, and medulla (Jave-Suarez et 
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al., 2002; Potter et al., 2006). Two independent studies employing loss- and 
gain-of-function of Hoxc13 demonstrated the crucial role for this gene in hair 
shaft differentiation (Godwin and Capecchi, 1998; Tkatchenko et al., 2001). In 
Hoxc13-null mice external hairs failed to grow, thus resulting in a completely 
nude appearance and defective nail development (Godwin and Capecchi, 
1998). In transgenic mice overexpressing Hoxc13, there is a delayed formation 
of a thin and ‘rough’ hair coat during postnatal development and progressive 
alopecia during adulthood (Tkatchenko et al., 2001).  
The transcription factor Foxn1 is another important regulator of hair shaft 
differentiation (Nehls et al., 1994). Mutation of Foxn1 leads to the development 
of the nude phenotype in severely immunocompromised nude mice (Flanagan, 
1996; Nehls et al., 1994). Whereas wild type and heterozygous animals start to 
develop a dense hair coat around postnatal day 5 (Flanagan, 1966), hairs do 
not emerge from the dorsal skin of mice homozygous for any of the reported 
allelic mutations in the Foxn1 gene. The hair shafts in nude mice were found to 
bend and coil as soon as they enter the hair canal (Flanagan, 1966). Foxn1 was 
found to control the expression of keratins in the cortex of the hair shaft and is 
responsible for broken hair shafts being produced (Schlake et al., 2000). 
1.3.3 Inner Root Sheath 
The inner root sheath is adjacent and bound to the growing hair shaft and is 
responsible for guiding the hair shaft in its passage outward (Rogers, 2004; 
Stenn and Paus, 2001). It is made up of three layers which are the cuticle, 
Huxley’s and Henle’s layers. It functions as a physical barrier that separates the 
hair shaft from the outer root sheath, which creates the external concentric layer 
of epithelial cells (Schlake, 2007; Stenn and Paus, 2001). The inner root sheath 
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ensures the maintenance of a constant desmosomal anchorage of the 
companion layer which is required for an optimal moulding and guidance of the 
growing hair (Rogers, 2004; Stenn and Paus, 2001). The inner root sheath and 
hair shaft are tied together by their interlocked cuticle structures. The inner root 
sheath packaged shaft uses the innermost, companion layer of the outer root 
sheath as a slippage plane for orientation to move straight forward the skin 
surface (Krause and Foitzik, 2006; Stenn and Paus, 2001). The lineages of the 
inner root sheath have shown to express a variety of structural keratins, which 
are required for its mechanical strength. Cells of the inner root sheath produce 
keratins 1 & 10 and trichohyalin which collectively provide strength to the inner 
root sheath to support and guide its upward movement (Botchkareva and 
Randall 2009).  
The establishment of the inner root sheath cell lineage is dependent on the 
activities of several factors which include GATA3 and Cut1 (Ellis et al., 2001; 
Kaufman et al., 2003). The Cutl1 gene encoding CDP is a transcription 
repressor in diverse processes. CDP is expressed in progenitors and cell 
lineages of the inner root sheath. Cutl1 deficiency leads to the reduction in size 
of the growing inner root sheath, accompanied by deregulated transcription of 
Shh, followed by cyst formation (Ellis et al., 2001). GATA-3 is a transcription 
factor, which is expressed in the Huxley and Cuticle layers of the inner root 
sheath (Kaufman et al., 2003). Ablation of GATA-3 expression has been shown 
to lead to structural changes in the inner root sheath. GATA-3 deficient follicles 
are no longer spatially aligned and the hair shaft develops as an overdeveloped 
mass of irregular medulla, cortical and cuticle cells. This demonstrates the 
importance of GATA-3 in these two layers of the inner root sheath, which are 
critical for the proper differentiation and/or organisation of the hair shaft 
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(Kaufman et al., 2003). A recent study by Kim et al found that the transcription 
factor Dlx3 is downregulated by the overexpression of the hairless (Hr) 
transcription factor leading to abnormal formation of the inner toot sheath (Kim 
et al., 2012). Kim et al reported that through the overexpression of the hairless 
gene in transgenic mice, the formation of the inner root sheath was abnormal 
and the expression of Dlx3 and inner root sheath keratins were suppressed. 
They showed that Hr downregulated Dlx3 mRNA expression through 
suppression of Dlx3 promoter activity. In addition, they found that Dlx3 
regulated the expression of inner root sheath keratins, thus regulation of Dlx3 
by Hr affects inner root sheath keratin expression, modulating the formation of 
the inner root sheath (Kim et al., 2012). 
1.3.4 The Outer Root Sheath 
The outer root sheath is a non-keratinising proliferative cellular layer of the hair 
follicle, which surrounds the inner root sheath and is continuous with the basal 
layer of the epidermis (Tanaka et al., 1998). The outer root sheath emerges 
proximally in the middle of the anagen bulb and continues distally to combine 
with the infundibulum. The outer root sheath is established during the early 
stages of anagen by the downward migration of the regenerating epithelium and 
then sustains itself independent of the bulbar matrix by basal cell growth 
(Reynolds and Jahoda, 1991). It displays a curved extension below the 
sebaceous gland known as the bulge, a stem cell niche where relatively 
undifferentiated stem cells reside for keratinocytes and melanocytes. The outer 
root sheath contains progenitor cells originating from the bulge that deliver into 
the matrix of the bulb. The progeny of keratinocytes and melanocytes migrate 
down from the bulge to the matrix of the hair bulb before differentiating. 
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(Botchkareva et al., 2001; Cotsarelis et al., 1990). In addition to epithelial cells, 
other cell types are also present in the outer root sheath. In human hair follicles, 
Langerhans cells have been found in the infundibular epithelium, including the 
follicular bulge and rarely in the epithelium below the entry of sebaceous glands 
(Langbein et al., 2004). It has been shown that Sox9 is essential for outer root 
sheath differentiation and formation of the hair follicle stem cell compartment 
(Vidal et al., 2005). 
1.3.5. Hair Bulb 
The hair bulb comprises of keratinocytes and melanocytes cells that envelop 
the mesenchymal cells that make up the dermal papilla. The matrix is divided 
into two regions, the lower region consisting of rapidly proliferating keratinocytes 
and the upper region consisting of differentiating keratinocytes with limited 
proliferative activity (Legue and Nicolas, 2005; Schneider et al., 2009). The hair 
matrix also contains melanocytes which migrate from bulge and reside on the 
apex of the dermal papilla, providing melanin pigment to the growing hair shaft 
(Botchkareva et al., 2001; Slominski et al., 2004). 
The dermal papilla is a specialised, mesenchymal-derived structure made up 
fibroblasts and can be considered as being the ‘control centre’ of the hair 
follicle. It is believed to be integral to instruct hair follicles to grow and form a 
particularly sized and pigmented hair shaft (Jahoda et al., 1984; Matsuzaki and 
Yoshizato, 1998; Van Neste and Tobin, 2004). Decade old studies indicated 
that dermal papilla cells are capable of inducing hair follicle development and 
the formation of the hair shaft when placed in non-hairy skin (Jahoda et al., 
1984; Jahoda and Oliver, 1984; Jahoda and Reynolds, 1993; Jahoda et al., 
1993). In human hair follicles the size of the dermal papilla correlates with the 
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number of matrix cells and the size of hair shaft produced (Elliott et al., 1999). In 
mice the hair shaft diameter also depends on the proliferative activity of the 
matrix keratinocytes (Sharov et al., 2006).  
The importance of the dermal papilla was demonstrated in pioneering 
experiments in which transplanted micro-dissected dermal papillae induced hair 
follicle growth (Jahoda et al., 1984; Reynolds and Jahoda, 1992). Several 
studies have implied that the dermal papilla acts a niche for regulating stem 
cells. Panteleyev et al showed that mice with mutant Hr gene, dermal papilla 
cells fail to migrate upwards and break into clusters during the first catagen and 
subsequent hair cycles cease (Panteleyev et al., 1999). 
The dermal papilla displays strong alkaline phosphatase activity during the hair 
growth cycle (Handjiski et al., 1994). The activity of alkaline phosphatase has 
been used as an indicator to detect the dermal papilla during the hair cycle. 
Alkaline phosphatase activity in the dermal papilla and connective tissue sheath 
(also known as dermal sheath) has been shown to reach its highest level in 
early anagen stage and its expression was seen to decrease after the mid-
anagen of stage of the hair cycle. The changes in temporal and spatial alkaline 
phosphatase activity coincide with the hair-inductive property of the dermal 
papilla and dermal sheath (Iida et al., 2007; McElwee et al., 2003). Whereas, 
the role for alkaline phosphatase in the hair growth remains unclear, it has been 
shown that hair growth is reduced if alkaline phosphatase is inhibited (Iida et al., 
2007). 
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1.3.7 Connective Tissue Sheath 
The connective tissue sheath, also known as the dermal sheath, envelops the 
epithelial components of the hair follicle. It consists of an outer connective 
tissue sheath and inner basement membrane called the hyaline or glassy 
membrane, which is continuous with the interfollicular basement membrane 
(Cotsarelis and Botchkarev 2012). The connective tissue sheath runs adjacently 
to the full length of the follicle on either side of the basement membrane. 
Around the upper follicle there is a thin connective tissue sheath continuous 
with the papillary dermis and around the lower follicle the connective tissue 
sheath is more prominent (Jahoda and Reynolds 2001; Cotsarelis and 
Botchkarev 2012). When transplanted under the skin, the connective tissue 
sheath has the ability to form a new dermal papilla and induce new follicle 
formation, suggesting cells of the connective sheath can induce dermal papilla 
cells in initiating hair growth  (Reynolds et al., 1999). It was shown that when 
the base of the hair follicle was amputated, it would regenerate with the dermal 
papilla reforming from adjacent connective tissue sheath cells, demonstrating 
that within the dermis they acted as progenitor cells (Inamatsu et al., 2006).  
 
1.4 Hair Follicle Morphogenesis 
Hair follicle morphogenesis is governed by unique expression of regulators 
which can either promote induction of follicles and subsequently hair follicle 
development, or are inhibitors of this process. These regulators encompass 
growth factors and their receptors, growth factor antagonists, adhesion 
molecules and intracellular signal transduction, producing the correct balance of 
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signals to regulate hair growth (Botchkarev and Paus, 2003; Stenn and Paus, 
2001). 
The formation of mammalian hair follicles occurs during embryogenesis through 
a series of reciprocal interactions between skin epithelial cells and underlying 
dermal cells (Hardy, 1992). In human skin, hair follicles begin to develop at 
approximately 9 weeks gestation, on the chin, upper lip and eyebrow regions of 
the embryo (Cotsarelis and Botchkarev 2012). It is morphologically divided by 
eight consecutive stages (Stages 0-8), characterised by the downgrowth of the 
developing follicle, the positioning of the dermal papilla, as well as development 
of the inner root sheath and harbouring melanocytes (Figure 1.4) (Paus and 
Cotsarelis, 1999).  
 
 
Figure 1.4. Embryonic stages of hair follicle morphogenesis. The process 
of hair follicle morphogenesis occurs relatively late in embryonic development 
which begins with the formation a hair follicle placode. A dermal condensate 
forms underneath the epithelial cells of the placode forming a hair germ. Further 
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downgrowth results in the formation a hair follicle peg. Continuing proliferation 
and differentiation eventually leads to the formation of a mature hair follicle. 
Adapted from Fuchs 2008 
 
It is believed that the first signal to induce hair follicle formation originates from 
the dermis. This theory was derived from the fact that when dermis from mouse 
vibrissae is grafted below the epidermis of dorsal skin, whiskers develop on the 
back (Horne et al., 1986; Jahoda et al., 1984; Oliver and Jahoda, 1988). Also, 
when dermis from hair-bearing skin is transplanted onto non-hairy regions such 
as palmoplantar skin, hair follicles begin to develop, or when the opposite is 
done and dermis from hairless region was combined with epidermis of a hairy 
region, no hair follicles developed (Hardy, 1992; Jahoda et al., 1984; Kollar, 
1970). This leads to the conclusion that the inductive properties lie within the 
dermis, since the origin of dermis dictates whether follicles developed. 
The initial stage of hair morphogenesis (stage 0) begins with a single epithelial 
layer of basal keratinocytes. The epithelial cells that receive this first dermal 
signal form a thickening of columnar cells known as a placode (stage 1) (Figure 
1.4, 1.5). Subsequently, a signal from the placode leads to the formation of a 
mesenchymal (dermal) condensate just beneath the placode. Further 
interactions between the epithelial placode and mesenchymal condensate 
induce the proliferation in both these structures, leading to further downgrowth 
(Millar, 2002; Schmidt-Ullrich and Paus, 2005). The elongated placode 
eventually surrounds the dermal condensate, which becomes the dermal 
papilla. Rapid keratinocyte proliferation leads to the formation of the hair peg 
(stage 2). Further downgrowth of the hair germ leads to the formation of the hair 
‘peg’ (stage 3-4), where the proximal keratinocytes begin to enclose the dermal 
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papilla, followed by the bulbous peg stage (stage 5-8). During stage 5, hair 
follicle keratinocytes begin to terminally differentiate forming the inner root 
sheath. The centre of the inner root sheath consists of terminally differentiated 
trichocytes, which go on to form the hair shaft (Schmidt-Ullrich and Paus, 2005). 
At stage 5, sebocytes become visible in the distal region of the developing hair 
follicle, while melanin granules and the hair shaft can be seen above the dermal 
papilla (Paus et al., 1999) Stages 6-7 are characterised by the visibility of the 
hair canal, the complete of enclosure of the dermal papilla and the tip of the hair 
shaft leaves the inner root sheath and enter the hair canal. At the final stage 8, 
the hair follicle reaches its maximal length and extends up the panniculus 
carnosus (in mice) and the hair haft emerges through the epidermis (Figure 
1.5) (Paus et al., 1999). 
In murine dorsal skin, hair follicles begin to develop at embryonic day 14.5 
(E14.5), initially appearing as small epithelial placodes. The dorsal skin of mice 
is known to produce four distinct follicle types that vary in length, thickness and 
shape of hair shaft. These distinct follicle types are the guard, awl, auchene and 
zigzag hairs, distinguished by their length and number of bends (Schlake, 2007; 
Schneider et al., 2009). The most abundant follicle type is the zigzag which 
contains two bends in the shaft; the shafts of guard and awl contain no bends 
and auchene shafts consist of one bend. The first epithelial placodes that 
appear at E14.5 eventually develop into the primary guard follicles. These 
constitute approximately 1-5% of adult mouse coat and are characterised by 
their large follicle size and longer hair shaft length. Awl and auchene follicles 
are induced in the second wave from E16.5 to postnatal day 0.5 and zigzag 
hairs form beginning at E18.5 (Schlake, 2007; Schmidt-Ullrich and Paus, 2005).  
25 
 
1.5 Key signalling pathways involved in hair follicle development 
1.5.1 Induction of hair follicle growth 
The induction of hair follicle formation is a controlled process involving spatial 
and temporal regulation of inductive and inhibitory signals that together lead to 
formation of mature hair follicles. The initial stages of hair follicle 
morphogenesis are believed to be regulated in a sequential process of signals 
that alternate from the epidermis and dermis (Botchkarev and Paus, 2003; 
Millar, 2002). Although the induction of follicular growth was shown to originate 
from the dermis, the underlying mechanisms remain to be unravelled.  
One of the major signalling pathways involved in hair follicle induction is Wnt/β-
catenin signalling. The targeted deletion of β-catenin via K14 promoter prevents 
the formation of hair placodes (Huelsken et al., 2001). Ectopic expression of the 
secreted Wnt inhibitor Dickkopf1 (Dkk1) in mouse epidermis results in a 
complete failure of placode formation and blocks patterned expression of 
placode markers (Andl et al., 2002). In contrast, over-expression of Wnt/β-
catenin signalling in the epidermis has been shown to induce extra hairs and 
hair-derived tumours (Gat et al., 1998; Millar, 2002). These data strongly 
suggest that Wnt signalling is crucial for initiating hair follicle development and 
Wnt signalling is believed to be essential for initiating the first dermal signal 
(Hardy, 1992), although it is still unclear which Wnt protein is crucial for inducing 
placode formation. After activation in the dermis, Wnt signalling also becomes 
active in the epidermis, where several Wnt proteins, including Wnt10a/b, and 
the secreted Wnt inhibitor Dkk4 are expressed (Bazzi et al., 2007; Zhang et al., 
2009). Dkk4 is a direct target gene of Wnt/β-catenin signalling and is 
predominantly expressed in the hair follicle placode (Bazzi et al., 2007; Sick et 
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al., 2006). It has been reported that Dkk4 may play a role in inhibiting Wnt 
activity in the surrounding cells (Zhang et al., 2009). Over-expression of Dkk4 in 
the epidermis leads to retarded formation of secondary hair follicles but does 
not affect primary follicles (Cui et al., 2010). More recently Chen et al showed 
that forced activation of β-catenin in the dermis led to hyperproliferation of 
dermal fibroblasts producing a thicker dermis, enlarged epidermal placodes and 
dermal condensates that lead to prematurely differentiated hair follicles (Chen 
et al., 2012). Ablation of β-catenin in dermal fibroblasts prior to hair follicle 
induction prevents the expression of epidermal placode markers and the failure 
of primary hair follicle formation. This implies that widespread Wnt signalling in 
the dermis regulates the first signal/s to promote hair fate of epidermal cells 
(Chen et al., 2012) 
Deletion of the transcription factor Lef-1, which is a transcriptional mediator of 
Wnt activity, resulted in an absence of most hair follicles in dorsal skin and lack 
of vibrissae follicles (van Genderen et al., 1994). In contrast, Lef-1 
overexpression leads to increased number of hair follicles as well as ectopic 
hair growth in other epithelial tissue (Zhou et al., 1995). Lef-1 has been shown 
to negatively regulate the expression of E-cadherin in hair germ keratinocytes 
and promotes the loss of their adhesion to neighbouring epidermal 
keratinocytes, thereby stimulating hair follicle induction (Jamora et al., 2003). It 
has also been shown that Wnt/β-catenin signalling has a pivotal role in the 
formation of de novo hair follicles after wounding in murine skin. The selective 
ablation of Wnt signalling leads to abrogation of wound-induced folliculogenesis 
(Ito et al., 2007). A study by Enshell-Seijffers revealed a signalling loop that 
utilises Wnt/β-catenin signalling in epithelial progenitor cells and their 
mesenchymal niche regulates and coordinates the interaction between these 
27 
 
compartments to guide hair follicle morphogenesis (Enshell-Seijffers et al., 
2010).  
The tumour necrosis factor (TNF) pathway, which is mainly composed of Eda-
A1 (ectodysplasin), Edar (ectodysplasin receptor) and Edardd (Ectodysplasin 
receptor death domain), has been shown to play a crucial role in the induction 
and development of the hair follicle. Eda is a ligand that that signals through 
downstream NFκB transcriptional activation after binding to Edar (Mikkola, 
2011; Mikkola et al., 1999). Edar is a type I transmembrane protein and a 
member of the TNF receptor superfamily, with a cysteine-rich domain in the 
extracellular region as well as a potential death domain in its intracellular region 
(Headon and Overbeek, 1999).  The deletion of both Eda and Edar in 
corresponding mouse mutants (Tabby and Downless) is accompanied by 
formation of a sparse coat and failure in induction of primary hair follicles 
(Headon and Overbeek, 1999). During embryogenesis Eda is detectable 
throughout the epidermis whilst Edar is expressed in early placodes. As 
embryogenesis progresses Eda becomes progressively restricted to the 
interfollicular epidermis (Laurikkala et al., 2002). Edardd  associates with the 
Edar protein via its death domain, resulting in the downstream activation of NF-
κB (Headon et al., 2001). Collectively, Eda-A1, Edar and Edardd function in a 
signalling pathway essential for morphogenesis of the primary hair follicles. 
Importantly, it has recently been shown that Edar is a Wnt-target gene whose 
expression is upregulated by Wnt signalling.  Inhibition of Wnt prevents 
expression of Edar and activation of NF-κB. In addition both Wnt10b and Dkk4 
have been shown to be target genes of NF- κB (Zhang et al., 2009). Therefore, 
Wnt/β-catenin signalling functions both as upstream and downstream of Eda-
A1/Edar/Edardd/NF-κB signalling. Furthermore, Eda-A1/Edar mediated NF-κB 
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activation has been demonstrated to induce Shh expression, which promotes 
follicular growth (Schmidt-Ullrich et al., 2006). In view of the fact that both Eda 
and Edar are only expressed in the epidermis, studies have suggested that the 
Eda signalling pathway is important for placode patterning, affecting the 
induction of primary and zigzag hair follicles, but not necessary for initial 
placode formation (Botchkarev and Fessing, 2005; Schmidt-Ullrich et al., 2006; 
Zhang et al., 2009). 
In addition to activators of hair follicle induction, the skin also contains a number 
of inhibitors of hair follicle induction. During hair follicle induction in mice, both 
BMP-2 and BMPRIa are expressed in the hair placode, while BMP-4 and 
noggin expression is seen in cells of mesenchymal condensation beneath the 
placode (Botchkarev et al., 1999a). It was shown that neutralisation of BMP-2 
and BMP-4 inhibitory activity by noggin stimulates the initiation phase in hair 
follicle development.  The deletion of noggin reduced placode density with the 
exception of guard hairs (Botchkarev et al., 1999a). As invagination of the 
epithelium begins there is a marked reduction in expression of E-cadherin, while 
P-cadherin is simultaneously up-regulated and prominent expression of P-
cadherin persists in the proximal region of the hair follicle (Hirai et al., 1989). It 
has been shown that two distinct signalling pathways contribute to the down-
regulation of E-cadherin; Wnt signalling, which results in the stabilisation of β-
catenin and inhibition of BMP signalling by noggin to produce Lef-1 (Jamora et 
al., 2003). Active BMP signalling is known to inhibit the transcription of Lef-1 
and contribute to maintenance of epidermal fate. However, noggin which is 
secreted from the dermal condensate of the secondary hair follicle interacts with 
BMP proteins and prevents receptor binding, leading to upregulation of Lef-1 
expression at the placode (Botchkarev et al., 1999a; Botchkarev et al., 2002). 
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As a consequence, Wnt/β-catenin signalling is activated and E-cadherin 
expression is downregulated in the placode of the secondary hair follicle 
(Jamora et al., 2003). In addition, it has also been demonstrated that transgenic 
mice overexpressing E-cadherin in the epidermis results in a lack of hair 
follicles, providing further evidence that the cadherin switch plays a crucial role 
in changing cell-to-cell contacts in the hair follicle placode and promoting 
downgrowth (Jamora et al., 2003). 
At the earliest stages of hair follicle induction, the molecular factors involved in 
determining epithelial cell fate for placodes versus interfollicular epidermis have 
been investigated (Nowak et al., 2008; Rhee et al., 2006). Two essential 
pathways which play a vital role in these cell fate decisions are EGF and KGF 
(also named FGF7). In a mouse model where FGFR2 receptor is knocked out, 
there is reduced follicular density and development of hair follicles is retarded 
(Petiot et al., 2003). Transgenic mice over-expressing FGF2 and FGF7 via K14 
promoter have a reduced number of hair follicles and display epidermal hyper-
proliferation, suggesting that FGF signalling may promote an epidermal fate 
rather than hair follicle cell fate (du Cros, 1993; Guo et al., 1993)  
Collectively, arrays of epithelial-mesenchymal interactions acting via at least 
four distinct signalling pathways (Wnt, Edar, BMP and Shh) are interconnected 
in a signalling cascade that contributes to primary hair follicle development. 
1.5.2 Hair follicle growth and differentiation 
Following induction of hair follicles, the epithelial cells of the placodes begin to 
proliferate and produce downgrowths which eventually leads to the 
development of the mature hair follicle. Two signalling pathways essential for 
this downgrowth are Shh and PDGF (Platelet-derived growth factor).  
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Expression of Shh is seen in the developing placode and in the growing bulb of 
hair follicles (Bitgood and McMahon, 1995; Iseki et al., 1996). Patched (Ptc), a 
receptor for Shh, is expressed in both epidermal and dermal compartments 
from an early stage (Karlsson et al., 1999). In Shh knockout mice, there is an 
initial epithelium invagination and mesenchymal condensation at E15.5; 
however hair follicles become developmentally arrested at this point and by 
E18.5, hair follicle development is significantly retarded (Chiang et al., 1999; St-
Jacques et al., 1998; Wang et al., 2000). The epithelium invagination and  
 
Figure 1.5. Hair Follicle Morphogenesis and Key Signalling Molecules 
Involved. At Stage 0, interaction between the epidermis and underlying dermis 
involves local hair follicle growth activators such as Wnt/β-catenin signalling 
overriding hair follicle growth inhibitors, creating an inductive field. In the 
following Stages 1-2 the hair placode becomes visible and downward growth is 
initiated. The dermal condensate and dermal papilla begin to form and within 
the developing placode, BMP signalling is down-regulated by specific BMP 
antagonists in order for hair placode growth to occur. In stages 3-8 various 
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molecules are involved in the formation of the different lineages of the 
developing hair follicle. Adapted from Schneider et al 2009; Schmidt-Ulrich and 
Paus; Botchkarev and Paus 2003. 
formation of mesenchymal condensates indicates that Shh is dispensable for 
hair follicle induction. The components of Shh, such as Ptch1, Smo, Gli1 and 
Gli2, are detected at lower levels, however levels of Wnt10b, Lef-1 and BMP2/4 
are not affected in arrested follicles, indicating that hair follicle induction is 
independent of Shh, but  Shh is necessary for hair follicle growth, and Shh 
signalling is either independent or operate as downstream of these inductive 
factors (Chiang et al., 1999; St-Jacques et al., 1998). 
More recently, Woo et al showed when Smo, a mediator of Shh signalling is 
knocked out in early embryonic dermis there is a loss of dermal papilla 
precursor, the dermal condensate and the phenotype is similar to that of Shh 
deletion, demonstrating that Shh signalling within dermal condensates is 
essential for the development of the dermal papilla and subsequently hair 
follicle maturation (Woo et al., 2012). 
The importance of PDGF in hair follicle morphogenesis was recognised due to 
the formation of sparse coats in PDGFa knockout mice, which eventually 
degenerate as the mice age (Karlsson et al., 1999). This study demonstrated 
the importance of epithelial-mesenchymal interaction as the PDGFa ligand is 
secreted exclusively by the epidermis and the PDGFRa receptor is exclusively 
expressed in the dermis (Karlsson et al., 1999). The majority of PDGFa mutant 
mice die during embryogenesis, with surviving mice displaying a sparse hair 
coat and thinner skin. The follicles that form appear to be normal indicating that 
PDGF signalling is not essential for hair follicle induction (Karlsson et al., 1999).  
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The TGFβ superfamily is also involved in regulating hair follicle development 
(Foitzik et al., 1999; Paus et al., 1997). In TGFβ-2 knockout mice there is 
delayed follicular growth at E18.5, reduced number of hair follicles, whereas 
embryonic skin explants with exogenous TGFβ-2 stimulated hair follicle 
induction (Foitzik et al., 1999).  
 
BMP signalling is also required for differentiation of hair follicles. Mutation of 
BMPR1a gene leads to a reduction in levels of p-Smad 1/5/8 via which BMP 
signalling takes place, causing abnormal hair follicle formation (Andl et al., 
2004). Andl et al demonstrated that CRE-mediated mutation of the gene 
encoding BMPR1a in the surface epithelium of mice, prevented external hairs 
from forming. The hair shaft and inner root sheath failed to differentiate and 
expression of known transcriptional regulators of follicular differentiation such as 
Foxn1 and Gata3 were markedly downregulated or absent in hair follicles of 
mutant mice (Andl et al., 2004). Lef-1 expression was maintained, but nuclear 
β-catenin was found to absent from the epithelium of severely affected mutant 
follicles, indicating that activation of the WNT pathway lies downstream of 
BMPR1a signalling in postnatal hair follicles. Mutant hair follicles failed to 
undergo catagen and instead continued to proliferate leading to the formation of 
follicular cysts and matricomas (Andl et al., 2004).  
 
Notch signalling is another pathway involved in the growth and differentiation of 
hair follicles. During embryogenesis, Notch1 expression is seen in the 
epidermal part of the hair placode, but not in the underlying mesenchymal part 
(Kopan and Weintraub, 1993; Powell et al., 1998). Notch1 and its ligands 
Jagged1/2 are expressed in the precortex, differentiating cells of the inner root 
sheath and the hair shaft. Overexpression of Notch1 Intracellular Domain 
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(NICD) in the cells of the precortex leads to aberrant differentiation and hair loss 
by the end of the first hair cycle (Lin et al., 2000). Although Notch is not 
necessary for induction of hair follicles, it plays a key role in cell differentiation 
within hair follicles during late embryogenesis and adult life (Aubin-Houzelstein, 
2012). 
1.6 The Hair Cycle 
The hair cycle encompasses the dynamic, rhythmic morphological changes 
orchestrated via a series of epithelial-mesenchymal interactions. The hair cycle 
consists of a growth phase (anagen), regressive phase (catagen) and a phase 
of relative quiescence (telogen). Thus an obvious question is why do hair 
follicles cycle? The reasons as to why the hair cycle occurs from an 
evolutionary perspective in mammalian animals, is to encompass several 
functions, which includes the ability to renew the protective function of hair 
(thermoregulation, camouflage) and adaptation to seasonal changes (shedding, 
social and sexual communication) (Stenn and Paus, 2001; Wu et al., 2008).  
The purpose of hair cycling in humans from an evolutionary viewpoint is not as 
obvious, as these functional traits are not essential for human survival. 
However, possible reasons could be the cleansing of skin surface of debris and 
excretion of hazardous chemicals by encapsulation within trichocytes (Krause 
and Foitzik, 2006). Nonetheless, the hair cycle dictates the different 
characteristics of hair found across the body. The human body produces 
variations of hair depending on the location of the body. On areas such as the 
scalp and eyebrows, follicles consist of long, thick, terminal hairs, whereas 
areas such as the body and forehead are covered with short, thin and often 
unpigmented vellus hairs (Randall, 2008; Schneider et al., 2009).  
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The length of different hairs produced depends on the duration of the growth 
phase anagen, which can last from 2 to 6 years. Approximately 85% to 90% of 
all scalp hairs are within anagen follicles. The regressive phase catagen lasts 
only for a few weeks, followed by the relatively quiescent telogen phase, which 
lasts 2 to 4 months (Krause and Foitzik, 2006; Tobin, 2006).  Several disorders 
of hair growth occur due to abnormalities in hair follicle cycling. Androgenetic 
alopecia, also known as male pattern baldness occurs due to shortening of the 
anagen phase, leading to hair loss due to the transformation of terminal hair 
follicles to vellus hair follicles. Hirsutism, a disorder in which excess hair growth 
occurs is due to a prolonged anagen phase and the conversion of vellus hair 
follicles to terminal hair follicles (Krause and Foitzik, 2006; Otberg et al., 2007). 
Therefore, understanding the underlying mechanisms that control this cycle and 
how the ‘hair cycle clock’ is regulated, will allow for clinical and pharmacological 
manipulations that will help to combat disorders of the hair.  
The hair cycle in the back skin of mice is initially highly synchronised. Plikus et 
al showed that as mice age, hair follicle cycling slows down and patches of 
coordinated hair cycling eventually form distinct hair cycle domains, which 
become increasingly scattered as mice age (Plikus et al., 2008).  The cycle in 
human hair follicles however, occurs in an autonomous pattern and can take up 
to 6 years (Krause and Foitzik, 2006). During the hair cycle, the lower inferior 
part of the hair follicle segment undergoes dynamic changes in morphology, 
whereas the upper ‘permanent’ region of the hair follicle maintains its structure 
throughout the cycle. 
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1.6.1 Telogen 
Telogen is a phase of relative quiescence with regards to proliferative activity. 
The epithelial cells of the lower telogen follicle do not show significant DNA or 
RNA synthesis (Vogt et al., 2008). Telogen follicles are reduced to 
approximately about half the size of anagen follicles and do not extend beyond 
the upper dermis. They are characterised by their short length and lack of 
pigmentation due to the destruction of melanocytes and the absence of the 
inner root sheath. The compact round dermal papilla is closely attached to the 
secondary hair follicle germ containing hair follicle stem cells (Stenn and Paus, 
2001; Vogt et al., 2008). 
The hair follicle transition and transformation from telogen to anagen stages of 
the hair cycle are unique process of programmed organ regeneration 
characterised by activation of cell proliferation in the follicular germinative 
compartment located in the most proximal part of the telogen hair follicles close 
to dermal papilla (Stenn and Paus, 2001). The first telogen in mice lasts several 
days, whereas the second telogen lasts up to 3 weeks and the third is even 
longer. After each cycle the duration of telogen increases and follicular cycling 
slows down resulting in progressive asynchrony in pelage follicles and the 
formation of distinct hair cycle domains (Muller-Rover et al., 2001; Plikus et al., 
2008). The research by Plikus et al led to redefinition of the hair cycle, with 
telogen divided into two phases, refractory telogen and competent telogen 
(Plikus et al., 2008). The refractory phase named so as it is refractory to follicle 
growth stimuli, characterised by the upregulation of BMP2/4. The competent 
phase characterised by the high sensitivity of bulge stem cells to anagen 
inducing factors (Plikus et al., 2008). 
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Although generally described as the resting phase, the components of telogen 
follicles (bulge, secondary hair germ and dermal papilla) are in fact engaged in 
cellular communication and in reality telogen follicles are far from being 
‘quiescent’ (Botchkarev and Paus, 2003). Critical for initiation of the telogen-
anagen transition seems to be a balance of local growth stimulators and 
inhibitors in the proximal region of the telogen hair follicle (Botchkarev and 
Paus, 2003). In telogen follicles, the bulge comes to rest above the secondary 
hair germ, which is in contact with the underlying dermal papilla, allowing for 
direct interaction between bulge stem cells and the dermal papilla. The dermal 
papilla is vital for stem cell activation and initiation of a new hair cycle. Once a 
critical level of stem cell activators is reached, anagen is induced (Krause and 
Foitzik, 2006). Activation of the Shh pathway in particular induces hair follicle 
transition from telogen to anagen (Sato et al., 1999). Confirmation of the high 
sensitivity of telogen follicles to Shh pathways was shown by the initiation of 
anagen through a single topical application of synthetic, nonpeptidyl small 
molecule agonists of the Hh pathway (Paladini et al., 2005). Conversely, 
telogen skin contains inhibitors of hair growth such as BMP2/4. It has been 
demonstrated that the initiation of anagen requires inhibition of BMP4/BMPRIa 
signalling by noggin. In the telogen hair follicles, BMP4 is produced by dermal 
papilla fibroblasts and keratinocytes of the matrix, interacting with BMPRIa, 
which is selectively expressed in the secondary hair germ and therefore 
inhibiting the early onset of anagen development (Botchkarev et al., 2001a). 
Alterations to the growth modulators in the telogen stage may lead to the 
initiation or prevention of anagen. Therefore local balance of growth and 
stimulators and inhibitors in the proximal part of the follicles appears to be 
critical for new growth wave initiation (Botchkarev and Paus, 2003). Greco et al 
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found that in telogen follicles, Fgf7 and Fgf10 are expressed in the dermal 
papilla and act as activators of hair regeneration by stimulating the proliferation 
of hair germ cells and not the bulge during the telogen-anagen transition (Greco 
et al., 2009).  
Kimuara-Ueki M et al showed that Fgf18 is expressed in the stem cell niche 
throughout telogen, and that it regulates the hair cycle through the non-growth 
phases (Kimura-Ueki et al., 2012). When the Fgf18 gene is conditionally 
knocked out in K5 expressing epithelial cells in mice, telogen becomes very 
short, giving rise to a rapid succession of hair cycles. In WT mice, hair follicle 
growth during anagen is strongly suppressed by local delivery of FGF18 protein. 
Their study demonstrated that epithelial FGF18 signalling and its reduction in 
the milieu of hair follicle stem cells are crucial for the maintenance of resting 
and growth phase, respectively (Kimura-Ueki et al., 2012).  
At the end of telogen, the hair germ stabilises β-catenin (Greco et al., 2009). 
Choi et al showed that β-catenin is required within bulge and secondary hair 
germ cells for anagen initiation, with the deletion of β-catenin in K15 promoter-
active bulge and secondary hair germ cells preventing follicles from progressing 
through anagen (Choi et al., 2013). Recently, Xing et al demonstrated that 
Wnt5a may inhibit the telogen-anagen transition to maintain a quiescent state of 
hair follicle stem cells (Xing et al., 2013). They showed that Wnt5a is expressed 
in cells of the bulge and secondary hair germ of telogen follicles. 
Overexpression of Wnt5a in the dorsal skin of mice led to a prolonged telogen 
stage and inhibition of anagen induction. However, after an extended period of 
time, four pelage hair types grew from hairless skin that was induced by Wnt5a, 
producing hair shafts with a normal phenotype. They showed that the 
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expression of β-catenin and some target genes of canonical Wnt signalling 
decreased after Wnt5a treatment (Xing et al., 2013). 
Many signalling pathways work in tandem to regulate stem cell activity and are 
vital in the transition from telogen-to-anagen. The activation of stem cells from a 
quiescent state leading to proliferation and differentiation is a complex process, 
with the factors involved still being elucidated. Pathways which have been 
shown to be critical to these processes are the Wnt and BMP pathways. 
Although the cells of the telogen bulge exist in a Wnt restricted environment 
(DasGupta and Fuchs, 1999), they do however express transcriptional partners 
of β-catenin allowing them to process Wnt signals. In the quiescent bulge, Tcf3, 
a transcriptional cofactor of β-catenin, promotes stem cell quiescence and 
prevents differentiation in the absence of Wnt ligand (Nguyen et al., 2006). Also, 
Tcf4 along with Tcf3 promote self-renewal of stem cells of hair follicles and the 
epidermis during wounding (Nguyen et al., 2009). In the telogen-anagen 
transition in adult hair follicles, when β-catenin is continually expressed in 
resting stem cells, hair follicles precociously enter the anagen phase, 
implicating its role in activating bulge stem cells (Lo Celso et al., 2004; Lowry et 
al., 2005; Van Mater et al., 2003).  
BMP signalling has also been shown to be important in the regulation of bulge 
stem cells. BMP signalling represses bulge cell proliferation and the loss of 
BMP signalling results in premature bulge cell activation (Blanpain et al., 2004; 
Kobielak et al., 2007). Plikus et al showed that cyclic dermal BMP signalling 
regulates stem cell activation during hair regeneration (Plikus et al., 2008). They 
showed that the wave of BMP2 expression is out of phase with Wnt/β-catenin 
signalling, which promotes the activation of stem cells, indicating the balance 
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between Wnt/β-catenin and BMP signalling is important in regulating the 
transition from quiescence to activation (Plikus et al., 2008).   
A recent study by Nakajima et al showed the MED1 (mediator complex subunit 
1) facilitates the maintenance of stem cell quiescence in the epidermis and hair 
follicle (Nakajima et al., 2013). Mice engineered with keratinocyte specific 
ablation of MED1, developed a normal epidermis and appendages and were 
macroscopically and microscopically normal until the second catagen phase of 
the hair cycle. The hair cycle in MED1 null mice was spontaneously repeated 
after the second telogen, which does not occur in WT mice (Nakajima et al., 
2013). In normal mice telogen can last from thirty to sixty days (Muller-Rover et 
al 1999), however in MED1 null mice hair follicles entered the third anagen 
synchronously after only a week after the second telogen. After six months of 
age, MED1 null mice could not enter anagen, leading to sparse hair formation 
(Nakajima et al., 2013). FACS analysis using the bulge stem cell markers CD34 
and integrin α6 found the number of stem cells was similar in 3 week old MED1 
null and wild type mice, but the number of stem cells were reduced in MED1 -/- 
mice at 2 months of age (Nakajima et al., 2013). 
1.6.2 Anagen 
Anagen is the growth phase of the hair cycle and can be divided into 6 stages 
defined by specific morphological criteria (Muller-Rover et al., 2001). Anagen I 
is characterised by the growth of the dermal papilla and onset of mitotic activity 
in the overlying epithelium. During anagen II bulb matrix cells envelop the 
dermal papilla and begin differentiation. At anagen III the bulb matrix cells show 
differentiation into all follicular components. Anagen IV marks the reactivation of 
melanocytes. The hair shaft emerges at anagen V and dislodges telogen hair. 
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The new hair shaft emerges from the skin at anagen VI (Muller-Rover et al., 
2001). It is characterised by rapid proliferation of keratinocytes that ultimately 
leads to the generation of a new hair shaft. During the anagen stage, the 
differentiation of epithelial stem cells leads to at least 8 different cell lines. This 
includes the formation of the outer root sheath, companion layer, Henle’s and 
Huxley’s layers, cuticle of the outer root sheath, cuticle of the hair shaft, shaft 
cortex and shaft medulla (Krause and Foitzik, 2006). The pigmentation and 
synthesis of the hair shaft occurs only during the anagen phase. In humans, 
during the first ten hair cycles in scalp follicles this works optimally, meaning 
until approximately 40 years of age. Subsequently there seems to be a 
genetically regulated exhaustion of the pigmentary potential of each follicle 
leading to greying of hair (Van Neste and Tobin, 2004). In mice the 
pigmentation of skin is coupled to the each stage of the hair cycle (Muller-Rover 
et al., 2001) 
The onset of anagen requires a new lower follicle to be formed, which is 
produced by proliferation of the secondary hair germ. The dermal papilla and 
the overlying follicular epithelium are vital for this process as they activate these 
stem cells from the bulge region during the telogen phase of the hair cycle 
leading to the formation of highly proliferative keratinocytes which generate the 
anagen bulb (Cotsarelis et al., 1990; Paus and Cotsarelis, 1999). During 
anagen, relatively undifferentiated bulge cell progeny migrate down toward the 
dermal papilla and rapidly proliferate. This leads to the generation of transiently 
amplifying matrix cells, which begin to terminally differentiate causing the hair 
follicle to move deeper into the dermis and this movement down leads to the 
formation of the inner root sheath and hair shaft (Cotsarelis et al., 1990). At late 
anagen, the bulb is fully developed and envelops the dermal papilla which is 
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located deep in the subcutis and the hair shaft emerges from the skin (Muller-
Rover et al., 2001). 
Several key pathways are involved in the anagen phase which includes Wnt/β-
catenin, Shh and BMP signalling (Botchkareva et al., 1999; Foitzik et al., 1999; 
Schmidt-Ullrich and Paus, 2005). The ablation of β-catenin not only prevents 
hair follicle morphogenesis but also impairs postnatal hair cycling (Huelsken et 
al., 2001). When β-catenin was ablated after follicles were formed, hairs were 
completely lost after the first cycle (Huelsken et al., 2001). It was shown that 
Wnt10a and b are expressed in postnatal follicles at anagen onset, but are 
absent from follicles in telogen (Reddy et al., 2001). Wnt/β-catenin signalling is 
also required for the differentiation of matrix keratinocytes in generating the hair 
shaft (DasGupta and Fuchs, 1999; Merrill et al., 2001).  
Recently Myung et al showed that Wnt ligands secreted by the hair follicle 
epithelium are required for anagen induction and subsequently adult hair follicle 
regeneration (Myung et al., 2013). The loss of Wls (Wingless) in the follicular 
epithelium resulted in hair cycle arrest. Both the follicular epithelium and dermal 
papilla showed markedly decreased Wnt/β-catenin signalling during anagen 
induction compared with control hair follicles. Surprisingly, hair follicle stem cells 
that are responsible for follicle regeneration maintained expression of stem cell 
markers but exhibited significantly reduced proliferation (Myung et al., 2013). An 
elegant study by Choi et al showed that Wnt/β-catenin signalling is vital for hair 
follicle stem cell proliferation (Choi et al., 2013). Choi et al approached through 
three different methods; the first was through the inducible deletion of β-catenin 
globally in skin epithelia, the second was the deletion of β-catenin only in hair 
follicle stem cells and third only in the interfollicular epidermis and comparing 
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the phenotypes with those caused by the ectopic expression of Dkk1 (Choi et 
al., 2013). The deletion of β-catenin or ectopic Dkk1 expression blocked both 
plucking-induced and spontaneous anagen onset in adult mice. Interestingly 
they found that β-catenin was not required for hair follicle stem cell maintenance 
and follicles resumed proliferating after ectopic Dkk1 was removed, which 
supports findings of the study by Myung et al (Choi et al., 2013; Myung et al., 
2013). 
Although Shh is dispensable for hair follicle induction, it is required for the 
induction of anagen postnatally. Shh is expressed in a polarised manner on one 
side of the matrix named the lateral disk, which gives rise preferentially to the 
inner root sheath (Panteleyev et al., 2001). In mice over-expressing β-catenin, 
irregular patterns of Shh expression was seen on both sides of the hair follicle 
matrix, suggesting that Shh asymmetric expression in the matrix is vital for hair 
follicle polarity (Gat et al., 1998). Sato et al demonstrated that transient, 
localised overexpression of Shh in postnatal skin initiates the onset of the 
anagen growth phase of hair follicles (Sato et al., 1999). The overexpression of 
Shh led to increased follicle size, increased dermal and epidermal depth, 
increased melanogenesis and increased hair growth. These are all consistent 
with changes that occur as mouse skin enters anagen (Sato et al., 1999). When 
Shh is blocked through the administration of a Shh inhibitor, anagen 
progression is blocked (Wang et al., 2000). These studies collectively indicate 
that Shh plays a role in mediating the anagen phase.  
The vitamin D receptor (VDR) has also been shown to be vital for anagen 
induction. VDR null mice undergo normal hair follicle morphogenesis but hairs 
fail to cycle (Sakai and Demay, 2000). Restoration of VDR in the keratinocytes 
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of VDR null mice restores the hair cycle defect which leads to the development 
of alopecia (Chen et al., 2001).  
Insulin-like growth factor 1 (Igf-1) has also been identified in regulating hair 
follicle growth. Transgenic overexpression of Igf-1 in murine skin led to some 
hair follicles becoming elongated and guard hair shafts were longer than wild-
type littermates (Weger and Schlake, 2005). Re-initiation of hair growth during 
the hair cycle was significantly retarded leading to a perturbed hair coat 
phenotype in Igf-1 transgenic mice. The study also revealed that this effect was 
due to the absence of zigzag hairs which adopted an alternative structure. 
Abnormal hair shaft differentiation was seen in Igf-1 transgenic mice and Pdgfra 
was identified as a molecular target of transgene expression. Therefore, Igf-1 
has a mitogenic and morphogenetic function in pelage hair follicle (Weger and 
Schlake, 2005). 
Hair follicle regeneration also requires BMP antagonism, as BMP signalling 
antagonises Wnt and Shh signalling. Recently Oshimori and Fuchs discovered 
that TGF-β2 counterbalances BMP mediated repression in hair follicle stem cell 
activation (Oshimori and Fuchs, 2012). Hair follicle stem cells that could not 
detect TGF-β2 exhibited significant delays in hair follicle regeneration. They 
showed that Tmeff1 was a target gene of the TGF-β2/Smad2/3 pathway which 
restricts and lowers BMP thresholds in hair follicle stem cells (Oshimori and 
Fuchs, 2012).  
 
A study by Yuhki et al also confirmed the findings of Andl et al (Andl et al,. 
2004), and also showed that BMPR1a is not only vital for hair follicle growth 
during development, but also vital for hair follicle cycling and hair shaft 
differentiation during the hair cycle (Yuhki et al., 2004). Using hair specific 
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Bmpr1a knockout mice (Hair-Bmpr1a KO mice), they found abnormal hair 
follicle differentiation and reduced cell growth of interfollicular epidermal cells in 
the foetal skin of these mutant mice (Yuhki et al., 2004). During postnatal 
development, Hair-Bmpr1a KO mice displayed a reduction in the number of hair 
follicles at 2 weeks of age and 10 month old mutant mice were hairless in 
affected regions (Yuhki et al., 2004). They also found that the hair shaft and 
inner root sheath development was severely impaired, with cysts forming at the 
hair canal of mutant hair follicles (Yuhki et al., 2004). In Hair-Bmpr1a KO mice, 
the translocation of β-catenin into the nucleus was significantly reduced in 
anagen follicles during the hair cycle. During the second anagen phase, they 
found abnormality of hair follicles, impaired cell cycling of matrix cells and 
complete hair loss in mutant mice (Yuhki et al., 2004). 
 
1.6.3 Catagen 
Catagen is the dynamic transition between anagen and telogen consisting of 8 
different stages. The catagen phase encompasses highly controlled involution 
of the hair follicle via apoptosis and terminal differentiation (Muller-Rover et al., 
2001).  
During catagen the lower ‘cycling’ region of each hair follicle regresses entirely 
in a process that includes apoptosis of epithelial cells in the bulb and outer root 
sheath, the outermost epithelial layer (Lindner et al., 1997). This regression of 
the hair follicle in catagen is characterised by a cessation of proliferation and 
differentiation of hair matrix keratinocytes, termination of melanogenesis and 
activation of massive apoptosis in the hair matrix (Botchkareva et al., 2006; 
Krause and Foitzik, 2006; Lindner et al., 1997; Mecklenburg et al., 2000). In 
contrast to the outer root sheath and hair matrix there is no programmed cell 
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death in the dermal papilla, at least in part due to the expression of the 
apoptosis suppressor Bcl-2 (Lindner et al., 1997; Muller-Rover et al., 1999). 
Catagen is also characterised by the formation of a club hair that connects the 
proximal part of the hair shaft with the surrounding hair follicle epithelium and 
anchors hair in the telogen hair follicle. During catagen, the dermal papilla is 
transformed into a cluster of quiescent cells in close contact with the regressing 
epithelium, which moves from the subcutis to the dermis/subcutis border to 
contact the distal portion of the follicular epithelium, including the secondary hair 
germ and the bulge (Botchkareva et al., 2006; Muller-Rover et al., 2001).  
One of the important catagen inducers is Fgf5 (Hebert et al., 1994). The 
expression of Fgf5 is seen in the outer root sheath at anagen VI and is 
downregulated just before catagen onset (Hebert et al., 1994; Rosenquist and 
Martin, 1996). Fgf5 null mice have a prolonged anagen phase causing an 
angora phenotype with hair twice as long as normal (Sundberg et al., 1997). In 
addition to Fgf5 other factors known to promote the transition from anagen to 
catagen include epidermal growth factor (EGF), neurotrophins such as brain-
derived neurotrophic factor (BDNF),  NT-3, NT-4 as well as TGFβ-family 
members (Alonso and Fuchs, 2006) 
In mice with a targeted disruption of EGFR (epidermal growth factor receptor), 
follicles have an extended anagen phase (Hansen et al., 1997). Members of the 
neurotrophin family which includes BDNF, NT-3 and 4 and their high affinity 
receptor TrκB were also shown to be regulators of catagen (Botchkarev et al., 
2000; Botchkarev et al., 1999b; Botchkarev et al., 2003). BDNF and NT-4 were 
expressed in the regressing hair follicle compartments, whereas TrkB was seen 
in the dermal papilla, epithelial strand, and hair germ. BDNF or NT-4 knockout 
46 
 
mice showed significant catagen retardation, whereas BDNF-overexpressing 
mice displayed acceleration of catagen and significant shortening of hair length 
(Botchkarev et al., 1999b). Neurotrophins accelerate catagen most likely by 
stimulating the p75 neurotrophin receptor (p75NTR), which is expressed in the 
regressing outer root sheath and is known to mediate apoptosis when activated 
alone (Botchkarev et al., 2000; Botchkarev et al., 2003). Spontaneous catagen 
development was compared in vivo between p75NTR KO and WT mice. There 
was significant catagen retardation in p75NTR KO mice compared to WT 
(Botchkarev et al., 2000). 
The transcription factor p53 mediates a variety of biological responses including 
apoptotic cell death. p53 is strongly expressed and co-localised with apoptotic 
markers in the regressing hair follicle compartments during catagen (Botchkarev 
et al., 2001b). In p53 KO mice there is a significant retardation of catagen 
compared to WT mice, accompanied by significant decrease in the number of 
apoptotic cells in the matrix (Botchkarev et al., 2001b). 
 
TGFβ-1 is also involved in regulating catagen. In TGFβ-1  null mice, hair 
follicles were found to be still in early catagen at postnatal day 18, whereas WT 
mice had entered telogen (Foitzik et al., 2000) . In addition, TGFβ-1 null mice 
displayed a higher number of Ki67 positive cells and fewer apoptotic cells, 
compared to WT.  Inversely, when TGFβ-1 was injected into the back skin of 
mice, it induced premature catagen development, coupled with a decrease in 
proliferating follicular keratinocytes cells and an increase in TUNEL positive 
cells (Foitzik et al., 2000). In CRE-mediated mutation of the gene encoding 
BMPRIa hair follicle matrix cells failed to differentiate towards hair shaft or inner 
root sheath and expression of several known transcriptional regulators of hair 
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shaft and inner root sheath differentiation was decreased or absent. Mutant 
follicles failed to undergo catagen, instead continuing to proliferate to produce 
matricomas and follicular cysts (Andl et al., 2004). 
 
An additional controller of the catagen phase was identified as the hr (hairless) 
gene. The hr gene is responsible for the strong connection between the 
condensing DP and the diminishing hair follicle epithelium in catagen and 
telogen follicles (Panteleyev et al., 2000). The hr transcription factor has been 
shown to be an important regulator of apoptosis in the hair follicle. Apoptosis is 
strongly increased in the hair matrix keratinocytes of hr mutant mice, resulting in 
premature entry of follicles to catagen. This subsequently leads to disintegration 
of the dermal papilla from the follicular epithelium and permanent hair loss 
(Panteleyev et al., 2000). Vitamin D receptor (VDR) gene ablation in mice leads 
to hair loss and the phenotype resembled hair loss caused by mutations in the 
hr gene (Miller et al., 2001), thereby suggesting a common signalling pathway 
for both hr and VDR. Subsequently it was shown that hr protein serves as a 
transcription co-repressor for the VDR. This suggests that interactions between 
hr protein and VDR may contribute to apoptosis in hair follicle matrix 
keratinocytes (Hsieh et al., 2003; Potter et al., 2001)  
Wnt signalling has also been implicated in regulating the catagen phase. 
Recently, using recombinant human Dkk-1, Kwack et al showed that Dkk-1 
promotes catagen progression (Kwack et al., 2012). When Dkk-1 was 
neutralised using an anti-Dkk-1 antibody, catagen progression was delayed 
thus prolonging anagen. This correlated with a decrease in hair follicle length, 
whereas anti-Dkk-1 antibody led to an increase in hair follicle length (Kwack et 
al., 2012). 
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1.6.4 Exogen 
Considered to be independent from the rest of the hair cycle, the process of 
shedding hair is now recognised as a phase termed exogen. The exogen phase 
centres on the release of club fibre and any signalling or structural changes that 
may control the process of the club fibre being released (Higgins et al., 2009; 
Stenn, 2005).  It is the least understood phase and there are currently two 
hypotheses regarding the process of shedding the club fibre. The first is that it is 
a passive process and that the shedding of club fibre is by caused by 
mechanical force by the new emerging hair shaft which pushes out the club 
fibre. The second is that it is an active process which is regulated through 
signalling which controls the breakdown of club fibre and its surrounding 
epithelial sac, leading to the club fibre being released (Higgins et al., 2009). A 
study by Milner et al suggests that the theory of club fibre being physically 
pushed out by a new growing hair fibre is unlikely (Milner et al., 2002). Using 
microscopy, examination of hair shafts shed and plucked telogen hair shafts 
reveal distinct morphological differences in the bases. In shed hairs the base of 
the hair fibres have sculpted edges and are bordered by cell membranes with 
deteriorating nuclei, whereas plucked telogen hairs have a smooth edged 
border and are rich in cells with intact nuclei and with separation fractures within 
basal cell cytoplasm (Milner et al., 2002). The morphology of the base of the 
hair suggests that exogen involves a proteolytic event occurs in the cells of the 
telogen shaft. Studies in desmoglein-3 knockout mice showed that these mice 
retain hair shafts for longer, reiterating the importance of adhesion molecules 
and programmed cell death in the retention and release of club fibres (Koch et 
al., 1998)   
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Figure 1.6. The Hair Cycle. The hair cycle consists of three different phases: 
anagen (growth phase), catagen (regression phase) and telogen (quiescent 
phase). In order to continuously renew hair follicle growth to replace the hair 
that degenerated and was released, it requires a limitless supply of stem cells, 
which are located in the bulge. Periodically, upon initiation of a new anagen, 
division of stem cells provides proliferative progeny that are directed by the 
dermal papilla to differentiate and form a new hair shaft. IRS, inner root sheath 
(blue); ORS outer root sheath. Adapted from Fuchs 2001. 
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1.7  Hair Follicle Stem Cells 
Adult stem cells have the unique trait of generating differentiated cell types 
within the tissue in which they exist and are considered to have the ability to 
indefinitely self-renew in order to maintain the stem cell pool. These properties 
of stem cells allows them to maintain tissue homeostasis as well contribute to 
regeneration after injury (Blanpain and Fuchs, 2009; Cotsarelis et al., 1990). 
The hair follicle shows dynamic, morphological changes throughout adult life, 
regenerating in continuous cycling bouts. As a result of these changes, it has 
long been hypothesised that the hair follicle should possess a niche of stem 
cells that are relatively quiescent and function as a reservoir of stem cells for 
the hair cycle. In fact this cyclical process of growth and regression which 
occurs throughout a lifetime is largely governed by the presence of multipotent 
epithelial stem cells which reside in a specific niche referred to as the ‘bulge,’ a 
name first coined over a century ago (Stohr 1903). This niche provides the ideal 
microenvironment, including neighbouring cells and molecular signals, from 
where these hair follicle stem cells regulate not only hair growth, but also tissue 
homeostasis and wound repair (Fuchs, 2008). The accessibility of hair follicles 
makes their stem cell population, located in this specific niche, an attractive 
model for studying adult stem cells. These adult stem cells are characterised by 
their slow-cycling nature, thought to help maintain their stemness and more 
specifically their ability to self-renew and remain undifferentiated throughout a 
lifetime. In maintaining normal homeostasis, stem cells often exit their niche and 
progress to become transit-amplifying cells, undergoing rapid divisions before 
committing to terminal differentiation (Fuchs, 2008; Myung and Ito, 2012).  
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In 1990, a breakthrough study by Cotsarelis et al, determined that slow-cycling, 
label retaining cells (LRCs) in murine hair follicles, were located at the bulge 
identifying that this was the niche in which epithelial stem cells reside 
(Cotsarelis et al., 1990). By utilising 3H-thymidine ‘pulse’, which labels newly 
synthesised DNA, the labelled DNA becomes diluted as TA cells rapidly divide, 
leaving stem cells which rarely divide with traceable levels of the label. An 
elegant study by Tumbar et al using tetracycline regulated histone H2B linked to 
GFP (green fluorescent protein) also demonstrated the location of LRCs. After 
mice were continuously fed Tetracycline to suppress expression H2B-GFP, only 
slow cycling bulge were detected as H2B-GFP LRCs (Tumbar et al., 2004). 
They also showed that during anagen, newly formed GFP-positive stem cells 
originating from the bulge, form the outer root sheath, the cells of the hair matrix 
and inner root sheath, indicating their origins in the bulge of the outer root 
sheath. When skin was wounded, these GFP-labelled stem cells exited the 
bulge, migrated, and proliferated to repopulate the infundibulum and epidermis 
(Tumbar et al., 2004). Another study by Oshima et al showed that in bulge cells 
traced with a lacZ reporter gene in mice, bulge-derived cells migrate to the 
matrix of the follicle during anagen and contribute to all cell layers of the hair 
follicle (Oshima et al., 2001). Clonogenic assays carried out in dissected bulge 
from rat whiskers showed the highest colony-forming efficiency in comparison to 
keratinocytes of the matrix (Kobayashi et al., 1993). Although bulge stem cells 
are multipotent and can differentiate into all epidermal lineages as 
demonstrated by implantation into immunodeficient mice and are involved in the 
homeostasis of hair follicles cells below the sebaceous gland, they do not 
contribute to the formation of the sebaceous gland and interfollicular epidermis 
under normal physiological conditions (Levy et al., 2005; Morris et al., 2004). 
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However, under conditions such as wounding, bulge stem cells contribute to the 
reepithelialisation of the interfollicular epidermis (Cotsarelis et al., 1990; Jaks et 
al., 2008; Nowak et al., 2008; Tumbar et al., 2004). 
Identifying molecular markers that are bulge-specific has provided a more in 
depth characterisation of bulge stem cells. These markers encompass cell 
surface markers, integrins, keratins and transcription factors. Hair follicle stem 
cells express the integrins α6β4 and α3β1, K5, K14 and K15, CD34 and Lgr5. 
(Blanpain et al., 2004; Morris et al., 2004; Tumbar et al., 2004). The 
identification of CD34 as a bulge stem cell marker allowed bulge cells to be 
characterised in cell culture, where CD34 positive cells showed enhanced 
colony forming ability as well as the reconstitution of hair follicle and 
interfollicular epidermis (Blanpain et al., 2004; Trempus et al., 2003; Trempus et 
al., 2007). K15 was initially shown to be expressed in the bulge in human 
follicles (Lyle et al., 1998).  It was identified as a marker after in vivo lineage 
tracing experiments showed that the progeny of K15 positive stem cells 
contributed to all epithelial lineages of the hair follicle (Morris et al., 2004). 
Lhx2, a downstream target of Shh, was one of the first stem cell markers found 
to be expressed specifically in embryonic placodes in addition to stem cells of 
the bulge in postnatal hair follicles. Lhx2 has been shown to have a key role in 
hair follicle stem cell maintenance and activation. Loss-of-function mutations of 
Lhx2 has shown to lead to formation of fewer number of hair follicles, but with 
the presence of more active stem cells, which are unable to maintain stem-cell 
characteristics in mouse skin (Fuchs, 2007; Rhee et al., 2006). Recently 
Folgueras et al demonstrated that Lhx2 regulates a significant number of hair 
follicle stem cell signature genes and cytoskeletal and adhesion molecules 
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within the hair follicle stem cell niche (Folgueras et al., 2013). Surprisingly, the 
reason they found as to why Lhx2 loss leads to baldness was not due to 
exhaustion of hair follicle stem cell proliferative activity or blocking Wnt 
signalling at the niche base, but that the loss perturbs hair follicle stem cell 
polarisation and niche architecture. Without Lhx2, the niche can no longer 
anchor its hair and maintain the proper behaviour of its stem cells (Folgueras et 
al., 2013).  
When the transcription factor Sox9 (sex determining region Y)-box 9 is 
conditionally ablated postnatally in the skin, the expression of the bulge stem 
cells marker CD34 is lost and hair follicles fail to cycle (Vidal et al., 2005). When 
Sox9, which is originally expressed in suprabasal cells of the hair follicle 
placode and later in the bulge, is ablated in the embryo, hair morphogenesis 
ceases, sebaceous glands fail to form and bulge cells fail to form  (Nowak et al., 
2008). In addition to these markers, hair follicle stem cells can also be identified 
by other markers which include Nestin (Li et al., 2003), Tcf3 (Nguyen et al., 
2006), Nfatc1 (Horsley et al., 2008), Lgr6 (Snippert et al., 2010) and Gli1 
(Brownell et al., 2011). 
Although a definite hair follicle stem cell marker in the mouse has not been 
determined, in the human hair follicles several bulge stem cell markers have 
been identified, in particular CD200 positive cells show a high-colony forming 
ability (Ohyama et al., 2006). In addition, K15 was found to be preferentially 
expressed in the bulge of human hair follicles (Cotsarelis, 2006). Overall, bulge 
stem cells can be dependably identified and thus studied via their slow-cycling 
feature, their location and the existence of a wide variety of molecular markers. 
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Until recently, the bulge was considered the most vital epithelial stem cell pool 
required for follicular regeneration. However, the distinct structure which sits 
above the dermal papilla in the telogen follicle referred to as the secondary hair 
germ is now recognised as a distinct niche itself. Ito et al examined 
morphogenesis of the telogen bulge and secondary hair germ during catagen 
after inducing anagen via depilation. Using BrdU pulse-chase they determined 
almost all label uptake occurred by hair follicle epithelial cells during early 
anagen. As anagen progresses the label was confined to the upper outer root 
sheath corresponding to the bulge area, but the label became undetectable in 
the proliferating lower matrix cells (Ito et al., 2004). In the telogen phase, the 
bulge of the telogen follicle and the secondary hair follicle consisted mainly of 
label retaining cells, demonstrating that the bulge of telogen follicle and the 
secondary hair germ are regenerated by label retaining cells of anagen follicles 
(Ito et al., 2004). Greco et al also showed this in the spontaneous hair cycle 
(Greco et al., 2009). They demonstrated using BrdU pulse-chase, that during 
early hair follicle regeneration the first cells to incorporate BrdU are cells of the 
secondary hair germ, followed by bulge stem cells, suggesting a two-step 
mechanism of hair follicle regeneration (Greco et al., 2009). 
In contrast to the bulge, the cells of the secondary hair germ do not express 
CD34 or Nfatc1 but are rich in P-cadherin positive cells (Greco et al., 2009). 
The G-protein coupled receptor Lgr5 is expressed on keratinocytes of the 
secondary hair germ, in the telogen bulge and the lower outer root sheath of 
anagen follicles (Jaks et al., 2008). The expression of Lgr5 overlaps with CD34 
and K15 in the telogen follicle, from the lower bulge to the secondary hair germ. 
Although Lgr5 positive cells seldom include LRCs and actively proliferate at 
anagen onset, they behave as fully functional stem cells in vitro and in vivo thus 
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supporting the coexistence of quiescent and active stem cells (Jaks et al., 2008; 
Li and Clevers, 2010). 
The bulge also acts a source of stem cells for the sebaceous gland. The 
sebaceous gland is a terminally differentiated structure that is a part of the 
pilosebaceous unit.  It buds from the upper outer root sheath, residing above 
the bulge. Differentiated sebocytes produce and secrete lipid-rich sebum into 
the hair canal that is excreted onto the skin surface (Alonso and Rosenfield, 
2003). In mice, the stem cells that give rise to the sebaceous gland are located 
in the central isthmus, directly above the bulge and are marked by the presence 
of Lgr6 positive cells (Snippert et al., 2010). Lineage tracing revealed that this 
population of Lgr6 positive cells are multipotent and can also produce the hair 
follicle and the interfollicular epidermis (Snippert et al., 2010). Horsley et al 
discovered a population of cells within the sebaceous gland that expressed 
Blimp1 (B lymphocyte-induced maturation protein 1) (Horsley et al., 2006). They 
showed that when Blimp1 expression is suppressed, abnormally large 
sebaceous glands form, with enhanced pools of slow-cycling progenitors and 
proliferative cells, in addition to increased c-Myc expression (Horsley et al., 
2006).  
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Figure 1.7. Stem cell populations of the hair follicle. Hair follicle stem cells 
reside in the bulge, while a pool of progenitor cells, which forms the secondary 
hair germ, is situated directly below the bulge and in contact with the 
mesenchymal dermal papilla. Other epithelial cell populations exist in defined 
anatomical tissue compartments located above the bulge. The hair follicle niche 
displays a pronounced molecular heterogeneity, which is evident by the 
distribution and level of expression of various genes Adapted from Rompolas 
and Greco (2014).  
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1.8 MicroRNAs 
MicroRNAs (miRNAs) are a class of small, approximately 22nt long, non-coding 
RNAs that control diverse biological functions by promoting degradation or 
inhibition of translation of target mRNAs (Ambros, 2004; Bartel, 2004). Since 
the initial discovery of the first miRNA lin-4 in C.Elegans in 1993 (Lee et al., 
1993) thousands of miRNAs have been discovered in unicellular eukaryotes, 
plants and animals signifying the vital role that miRNAs play in gene regulation 
(Siomi and Siomi, 2010). The initial discovery of the first miRNA lin-4 in 1993 
did not set a precedent for research into the world of miRNAs. It was several 
years later when research carried out by Craig Mello and Andrew Fire 
describing the phenomena of RNA interference (RNAi) (Fire et al., 1998), which 
led them to receiving the Nobel Prize in Physiology or Medicine in 2006. Using 
the C. Elegans model they found that a few molecules of dsRNA were sufficient 
to reduce the expression of a specific mRNA (Fire et al., 1998). A second 
miRNA, let-7, which controls the larval development of C.elegans was 
discovered by Reinhart el al several years later (Reinhart et al., 2000). These 
two small RNAs lin-4 and let-7 were initially named as small temporal RNAs 
(stRNAs) (Pasquinelli et al., 2000) due to their involvement in the control of 
development and were renamed as miRNAs in 2001 (Lagos-Quintana et al., 
2001). Other types of small RNAs have also been found in plants and animals, 
which include endogenous small interfering RNAs (siRNAs) (Ambros et al., 
2003; Reinhart and Bartel, 2002) and Piwi-interacting RNAs (piRNAs) (Aravin et 
al., 2007). Although miRNAs fall into the phenomenon of RNAi, they differ from 
other small RNAs in their biogenesis. miRNAs form distinct hairpin structures 
(Bartel, 2004),  whereas other endogenous small RNAs are derived from much 
longer hairpins that produce a wider range of small RNAs (siRNAs), or from 
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precursors without any suspected double-stranded feature (piRNAs) (Bartel, 
2009). 
miRNAs are now recognised as fundamental players in biological processes 
from development, cell proliferation, differentiation, maintenance of stem cells to 
apoptosis (Abbott et al., 2005; Cheng et al., 2005; Yi et al., 2008). 
Approximately 800 miRNA genes have been identified in the human genome, 
which is ~3% of the number of protein-coding genes and it is estimated 
approximately 30% of genes may be regulated by miRNAs. Thus miRNAs 
constitute one of the most abundant classes of gene-regulatory molecules (Krol 
et al., 2010). It is widely acknowledged that miRNAs control the expression of 
genes through Watson-Crick base pairing to the 3’- untranslated region (3’-
UTR) of target mRNAs and inhibiting protein synthesis by either translational 
repression or degradation (Krol et al., 2010; Siomi and Siomi, 2010). 
 
1.8.1 MicroRNA Biogenesis 
The biogenesis of miRNAs is evolutionary conserved and involves sequential 
endonucleolytic cleavages mediated by two RNase II enzymes Drosha and 
Dicer (Cullen, 2004). Transcription of microRNAs is one of the main regulatory 
steps in miRNA biogenesis. The first step in microRNA biogenesis begins with 
transcription by RNA polymerase II, however some miRNAs are transcribed by 
RNA polymerase III (Borchert et al., 2006). Mapping of the promoters of 175 
human miRNA genes through nucleosome positioning and  ChIP-on-chip 
analysis suggests that the characteristics of miRNA gene promoters such as 
frequencies of CpG islands, TATA box, initiator elements and histone 
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modifications are similar to those of protein coding genes (Corcoran et al., 
2009; Ozsolak et al., 2008).  
miRNAs are generally classified as “intergenic” or “intragenic” depending on 
their location in the genome. Intergenic miRNAs are known to be transcribed as 
independent transcription units, while intragenic miRNAs are believed to be 
processed from the introns of their hosting transcription units and hence share 
common regulatory mechanisms and expression patterns with its host gene 
(Ramalingam et al., 2014) 
Figure 1.9. Genomic organisation of microRNAs. A) MicroRNAs can be 
transcribed from intergenic regions which are distinct from known transcript 
units. (B) They can be transcribed as a cluster of primary transcripts with a 
shared promoter. (C) Intragenic miRNAs are found in the introns of annotated 
genes, both coding and non-coding and are transcribed from the same 
promoter as their host genes. (D) Intragenic miRNAs can also be transcribed as 
a cluster of miRNAs. 
 
Transcription by RNA pol II leads to the generation of primary microRNA (pri-
miRNA), which are hairpin structures generally several thousand nucleotides 
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(Figure 1.10). The initial step of microRNA processing is catalysed in the 
nucleus by the RNase III enzyme, Drosha (Denli et al., 2004; Lee et al., 2003; 
Zeng et al., 2005). Drosha cleaves at the base of the stem loop structure of the 
pri-miRNA to generate a ~60-100 nt hairpin pre-miRNA structure, with a 
characteristic 2 nt overhang at the 3’ end (Lee et al., 2003). Drosha forms a 
large complex known as the ‘microprocessor complex’ located in the nucleus 
and contains two RNase-III domains and an amino-terminal segment (Lee et al., 
2003). This complex consists of Drosha and its cofactor DiGeorge Syndrome 
Critical Region 8 (DGCR8), a protein containing two dsRNA-binding domains, 
which cleave pri-miRNAs to form pre-miRNAs (Chen and Meister, 2005; 
Gregory et al., 2004; Han et al., 2004). DGCR8 functions at least in part by 
binding to the junction between the single-stranded RNA and double-stranded 
region of the pri-miRNA stem in order to direct Drosha cleavage ~11 bp away 
from the region (Figure 1.10) (Han et al., 2006). 
Pre-miRNAs are approximately 70nt long with one to four nt 3’ overhangs, 25-
30 bp stems and relatively small loops. Drosha also generates either the 5’ or 3’ 
end of the mature miRNA, depending on which strand of the pre-miRNA is 
selected by RISC (Lee et al., 2003). After cleavage by Drosha, the pre-miRNA 
is transported out of the nucleus via interaction with Exportin-5 (Exp5) and Ran-
GTP. Exp-5 interacts with dsRNA longer than 14 bp and has been shown to 
bind directly and specifically to correctly processed pre-miRNAs (Lund et al., 
2004; Yi et al., 2003)  
Once in the cytoplasm, the pre-miRNA undergoes further processing by Dicer, 
which cleaves the pre-miRNA to an approximately 22nt long miRNA duplex 
(dsRNA product). The two strands of the duplex are separated with one strand, 
61 
 
known as the guide strand goes on to produce the mature miRNA, whereas the 
other passenger strand (miRNA*) is degraded. The mature miRNA associates 
with an Argonaute protein within the large protein complex RISC (RNA-induced 
silencing complex) forming the  miRNA-induced silencing complex (miRISC), 
where it acts as a guide to repress target mRNAs by binding to specific regions 
in the 3’-untranslated region (3’-UTR) (Fig 1.10) (Flynt and Lai, 2008; Schwarz 
et al., 2003). Although the exact mechanisms behind the targeting process of 
the miRISC complex are not fully understood, a key factor in targeting mRNAs 
is base pairing between nucleotides 2-7 of the miRNA transcript known as the 
‘seed region’ and the 3 UTR’ of target mRNA (Lewis et al., 2005).  
Similarly to Drosha, Dicer also has a double stranded binding protein, known as 
TRBP (the human immunodeficiency virus transactivation response RNA-
binding protein). Association of TRBP with Dicer enhances Dicer stability and 
processing activity (Haase et al., 2005). It was found that the Dicer-TRBP 
complex had a close association with the RISC complex. The knockdown of 
TRBP leads to Dicer destabilisation and subsequent loss of miRNA biogenesis 
(Chendrimada et al., 2005). 
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Figure.1.10 Biogenesis of MicroRNAs. miRNAs are initially transcribed in the 
nucleus by RNA polymerase II (RNA Pol II) as a long, capped and 
polyadenylated primary-microRNA (pri-miRNA). The Drosha complex, 
(consisting of Drosha and DGCR8) crops the pri-miRNA into a hairpin-shaped 
precursor-miRNA which is further processed by the Dicer complex (consisting of 
Dicer and TRBP). Following processing by the Dicer complex, the resulting 
miRNA:miRNA* is disassociated and the mature miRNA is incorporated into the 
RISC (forming the miRISC complex). Here it functions to mediate gene 
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silencing either by translational inhibition or by promoting the degradation of 
target mRNAs. Adapted from Gurtan and Sharp 2013. 
 
1.8.2 RISC complex 
The association of Dicer with several other proteins in a complex termed the 
RISC-loading complex (RLC) allows the tight coupling of Dicer cleavage to the 
incorporation of miRNA into the RISC (Chendrimada et al., 2005). After 
cleavage of the pre-miRNA by Dicer the outcome is the formation of an unstable 
dsRNA composed of the active guide strand (miRNA) and the passenger 
(miRNA*) strand. Selection of the miRNA strand which is incorporated into the 
RISC can be regulated in a cell-type and tissue-specific manner. An example of 
this is miR-30e-3p (termed 3p as it originates from the 3’ arm of the pre-miRNA 
transcript) which is expressed in the stomach whereas miR-30e-5p (from the 5’ 
arm) expression is expressed more specifically in the spleen (Ro et al., 2007). 
 The Argonaute family of proteins, consisting of Ago-1-4 are the primary 
components of the RISC complex and the effectors of miRNA mediated 
repression of target mRNAs (Hutvagner and Simard, 2008). Whilst all of the 
Ago proteins have the ability to interact with miRNAs and siRNAs, Ago2 is the 
only one with RNA cleavage activity and is thought to play a critical role in 
miRNA mediated mRNA silencing (Hutvagner and Simard, 2008). The total 
level of Ago proteins within cells also contributes to global miRNA biogenesis 
and regulation. When Ago proteins are ectopically expressed, it results in a 
significant increase in mature miRNAs (Diederichs and Haber, 2007).  
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1.8.3 Posttranscriptional Regulation of Gene Expression 
Depending on the complementarity to which miRNA binds to target genes, there 
are two possible outcomes for the targeted mRNA. One is that the target mRNA 
is cleaved and degraded. The other is translational repression of the target 
mRNA. The outcome of degradation or translational repression depends on the 
complementarity to which miRNA binds to target genes. For example in plants, 
the majority of miRNAs bind with near perfect complementarity, leading to 
mRNA cleavage and degradation (Jones-Rhoades et al., 2006). In animals 
however, near perfect complementarity is rare, with the majority of miRNAs 
generally  imperfectly pairing with target miRNAs, with the main characteristic 
being the pairing of the “seed” region with the 3 UTR’ therefore translational 
repression rather than degradation is the outcome (Grimson et al., 2007). The 
majority of bioinformatic prediction programs use this principle for target 
prediction based on seed recognition (Sethupathy et al., 2006). This interaction 
allows a single miRNA to inhibit the expression of hundreds of different mRNAs 
(Lim et al., 2005; Selbach et al., 2008). This unique characteristic contributes to 
the fact that the biological effect of miRNAs relies more on the synergy of 
collective target inhibition. The means by which miRNAs generally function is a 
moderate inhibition of numerous mRNAs, with only unique targets when 
inhibited producing strong phenotypes (Flynt and Lai, 2008). This ability of 
miRNAs makes them a core component of an already complex gene regulatory 
network, ensuring correct levels of protein expression.  
 
 
 
65 
 
1.8.4 Regulation of miRNAs 
The analysis of miRNA promoter regions indicates that miRNA transcription is 
complex as that of protein-coding genes and thus miRNA promoters are under 
the control of transcription factors, enhancers and epigenetic factors such as 
DNA methylation (Breving and Esquela-Kerscher, 2010). Several transcriptional 
factors such as p53, c-Myc and E2F have been identified as regulating the 
transcription of miRNAs. The tumour suppressor gene p53 was found to 
activate the transcription of the miR-34 family by binding to the promoter region 
for this family (Bommer et al., 2007; Chang et al., 2007; He et al., 2007). The 
oncogene c-Myc has been shown to up-regulate the expression of the miR-17-
92 cluster, but also represses a number of miRNAs (Mendell, 2008). 
Transcription factors belonging to the E2F family have also been reported to 
increase expression of several miRNAs (Bueno et al., 2010). miRNAs, such as 
the ones encoded by the mir-106b-25 or mir-15b-16-2 clusters were found to be 
induced by E2F1 or E2F3 in mouse embryonic fibroblasts. Using siRNA for 
E2F1-knockout or E2F3-knockdown in cell culture these miRNAs were 
downregulated, suggesting the functional relevance of these transcription 
factors in the control of these small RNAs (Bueno et al., 2010). 
Recent evidence has emerged that miRNAs themselves are regulated by other 
classes of RNA. Endogenous RNAs also referred to as competitive endogenous 
RNA (ceRNA), as they influence each other’s levels by competing for the same 
pool of miRNA. ceRNA encompasses several types of RNA which includes 
pseudogenes, long noncoding RNA (lncRNA) and circular RNA (circRNA) (Bak 
and Mikkelsen, 2014). Work by Poliseno et al investigating the lncRNA tumour 
suppressor pseduogene PTENP1, brought into view that its biological function 
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maybe to act as a ‘decoy’ through sequestration of miRNAs to affect their 
regulation of expressed genes (Poliseno et al., 2010) . The 3’ UTR of PTENP1 
mRNA has 95% identity with the 3’ UTR of PTEN and contains sites for five 
miRNAs: miR-19, 21, 17-5p/20, 26 and miR-214 which carry conserved binding 
sites in the 3’ UTR of PTEN. The ability to bind to the same regulatory miRNA 
sequences that normally target the mRNA of the PTEN tumour suppressor gene 
prevents the down-regulation of PTEN mRNA and allowing its translation to 
protein (Poliseno et al., 2010). 
More recently, circular RNAs (circRNA) were discovered to act as natural 
‘miRNA sponges’ (Hansen et al., 2013). Hansen et al showed that a circRNA 
acts as a sponge for miR-7, thus named it as circular transcript for miR-7 (ciRS-
7). They observed 73 conserved binding sites for miR-7 in this circRNA and 
found it strongly represses miR-7 activity resulting in the upregulation of miR-7 
targets (Hansen et al., 2013) 
1.9 microRNAs in the Skin and Hair Follicle 
microRNA mediated regulation adds another dimension of gene regulation in 
controlling protein output. The significance of this additional level of regulation in 
skin development and homeostasis is unravelling, and began with several 
studies that targeted key components of miRNA biogenesis.  
Dicer is one of the key enzymes in processing miRNA to produce functional 
mature miRNA. Dicer knockout in mice leads to the arrest of mechanisms 
triggered by mature miRNA, consequently leading to developmental 
abnormalities in many organs causing embryonic lethality, with the embryo 
being aborted at E7.5 before skin development begins (Bernstein et al., 2003). 
Mice lacking DGCR8, which is required by the Drosha enzyme for processing 
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miRNAs, also led to the death of mice during early embryogenesis (Wang et al., 
2007)   
Pioneering studies to uncover a role of miRNAs in the skin showed that 
epidermal-specific deletion of Dicer using CRE-recombinase under the control 
of K14 promoter, eliminated production of all miRNAs, leading to severe defects 
in skin and hair follicle morphogenesis (Andl et al., 2006; Yi et al., 2006). These 
studies also revealed the differences between miRNA-dependent regulatory 
mechanisms required for formation of the epidermis and hair follicle. Dicer is 
present in developing hair placodes, the epidermis and outer root sheath of hair 
follicles (Andl et al., 2006). Hair follicles of newborn Dicer-deficient mice were 
initially underdeveloped and failed to invaginate into the dermis, but rather 
evaginated upward into the epidermis leading to formation of hair cysts (Andl et 
al., 2006; Yi et al., 2006). The failure to form and maintain hair follicles seems to 
be related to the early loss of stem cells, shown by a lack of bulge stem cell 
markers such as K15 and CD34 (Andl et al., 2006). The depletion of Dicer also 
led to the loss of expression of key signalling molecules, for instance Shh and 
Notch1 by postnatal day 7 (Andl et al., 2006). The loss of Notch1 may be 
responsible for the hyperproliferative epidermal phenotype (Proweller et al., 
2006) in Dicer-depleted epidermis. In contrast to the defective hair follicle 
morphogenesis, the interfollicular epidermis remained on the whole unaffected 
and maintained its normal differentiation (Andl et al., 2006; Yi et al., 2006). 
These studies demonstrated the remarkable differences in the formation of the 
epidermis in comparison to the hair follicle and imply that certain miRNA or their 
target genes are specific for follicular stem cells but not for that of the 
interfollicular epidermis. 
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In addition to playing a role in miRNA biogenesis, Dicer is known to process 
other classes of small RNAs. In contrast, its cofactor DGCR8 is considered 
essential for miRNA biogenesis. Following studies of Dicer knockout mice, Yi et 
al utilised mice harbouring a conditional null Dgcr8 allele and crossed them with 
mice expressing K14-Cre (Yi et al., 2009). Mice that were Dicer or DGCR8 
deficient showed indistinguishable phenotypes including evaginated follicles 
and severe defects in epidermal differentiation and barrier formation leading to 
dehydration and neonatal death (Yi et al., 2009). These studies hence establish 
that in skin, the primary function of both proteins is the biogenesis of miRNAs 
that are essential in the development of skin and hair follicles. They 
demonstrate that the loss of miRNA gene expression might differentially impact 
the execution of gene expression programs in distinct keratinocyte populations 
and that miRNAs exhibit a different effect on the follicular epithelium and the 
interfollicular epidermis.  
More recently, an elegant study by Teta et al demonstrated that miRNAs are 
essential for postnatal hair growth (Teta et al., 2012). A knockout of the Drosha 
and Dicer enzymes during the anagen phase prevented hair follicles from 
entering a normal catagen phase, with eventual follicular degradation and stem 
cell loss (Teta et al., 2012). When Drosha and Dicer were deleted in the resting 
telogen phase hair follicles, follicular structure or epithelial stem cell 
maintenance was not affected and anagen induction through plucking of hair 
shafts led to proliferation and formation of a primitive transit amplifying matrix 
population. However, mutant matrix cells exhibited apoptosis and DNA damage 
leading to follicular degradation (Teta et al., 2012). This study revealed multiple 
functions of Drosha and Dicer in suppressing DNA damage in proliferating 
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matrix cells, facilitating the catagen phase of the hair cycle and maintaining 
follicular structure and their associated stem cells.  
Ago proteins, which are vital components of the RISC complex, have also been 
shown to be vital for proper gene regulation. Recently Wang et al found that 
when both Ago1 and Ago2 are ablated together in the skin, the global 
expression of miRNAs is severely compromised causing severe defects in skin 
morphogenesis (Wang et al., 2012a). While these studies reveal that miRNAs in 
general are vital for formation and maintenance of skin and hair follicles, these 
knockout studies represent the loss of large sets of miRNAs and thus do not 
elucidate the significance of individual miRNA deletion in the skin.  
The profiling of miRNA in the cells of epidermal and hair follicle lineages 
revealed their distinct expression patterns in the epidermis and hair follicle. Five 
microRNAs, miR-199a, miR-214, miR-126, miR-143 and miR-152 were 
identified by Yi et al as being widespread in the hair follicle in comparison to 
their presence in the epidermis alone (Yi et al., 2006). The contrast in 
expression of miRNAs reveals the specific spatio-temporal patterns of gene 
silencing during skin development which contributes to the commitment of cells 
to either epidermal or hair follicle cell fate. 
1.9.1 microRNAs in the Skin and Hair Follicle Development 
Several miRNAs have been identified as exerting specific functions in the skin 
(Aberdam et al., 2008; Wang et al., 2013a; Yi and Fuchs, 2010). One particular 
miRNA, miR-205, is involved in regulating epidermal homeostasis and 
regeneration.  Recently Wang et al demonstrated one of the first examples of 
the deletion of single miRNA that causes severe developmental defects and 
compromises the function of skin and hair follicle stem cells (Wang et al., 
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2013a). They showed that miR-205 controls neonatal expansion of skin stem 
cells resulting in neonatal lethality with severe defects in epidermal and hair 
follicle growth (Wang et al., 2013a). The ablation of miR-205 impairs the 
proliferation of interfollicular progenitors, with miR-205 KO progenitors 
displaying significantly reduced proliferation in comparison to wild type, most 
likely contributing to the thinner epidermis in miR-205 KO mice (Wang et al., 
2013a). The proliferation of progenitors and stem cells in hair follicles was also 
compromised. In the hair follicle, BrdU analysis revealed that the hair follicle 
stem cells and outer root sheath progenitors were less proliferative in skin of KO 
mice. In contrast, the transit-amplifying matrix cells were equally proliferative 
between WT and KO mice (Wang et al., 2013a). The high enrichment of miR-
205 in the hair follicle stem cells and outer root sheath but not in matrix cells 
indicates that the miR-205 specifically compromises the proliferation of 
progenitors and hair follicle stem cells (Wang et al., 2013a). A study by Yu et al 
showed that miR-205 is expressed in the epidermis and protects keratinocytes 
from apoptosis by targeting SHIP2 (SH2-containing phospoinositide), enhancing 
the Akt-signalling pathway (Yu et al., 2008). When miR-205 is suppressed in 
keratinocytes, migration is impaired due to cytoskeletal reorganisation, 
reduction in filamentous actin levels and an increase in focal contacts (Yu et al., 
2010). 
Yi et al also showed that one particular miRNA, miR-203, is scarcely detectable 
in mouse epidermis at E13.5 skin (when the skin is still a single layered 
epithelium), but was discovered as one of the most abundant miRNAs after 
embryonic day 15, when stratification begins, suggesting that its expression is 
induced during differentiation and stratification (Yi et al., 2008). In-situ 
hybridisation of mature skin revealed that miR-203 is expressed at high levels in 
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differentiated cells for instance the suprabasal epidermis and the inner root 
sheath of the hair follicle, but not expressed in areas of progenitor or stem cells 
such as the basal layer of the epidermis, in the hair follicle bulge or matrix (Yi et 
al., 2008). Transgenic mice over-expressing miR-203 in the epidermal basal 
layer frequently died shortly after birth and were characterised by a thinner 
epidermis and depletion of K5 positive basal layer cells (Yi et al., 2008). miR-
203 has only limited potential to induce terminal keratinocyte differentiation 
(Lena et al., 2008), signifying that the main function of this miRNA is to restrict 
the epidermal proliferation and induce epidermal differentiation. Thus miR-203 
defines a molecular boundary between proliferation and differentiation in 
suprabasal cells.  
The transcription factor p63 was identified as an important target of miR-203 in 
epidermal keratinocytes (Lena et al., 2008; Yi et al., 2008). During 
embryogenesis p63 initiates epithelial stratification and maintains the 
proliferative potential of keratinocytes in the basal layers of mature epidermis 
(Koster and Roop, 2004). p63 belongs to the p53 family and the p63 gene 
expresses two proteins, one with an amino-terminal transactivation domain 
(TAp63) and one without (ΔNp63).  Each isoform performs a distinct function in 
controlling keratinocyte proliferation and differentiation (Candi et al., 2006). miR-
203 targets the ΔNp63, which is strongly expressed in the basal layer and is an 
essential regulator of stem cell maintenance in stratified epithelial tissues. 
Deletion of p63 in mice results in loss of all stratified epithelium (Senoo et al., 
2007). When stem cells begin to differentiate into stratified epithelium in 
producing the epidermal barrier, miR-203 expression increases to suppress the 
activity of p63. The translational repression of p63 by miR-203 results in the 
inhibition of the proliferative potential of epidermal stem cells. Consequently, the 
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down regulation of p63 allows terminal differentiation to take place (Yi et al., 
2008). This study provides an example of how miRNAs act as mediators, with 
miR-203 ensuring the transition of keratinocytes from proliferative, 
undifferentiated cells to terminally differentiated squamous epithelium. By 
mediating this process of differentiation, miR-203 helps form the vital skin 
barrier required to prevent dehydration and protect underlying organs from 
external threats.  
Recent studies by Amelio et al have shown the importance of another miRNA, 
miR-24, in regulating epidermal differentiation by controlling actin adhesion and 
cell migration, and hair follicle morphogenesis by targeting Tcf-3 (Amelio et al., 
2013; Amelio et al., 2012) . Using human keratinocytes and mouse epidermis, 
they demonstrated that miR-24 directly controls actin cable formation and cell 
mobility. Over-expression of miR-24 in proliferating cells was sufficient to trigger 
keratinocyte differentiation both in vitro and in vivo and directly targeted several 
cytoskeletal modulators (PAK4, Tks5 and ArhGAP19) (Amelio et al., 2012). 
When these targets were silenced the effects were the similar as produced by 
miR-24 over-expression. Restoration of these three targets blocked the effects 
of miR-24 over-expression (Amelio et al., 2012). Transgenic mice over-
expressing miR-24 via K5 promoter resulted in defected hair follicle 
morphogenesis, with thinning of the hair coat and altered hair follicle structure 
(Amelio et al., 2013). They found altered expression of differentiation markers 
and that miR-24 directly represses the hair keratinocyte stemness regulator Tcf-
3 (Amelio et al., 2013). 
 
 
73 
 
1.9.2 MicroRNAs and the Hair Follicle Cycle 
Global miRNA profiling in the skin during the distinct stages of the hair cycle 
revealed diverse changes in expression of over 200 miRNAs (Mardaryev et al 
2010). Although the bulk of these miRNAs were associated with the telogen 
phase of the hair cycle (Mardaryev et al., 2010), several have been shown to be 
vital for hair follicle growth. While the phenotypes observed in conditional 
knockout mice indicate that miRNAs overall are vital for normal hair growth, 
Mardaryev et al demonstrated the significance of an individual miRNA in the 
hair growth cycle (Mardaryev et al., 2010). It was shown that miR-31 is involved 
in regulating the anagen phase in the hair cycle through negative regulation of 
Fgf10, the components of BMP and Wnt signalling sclerostin and BAMBI, Dlx3 
transcription factor, in addition to keratin genes. MiR-31 directly targets K16, 
K17, Dlx3 and Fgf10 (Mardaryev et al., 2010). Inhibition of miR-31 in the early 
and mid anagen phase resulted in accelerated anagen phase and altered 
differentiation of hair matrix keratinocytes (Mardaryev et al., 2010). 
A study by Zhang et al. demonstrated that a subset of miRNAs was 
preferentially expressed in the bulge (Zhang et al., 2011), which is a reservoir of 
multipotent stem cells that give rise to several cell lineages, including 
keratinocytes, sebocytes and the melanocytes (Botchkareva et al., 2001; 
Cotsarelis, 2006; Snippert et al., 2010). Specifically miR-125b is strongly 
expressed in stem cells and dramatically decreased in stem cell progeny and 
was functionally relevant to tissue homeostasis (Zhang et al., 2011). The 
functions of miR-125b were identified by sustaining its expression in K14 
expressing cells where it is normally expressed at low levels, such as the outer 
root sheath and the matrix. Overexpression of miR-125b in skin stem cells and 
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their progeny in transgenic mice resulted in hyperthickened epidermis, enlarged 
sebaceous glands and the development of alopecia. All these effects were fully 
reversible upon restoring normal miR-125b expression (Zhang et al., 2011). 
Two key transcription factors, Blimp1 and Vdr, were identified as are direct 
targets of miR-125b, which function as mediators of the phenotypic properties 
produced in miR-125b transgenic mice (Zhang et al., 2011). Vdr is required for 
hair follicle differentiation (Palmer et al., 2008), whilst Blimp1 is a critical 
regulator of sebaceous gland development (Horsley et al., 2006). Thus it has 
been speculated that by co-ordinately fine-tuning a large number of proteins, 
miR-125b acts as a rheostat to regulate the control of stem cell proliferation, 
differentiation and cell fate (Yi and Fuchs, 2011; Zhang et al., 2011).  
 
1.9.3 MicroRNAs and the Hair Follicle Pigmentation 
The pigmentation of hair follicles occurs through interactions between matrix 
keratinocytes, melanocytes, and fibroblasts of the dermal papilla. These three 
components make up the follicular melanin unit (Slominski et al., 2005).  The 
process of melanogenesis is a multistep process controlled by several key 
enzymes which includes tyrosinase (Tyr), tyrosinase-related protein 1 (Trp1), 
tyrosinase-related protein 2 (Trp2) (Yamaguchi and Hearing, 2009). The 
microphthalmia associated transcription factor (MITF) is the most vital 
transcription factor involved in regulating melanocyte functions (Lin and Fisher, 
2007; Yamaguchi and Hearing, 2009). Levy et al showed that MITF directly 
regulates expression of Dicer, which expression is upregulated during 
melanocyte differentiation (Levy et al., 2010). They showed increased levels of 
Dicer and Mitf in the differentiated melanocytes located in the bulb of anagen 
hair follicles, in comparison to bulge where the melanocyte stem cells reside 
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(Levy et al., 2010). The correlation of Dicer and MITF mRNA expression was 
also investigated via qRT-PCR in primary human melanocytes and expression 
patterns were found to highly parallel.  A knockout model was developed using 
mice harbouring the floxed Dicer allele, bred with mice expressing CRE-
recombinase driven by the tyrosinase promoter. The targeted deletion of Dicer 
in the melanocyte lineage led to loss of epidermal and follicular melanocytes 
and mice subsequently developed a white coat (Levy et al., 2010).The effects of 
Dicer on melanocyte survival were mediated by miR-17, because the 
upregulation of miR-17 correlated with a decrease in expression of the pro-
apoptotic gene BIM. In addition, partial rescue of melanocytes from apoptosis 
caused by loss of Dicer was achieved by BIM knockdown using (Levy et al., 
2010) 
1.9.4 MicroRNAs as Downstream Effectors 
The downstream regulation of miRNAs is also involved in controlling the 
characteristics of skin keratinocytes. A study by Antonini et al showed that p63 
maintains cell cycle progression by directly repressing members of the miR-34 
family (Antonini et al., 2010). When p63 expression was reduced in primary 
mouse keratinocytes using siRNA, increased levels of miR-34a and miR-34c 
was observed, with concomitant cell cycle arrest and inhibition of the cell cycle 
regulators cyclin D1 and Cdk4. Down-regulation of miR-34a and miR-34c 
substantially restored cell cycle progression and expression of cyclin D1 and 
Cdk4, indicating that these specific miR-34 family members have a significant 
role downstream of p63 in controlling epidermal cell proliferation (Antonini et al., 
2010).  
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A study by Ahmed et al identified that BMP4 negatively regulates the 
expression of miR-21 in epidermal keratinocytes and the anti-tumour activity of 
BMPs in the skin is mediated, at least in part via miR-21 target genes, such as 
Pdcd4, Timp1, Pten and Tpm1 (Ahmed et al., 2011). In primary mouse 
keratinocytes transfected with BMP4 the expression of miR-21 was significantly 
reduced in the keratinocytes. Consistent with this finding was the significantly 
increased levels of miR-21 in transgenic mice overexpressing the BMP 
antagonist noggin under control of the K14 promoter. Transfection of primary 
mouse keratinocytes with a miR-21 mimic, led to the identification of the 
existence of two groups of BMP target genes, which are differentially regulated 
by miR-21 (Ahmed et al., 2011). These included selected BMP-dependent 
tumour-suppressor genes (Pten, Pdcd4, Timp3 and Tpm1) negatively regulated 
by miR-21, as well as miR-21-independent Id1, Id2, Id3 and Msx2 that 
predominantly mediate the effects of BMPs on cell differentiation. In primary 
mouse keratinocytes and HaCaT cells transfected with miR-21 mimic, miR-21 
prevented the inhibitory effects of BMP4 on cell proliferation and migration 
(Ahmed et al., 2011) 
Taken together, these studies reiterate the concept that microRNAs play an 
important role in skin and hair follicle biology. The balance of gene expression is 
regulated through the targeting of several signalling pathways by miRNA, in 
distinct skin cell populations, essential for execution differentiated-associated 
gene expression programs and cell communication during development and 
homeostasis. However, more research is required to elucidate the role of 
additional individual miRNAs in controlling gene regulation during hair 
development and cycling, wound response, and skin aging.  
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Research Aims 
Hair follicle development and growth encompass numerous biological 
processes that occur in the human body such as cell proliferation, 
differentiation, migration and apoptosis. Therefore the hair follicle serves as a 
crucial and viable model which transcends hair biology. miRNAs have emerged 
as crucial layer of gene regulation that control various biological functions. In 
recent years, considerable progress has been made in in identifying the 
molecular mechanisms underlying the regulatory functions of miRNAs in skin 
and hair follicle development and growth (Aberdam et al., 2008; Andl et al., 
2006; Yi et al., 2006; Yi et al., 2009). However, the regulatory role of many 
miRNAs in skin and hair follicle homeostasis remains to be elucidated, which 
could provide a greater insight into how biological processes function normally 
and in disorders which arise in the skin and hair follicle. 
 
This project investigates the role for microRNA-214 in hair follicle development 
and cycling. It will be addressed via the following aims: 
(i) To investigate the spatio-temporal expression of miR-214 during hair 
morphogenesis and hair cycling by utilising quantitative PCR analysis and  
in-situ hybridisation 
(ii) To determine the regulatory role of miR-214 on hair follicle development 
and cycling by exploring a phenotype of doxycycline-inducible miR-214 
(K14-rtTA/TRE-miR-214) transgenic mice. How modulation of miR-214 
levels affects proliferation and differentiation will be defined.   
(iii) To determine genome-wide changes in the keratinocyte gene expression 
programme induced by miR-214: microarray analysis, qRT-PCR validation 
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and immunofluorescence analysis will be utilised to compare changes in 
gene expression in the skin and hair follicles of K14-rtTA/TRE-miR-214 
and wild-type mice. 
(iv) To identify miR-214 target genes in the keratinocytes by employing the 
bioinformatic analysis and luciferase reporter assays. 
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2.0 Material and Methods 
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2.1 Animals 
Animal studies were performed under protocols approved by Home Office 
Project Licence (UK) and Boston University (USA). K14-rtTA/TRE-miR-214 
mice were generated on FVB background. Mice had free access to food 
(standard rodent diet) and water. Animal housing was maintained under 
continuous 12-hour light and dark cycles with temperature and humidity at 
21±1°C and 40-60%, respectively. All animal handling and experimentation was 
undertaken by Dr A Mardaryev at the University of Bradford and Dr A Sharov at 
Boston University. 
TRE-miR-214 construct was generated by Dr M Ahmed (University of Bradford). 
To generate TRE-miR-214 construct, DNA fragment, containing the primary-
mmu-miR-214 coding sequence was isolated from pCMV-miR-214 plasmid 
DNA (Origene, USA) followed by blunt-end ligation into the pSTblue-1 vector 
(Millipore, UK). This fragment was then excised and ligated into BamHI-SalI 
sites of the pTRE2-Dual 2 plasmid (Clontech, UK), which contains a pTight 
promoter consisting of a modified minimal CMV promoter, and seven direct 
repeats of a 36 bp regulatory sequence that contains the 19 bp tet-operator 
sequence, mCherry, and an internal ribosome entry site (IRES2) (Figure 2.1). 
All cloning was verified by sequencing. A PspxI fragment from TRE-miR-214 
construct was purified and pronuclear injections were performed in the 
Transgenic Core at the Boston University School of Medicine using FVB/NJ 
mice as a genetic background.  
Founders were identified by PCR using transgene promoter specific DNA 
primers: forward; 5-GTTCATGTACGGCTCCAAG-3 and Reverse; 5-
CGCAGCTTCACCTTGTAG-3. To generate double-transgenic K14-rtTA/TRE-
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miR-214 mice, TRE-miR-214 mice were crossed with K14-rtTA according to 
standard protocols. To activate expression of tet/doxycycline-responsive 
transgenes, mice were fed chow containing 625mg Doxycycline (Dox)/kg chow 
(Bio-Serv). 
 
 
Figure 2.1. Inducible miR-214 transgene construct under control of tetracycline-
response element 
 
2.1.2 Genotyping  
Genotyping was carried out using conventional PCR. Approximately 80 
cryosections of tissue samples, cut 10μm thick in sterile conditions were added 
to a 1.6ml eppendorf tube kept on dry ice. Samples were briefly spun down 
before the addition of 50 mM NaOH (600μl per tube). Samples were placed in a 
water-bath at 90°C for at least 30 minutes to favour tissue degradation and DNA 
extraction. The reaction was inactivated by adding 50μl of 1M TrisHCl (ph 7.6) 
to each tube. Following this samples were mixed using a vortex and spun down 
at 14,000g for 5 minutes at 4°C. 2μl of supernatant containing DNA was then 
used for the PCR reaction. The following amounts were used for each PCR 
reaction: DNA 2μl, Primer Forward (1x) 0.1μl Primer Reverse (1x) 0.1μl dNTPs 
(0.2mM) 0.4μl Taq Polymerase 0.1μl Buffer (5X) 4μl H2O 13.3μl. Following PCR, 
amplified products were detected using gel electrophoresis. Samples were 
subjected to electrophoresis at 100V on 1% agarose gel stained in ethidium 
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bromide. A 1kb molecular weight ladder was used in addition to positive and 
negative controls.  
 For K14-rtTA mouse genotyping, primer sequences were used provided by the 
Jackson Laboratory, including forward primer: oIMR7862 - 5′-
CACGATACACCTGACTAGCTGGGTG-3′ and reverse primer oIMR7863: 5′-
CATCACCCACAGGCTAGCGCCAACT-3.′ For TRE-miR-214 mice, the forward 
primer 5’-AGAACGTATGTCGAGGTAG-3’ and reverse primer 5’ –
TTGGAGCCGTACATGAAC-3’ were used. 
PCR was performed under the following cycling conditions: 94°C for 3 minutes, 
[94°C for 30 seconds, 67°C for 60 seconds, 72°C for 60 seconds] for 35 cycles, 
72°C for 2 minutes) 
 
2.2 Tissue collection 
Tissue samples were collected at several developmental time-points using 
established procedures (Paus et al., 1999). Embryonic and postnatal samples 
were collected after pregnant mice were fed doxycycline at embryonic day 10 in 
order to activate expression of tet/doxycycline-responsive transgenes. Tissue 
samples were collected at embryonic day 15, 17 and 19 (E15, E17, E19). For 
postnatal samples tissue was collected at postnatal days 1 and 8.  
The hair cycle was induced in the back skin of 9-week-old mice by depilation 
using a wax/rosin mixture. At this point follicles are in telogen and the depilation 
of mice induces a new anagen phase across the depilated area (Muller-Rover 
et al., 2001). Before depilation, mice were fed doxycycline continuously for 1 
week and tissue samples were collected at 3, 5, 8 and 12 days post depilation. 
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Harvested skin was embedded in OCT mounting media (Tissue tek, CA, USA) 
and frozen in liquid nitrogen (Paus et al., 1999).  
2.2.1 Isolation and culture of primary mouse epidermal keratinocytes 
Primary mouse epidermal keratinocytes (PMEKs) were prepared from newborn 
mice at postnatal days 2-3. PMEKs were isolated and cultured as described 
previously (Lichti et al., 2008). Mice were euthanized following Home Office 
guidelines, by Dr A Mardaryev. Mouse pups were rinsed in deionised water and 
washed in 70% ethanol twice for 2 minutes.  The following procedures were 
carried out in a laminar-flow cell culture hood with sterilised tools. The limbs of 
the mice were removed at the joints to allow easier removal of skin. The tail and 
genitalia were removed and an incision was made along the dorsal midline and 
the skin was dissected from the body of the mice using forceps. The skin was 
floated dermis side-down in 0.25% trypsin without EDTA overnight at 4°C. 
Following overnight incubation with trypsin, the epidermis was separated from 
the dermis. The epidermis was transferred to a 50ml falcon tube containing 
Eagle’s minimal essential medium (EMEM) (Lonza, Slough, UK) supplemented 
with 4% chelated foetal bovine serum (FBS) (Gibco, UK), 100 units/ml pencillin 
& 100 μg/ml streptomycin, 0.05mM calcium chloride (Sigma- Aldrich), 2x10-9M 
3,3’ 5-triiodo-L-thyronine (T3) (Sigma-Aldrich), 2mM L-glutamine (Gibco, UK), 
0.4μg.ml hydrocortisone, 5μg/ml bovine serum, 10-10 M cholera toxin (Sigma-
Aldrich) and 10ng/ml epidermal growth factor (EGF) (Invitrogen, UK).  The 
epidermis was minced using sterile scissors and a 10ml pipette to release the 
keratinocytes. This was followed by filtration using a sterile 70μm nylon filter 
(BD Biosciences) into a fresh falcon tube to remove cornified sheets. Cell 
culture plates were coated with type I collagen, prepared by coating the base 
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with a solution consisting of Hank’s balances salt solution (HBSS) (Gibco, UK), 
100mg/ml bovine serum albumin (BSA) (Sigma-Aldrich), 1M HEPES pH 6.5 
(Gibco, UK) and 3mg/ml collagen (Invitrogen). The excess collagen solution 
was aspirated and the plates were allowed to dry before plating the PMKs into 
at required density into media. PMEKs were grown in EMEM calcium-free 
medium (Lonza, Slough, UK) supplemented with 0.05 mM calcium, at 33°C, 8% 
CO2 (Scientific Laboratory Suppliers, Hessle, UK) until 60–70% confluent.  
2.2.2 Cell transfection 
PMEKs were transfected with 200 nM synthetic miR-214 inhibitor (anti-miR-
214), miR-214 mimic (pro-miR-214) or miRNA negative controls (Dharmacon), 
using Lipofectamine RNAiMax (Invitrogen, Paisley, UK). Lipofectamine 
RNAiMax and synthetic miRNA mixture was incubated for 20 minutes at room 
temperature in a ratio of 2:1 and subsequently added to PMEKs in antibiotic 
free media and incubated for 4 hours at 33°C, 8% CO2. After 4 hours, media 
was aspirated and complete media was added to the plates. Cells were 
harvested 24 hours after transfection and used for further analysis.  
2.2.3 Luciferase reporter assay. HaCaT cells were grown in Dulbecco's 
modified Eagle's medium (Invitrogen, UK) supplemented with heat-inactivated 
10% FBS in an atmosphere of 5% CO2 at 37°C, until 60–70% confluent. 3′UTR 
fragments of β-catenin and Shh containing miR-214 putative target sites were 
amplified from mouse genomic DNA using forward and reverse primers 
containing XhoI and NotI restriction sequences, respectively. For 3′UTR of β-
catenin fragment 5-CGAGGAGTAACAATACAAATGG-3 and 5-
CAGGTTCACTAGAACATAACAC-3 forward and reverse primers, respectively, 
were used. To amplify a fragment of 3’UTR of Shh 5-
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ATGAACGGACCTTCAAGAGC -3 and 5-GCATAGCAGGAGAGGAATGC -3 
primers were used. The amplified fragments were cloned at XhoI and NotI sites 
downstream of CV40 promoter-driven Renilla luciferase cassette in pCHECK2 
(Promega, UK). Site directed mutagenesis was performed using QuikChange II 
XL Site-Directed Mutagenesis Kit (Agilent Technologies, UK) to mutate β-
catenin binding site following manufacturer’s instructions. For dual luciferase 
assay, these constructs (200 ng) were co-transfected with 200 nM miR-214 
mimic or negative control mimic (Dharmacon) into HaCaT cells using 0.5 μl 
Lipofectamine 2000 (Invitrogen, UK) in 96-well plates. At 24 h after transfection, 
the relative luciferase activities were determined using Dual-Glo Luciferase 
Assay System (Promega, UK). Assay was performed in triplicate for three 
independent trials.  
2.2.4 TOPFlash and FOPFlash Wnt reporter assays. HaCaT cells were 
seeded onto 12-well dishes 24 hours before transfection. At 80% confluency, a 
TOPFlash Wnt reporter plasmid (Addgene plasmid 12456) was transfected into 
each well in combination with i) control oligonucleotide (200 nM), ii) 10μM of 
BIO (R&D Systems, UK), iii) pro-miR-214 (200 nM), and iv) pro-miR-214 (200 
nM) and 10μM BIO. BIO (6-bromoindirubin-3'-oxime) induces Wnt signalling by 
targeting Glycogen Synthase Kinase 3 (GSK3), a component of the β-catenin 
degradation complex (Sato et al., 2004). Transfection was performed using 
Lipofectamine 2000 (Invitrogen). FOPFlash (TOPFlash mutant) reporter plasmid 
(Addgene plasmid 12457) was used as a control. Lipofectamine 2000 and 
plasmid mixture was incubated for 20 minutes at room temperature in a ratio of 
2:1 and subsequently added to HaCats in antibiotic free media and incubated 
for 4 hours at 33°C, 8% CO2. The cells were cultured for 24 hours and relative 
luciferase activities were determined using Dual-Glo-luciferase assay system 
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(Promega, UK) on the Infinite 2000 micro-plate reader. All assays were 
performed in triplicate for three independent trials.  
2.3 RNA Isolation 
2.3.1 Isolation from the skin: 
Total RNA was isolated from snap frozen experimental samples by using TRIzol 
(Qiagen, Crawley, UK). Approximately 100 cryosections of tissue samples cut 
10μm thick in sterile conditions were added to a 1.6ml eppendorf tube kept on 
dry ice. One ml of TRIzol RNA isolation reagent was added to the tissue 
sections and homogenised via vortexing prior to storage at -80°C. RNA was 
isolated following manufacturer’s instructions. RNA samples were thawed out 
for approximately 5 minutes and vortexed to ensure complete homogenisation. 
Following this 100μl BCP (1-Bromo-3-chloropropane) was added and 
thoroughly mixed and incubated at room temperature for 15 minutes. Samples 
were centrifuged at 12,000xG for 15 minutes at 4°C and the aqueous phase 
was transferred to a new eppendorf tube. 500μl of isopropanol was added and 
incubated at room temperature for 15 minutes. Samples were again centrifuged 
for 8 minutes in order to for the RNA to form a pellet. 75% ethanol was added to 
samples followed by centrifugation at 7500xG for 5 minutes. The supernatant 
was removed and the RNA pellet was dissolved in sterile Tris-EDTA buffer.  
2.3.2 Isolation from cells 
Total RNA was isolated from cultured keratinocytes after transfection using 
TRIzol. 1ml was added to each well of a 6 well plate and a sterile cell scraper 
was used to detach cells before being added to a 1.6ml eppendorf and stored at 
-80°C. RNA was isolated as described in 2.3.1. 
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2.3.3 DNase treatment 
In order to reduce genomic DNA contamination, RNA samples were treated 
using Turbo DNase kit (Ambion). 0.1 volume 10X TURBO DNase buffer and 1μl 
TURBO DNase was added to the RNA and mixed gently. Samples were then 
incubated at 37°C for 20-30 minutes. Re-suspended DNase Inactivation 
Reagent was added to the sample (0.1 volume) and mixed well followed by 
incubation for 2 minutes at room temperature, mixing occasionally. Samples 
were centrifuged 10,000xG for 1.5 minutes and RNA was transferred to a fresh 
eppendorf tube. 
2.4. Real Time PCR for detection of miR-214 using TaQman method 
2.4.1 Principle: 
cDNA synthesis of miRNA requires a specialised novel stem loop Reverse 
Transcription (RT) primer during reverse transcriptase reaction. This stem loop 
RT primer overcomes the fundamental problem of miRNA being very short 
(approx. 22nt long). The TaqMan® Assay kit (Applied Biosystems, USA) 
overcomes this problem by extending the 3’ end of the mature miRNA, via 
binding of RT primer, therefore providing a longer reverse transcription product 
suitable for real time PCR (Chen et al., 2005; Schmittgen et al., 2008). 
2.4.2 TaqMan complementary DNA (cDNA) Synthesis: 
RNA was isolated from cells or tissue samples using TRIzol reagent (Qiagen, 
Crawley, UK) as described in 2.3.1 followed by Turbo DNase treatment, as 
described in 2.3.3. cDNA was synthesised using TaqMan® Assay Kit (Applied 
Biosystems, USA) following manufacturer’s instructions. The following reagents 
were used for each reverse transcription: 0.15 μl of 100mM dNTPs, 1μl of 
88 
 
multiscribe reverse transcriptase, 1.5μl 10X reverse transcriptase buffer, 0.19μl 
RNase inhibitor (20units/μl) and 4.6μl water. 7μl of this master mix was 
combined with 5ng of total RNA. This was mixed gently and 3μl of RT primer 
(Applied Biosystems, USA) assay was added to reaction mix followed by brief 
centrifugation. cDNA was synthesised using a Master Cycler gradient machine 
(Eppendorph, Cambridge, UK) under the following cycling conditions: 16°C for 
30 minutes, followed by 42°C for 30 minutes and 85°C for 5 minutes. 
2.4.3 Taqman real-time PCR procedure for miRNA expression 
Expression of miR-214 was determined using TaqMan real-time PCR Assay 
(Applied Biosystems, USA) under the following cycling conditions: 95°C for 10 
min, followed by 40 cycles of: 95°C for 15 s, and 60°C for 60 s. Differences 
between samples and controls were calculated based on the Ct (ΔΔCt) method 
and normalised to the small nucleolar RNA 202 values (SnoRNA) using Genex 
database software (Bio-Rad, UK). SnoRNAs are constitutively expressed 
across all tissues; the use of same assay chemistry and RNA isolation protocols 
makes snoRNAs ideal candidates for normalisation of miRNA expression (Chen 
et al., 2005). Data were pooled, the means ± SD. were calculated, and 
statistical analysis was performed using an unpaired Student's t-test.  
2.4.4 First-strand cDNA qRT-PCR: 
RNA was isolated from the cells or tissue as in 2.3.1. For qRT-PCR, 1μg of 
each RNA sample was used as a template for cDNA synthesis using Reverse 
Transcription synthesis system (Promega, UK). 1μg of RNA was incubated at 
70°C for 10 minutes. The following mixture was prepared on ice: 4μl 20μM 
MgCl2, 2μl of Reverse Transcription buffer 10X, 2μl dNTP mix 10mM, 0.5 μl 
RNase inhibitor, 0.6μl AMV Reverse Transcriptase, 0.5μg of random primers. 
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Final volume was made up 20μl. The mixture was added to the RNA and 
incubated in a thermal cycler with the following conditions: 23°C for 10 minutes, 
42°C for 15 minutes, 95°C for 5 minutes and 4°C for 5 minutes. 
2.4.5 Real-Time PCR procedure: 
qRT-PCR was performed with using Applied Biosystems Fast PCR mix, using 
10ng cDNA and 1μM primers. PCR primers were designed with Beacon 
Designer software (Premier Biosoft International; Table 1). Optimum annealing 
temperature was determined for primers by performing qRT-PCR at five 
different temperatures using mouse reference cDNA: 55°C, 57°C, 59°C and 
61°C and 63°C. Analysis of melting curves was used to determine optimum 
annealing temperature. Amplification was performed using the following 
conditions using StepOnePlus™ System PCR system (Applied Biosystems): 
95°C for 5 minutes, followed by 40 cycles of denaturation (95°C for 15 
seconds), annealing (30 seconds at temperature experimentally determined for 
each primer pairs) and elongation (72°C for 15 seconds). For each gene of 
interest, qRT-PCR was performed in triplicates. Differences between samples 
and controls were calculated using Ct (ΔΔCt) equitation method and normalised 
to the beta-actin. Beta-actin (β-actin) is frequently and constitutively expressed 
in most tissues and cells, thus referred to as a housekeeping gene. 
Table 1: List of primer sequences for qRT-PCR 
Gene 
Accession 
number Sense Sequence Anti-sense Sequence 
β-actin (ACTB) 
NM_007393 TTCCAGCCTTCCTTCTTG GGAGCCAGAGCAGTAAT
C 
β-catenin 
(Ctnnb1) 
NM_001165
902 
GCCACCAAACAGATACAT
AC 
CCTCTCAGCAACTCTACA
G 
Cyclin 
dependent 
kinase inhibitor 
2a 
NM_009877 
 
GCTCTTTGTGTTCCGCTG 
 
CTCTGCTCTTGGGATTGG 
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(Cdkn2a/p16) 
Cyclin 
dependent 
kinase inhibitor 
2d 
(Cdkn2d/p19) 
NM_009878 GGCTCCTACAGGCAACA
G 
TAGATGGCTCACACTTCA
GG 
Cyclin D1 
(Ccnd1) 
NM_007631 GAGACCATTCCCTTGACT
GC 
GAAATGAACTTCACATCT
GTGGC 
Cyclin D2 
(Ccnd2) 
NM_009829 GGATGCTAGAGGTCTGT
GAGG 
CCAACACTACCAGTTCCC
AC 
Cyclin B1 
(Ccnb1) 
NM_172301 ATAATCCCTCTCCAAGCC
CG 
CTGCTCTTCCTCCAGTTG
TC 
Cyclin 
Dependent 
Kinase 1 
(CDK1) 
NM_007659 ATCAGACTTGAAAGCGA
GGA 
GGTGTAAGTAACTCTTAA
CGAGTG 
Ectodysplasin 
receptor (Edar) 
NM_010100 
 
GCCCCACCGAGTTGCCG
TTT 
CCAGCCGCTCGATCTGC
ACC 
Lymphoid 
enhancer 
binding factor1  
(Lef-1) 
NM_001276
402 
 
ACTCCAAGCAAGGCATG
TC 
GGGTGATCTGTCCAACG
C 
Patched 2 
(Ptch2) 
NM_008958 
 
TCCGCACCTCATATCCTA
GC 
CTGTCTCAATTACAGCCA
CTCG 
Smoothened 
(Smo) 
NM_176996 GCTGGAGTAGTCTGGTT
CGT 
GAGTCTCCATCTACCTGA
GCC 
Sclerostin 
domain 
containing 1 
(Sostdc1) 
NM_025312 CTTCCTCCTGCCATTCAT
CTC 
GAACTCGACTGTTTCGAT
CCAG 
Sonic 
Hedgehog 
(Shh) 
NM_009170 GTTTATTCCCAACGTAGC
CGA 
 
CTTGTCTTTGCACCTCTG
AGTC 
 
 
 
2.5 Microarray 
Newborn K14-rtTA/TRE-miR-214 and WT mice were treated with doxycycline 
for 48 hr to induce miR-214 expression. Back skins were harvested and treated 
with dispase at 37°C for 30 min to obtain epidermis and hair follicle epithelium. 
Total RNA was isolated by TRIzol (Sigma) and processed for microarray 
analysis by using 41K Whole Mouse Genome 60-mer oligo-microarray (Agilent 
Technologies, Mogen, St. Louis, MO). Microarray data was validated using 
qRT-PCR from RNA samples of K14-rtTA/TRE-miR-214 and WT mice. 
Microarray gene expression data from K14-rtTA/TRE-miR-214 mice was 
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normalised to corresponding data from WT mice and functionally annotated by 
Dr K Poterlowicz at University of Bradford. Fold changes in gene expression 
were determined as a ratio of normalised expression values. 
2.6 In situ hybridization  
For miRNA detection, skin cryosections (10 μm) were fixed in 4% 
paraformaldehyde for 10 minutes at room temperature. After acetylation in 
triethanolamine buffer (4.5 mM triethanolamine, 6M HCl and 3 mM acetic acid 
anhydride) for 10 minutes and premobilisation (1% Triton X-100/1xDEPC 
treated phosphate buffer-saline) for 30 minutes, slides were hybridised with 2.5 
pmol DIG-labelled miR-214 probe (Exiqon, Copenhagen, Denmark) diluted in 
hybridization buffer (50% formamide DI, 2× SCC, 1% dextran sulfate, and 0.4 
mg/ml t-RNA) for 16-18 h at 55°C overnight. Slides were subsequently washed 
in 2x SCC (4 times, 10 minutes each at 67°C), 0.1x SCC (60 minutes at 67°C), 
0.2x SCC (10 minutes at Room Temperature). Immunodetection of miR-214 
was performed with sheep alkaline phosphatase conjugated anti-DIG antibody 
(1:5000; Roche, Germany) for 3 hours at room temperature, followed by a 
staining reaction with nitro-blue tetrazolium (NBT) and 5-bromo-4-chloro-3'-
indolyphosphate (BCIP) solution (Roche, Germany) for 16-18 hours at room 
temperature. Slides were washed twice using PBS, 5 minutes for each wash, 
before being mounted with mounting media. 
2.7 Immunohistochemistry 
For immunohistochemistry, tissue sections were fixed in either 4% PFA for 10 
minutes at room temperature or acetone for 10 minutes at -20°C. Tissue 
sections stained with phospo-H3 were additionally permeabilised with 100% 
methanol at -20°C for 10 minutes, followed by blocking in 10% donkey serum 
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for 1 hour. Primary antibodies used in this study are listed in Table 2. 
Cryosections were incubated with primary antisera overnight at 4°C, followed by 
application of corresponding Alexa-555-labelled or Alexa-488-antibodies 
(Invitrogen; diluted 1:200) for 1 hour at 37°C. Only primary antibody was used 
for a negative control. Incubation steps were interspersed by four washes with 
phosphate buffer-saline (PBS), 5 minutes each wash. Sections were counter 
stained with DAPI (4', 6-diamidino-2-phenylindole) in mounting media (Vector 
Labs). Image preparation and analysis were performed using a fluorescent 
microscope in combination with DS-C1 digital camera and ACT-2U image 
analysis software (Nikon, Tokyo, Japan). Confocal images were captured using 
the Zeiss LSM 510 Meta Confocal Microscope.  
Table 2: Primary Antibodies 
Antigen Host Dilution Source 
β-Catenin Rabbit 1:2000 Abcam, UK 
CD34 Goat 1:200 BD Pharmingen, UK 
Cytokeratin 10 Rabbit 1:500 Abcam, UK 
Cytokeratin 14 Guinea Pig 1:500 Acis, USA 
Dlx3 Goat 1:500 Santa Cruz, USA 
Edar Goat 1:500 R&D Sytems 
Ki67 Rabbit 1:100 Abcam, UK 
Lef-1 Rabbit 1:100 Cell signalling, UK 
Lhx2 Goat 1:200 Santa Cruz, USA 
Loricin Rabbit 1:100 Abcam, UK 
Phospho-histone H3 
(Ser28) Rabbit 1:100 Cell Signalling, UK 
Phospho-Smad 1/5/8 Rabbit 1:500 Abcam, UK 
Sox9 Rabbit 1:250 Santa Cruz, USA 
Shh Rabbit 1:100 Santa Cruz, USA 
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2.8 Alkaline phosphatase staining 
For morphological assessment of skin sections, alkaline phosphatase (AP) 
staining was performed. In the skin, alkaline phosphatase is strongly expressed 
by fibroblasts within the dermal papilla; hence it is a useful tool to identify stages 
of follicular development and cycling (Handjiski et al., 1994). For alkaline 
phosphatase staining cryosections (10μm) were fixed in 4% PFA for 10 minutes 
at room temperature and then washed twice in PBS, 5 minutes for each wash. 
Slides were then incubated in developing solution (100 mM NaCl pH 8.3, 100 
mM Tris, pH 9.5 and 20 mM HCL, 0.05% Naphtol ASBI phosphate, 0.5% DMF, 
25 mM Sodium Nitrite and 5% new fuchsin) for 15 minutes at room temperature, 
followed by counterstaining with haematoxylin for 1 minute at room 
temperature. Slides were washed in running water and mounted. 
2.9 Histomorphometry and statistical analysis.  
Histomorphometry analysis of hair follicles was performed using every tenth 
cryosection of dorsal skin of K14-rtTA/TRE-miR-214 and wild-type mice in order 
to exclude the repetitive evaluation of the same hair follicle. The number of hair 
follicles per mm of epidermal length was calculated using sections from dorsal 
skin of K14-rtTA/TRE-miR-214 and WT samples at the different developmental 
points, including E17.5, P0.5, and P8.5 days (n=3 per each experimental 
group).  
Proliferation in the epidermis was assessed by the calculation of the number of 
Ki67+ cells to the DAPI+ cells in 50-60 microscopic fields. Proliferation in the 
hair follicle was assessed by calculating the ratio of pH3(Ser28)+ to DAPI+ cells 
per hair bulb in 50 to 60 hair follicles of either K14-rtTA/TRE-miR-214 or WT 
mice. Hair bulb diameter was measured across the widest part of the bulb 
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(critical line of Auber) derived from three animals per experimental and control 
group. Altogether, 200–350 follicles in 50–60 microscopic fields, derived from 
three K14-rtTA/TRE-miR-214 animals from distinct time points were analyzed 
and compared to a corresponding number of hair follicles from the appropriate, 
age-matched wild-type mice.  
For the assessment of the hair shaft length and width, hair were plucked from 
the back skin of K14-rtTA/TRE-miR-214 (n=4) and wild-type mice (n=4) at P22, 
i.e., in the telogen phase of the hair cycle. Quantitative analysis of the different 
types of the hair shafts produced in dorsal skin (guard, awl, auchene and 
zigzag) was done by the analysis of approximately 250 plucked hair shafts 
using morphological criteria as described previously (Sharov et al., 2006)  
The percentage of hair follicles in different stages of hair cycle was assessed 
and calculated in K14-rtTA/TRE-miR-214 at day 3 and 5 post depilation- 
induced hair cycle, respectively, as well as in their corresponding wild-type 
littermates. All evaluations were performed on the basis of accepted, well-
defined morphologic criteria of hair follicle classification (Muller-Rover et al., 
2001).  
Comparative analysis of Sox9+ cells was done by evaluating the ratio of the 
number Sox9+ to DAPI+ cells in the outer root sheath (from the distal end of the 
bulb to the sebaceous duct). In total, 50 to 60 follicles of either WT or K14-
rtTA/TRE-miR-214 mice were included in the analysis. Data were pooled, the 
means ± SD. were calculated, and statistical analysis was performed using an 
unpaired Student's t-test. 
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3.0 Results 
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3.1 miR-214 exhibits discrete expression patterns in the epidermis and 
hair follicles in developing and postnatal skin 
To understand a role of miR-214 in the control of skin morphogenesis and hair 
follicle cycling, miR-214 expression was initially examined in mouse dorsal skin 
at different developmental stages. qRT-PCR analysis revealed low levels of 
miR-214 expression in embryonic skin at day 14.5 (E14.5) during onset of the 
hair follicle development, whilst its expression was dramatically elevated in the 
skin of newborn mice (Fig. 3.1 a). High miR-214 expression levels were 
maintained in the skin until postnatal day 12 (P12), whilst during transition to 
catagen (P16-17), its expression decreased and remained low during 
subsequent telogen phase (P20-22) (Fig. 3.1 b).  
In situ hybridisation analysis showed that in E14.5 skin, miR-214 expression 
was first seen in the supra-basal epiermal layers followed by more homogenous 
distribution among the distinct epidermal layers at E17.5 (Fig. 3.1 c). Hair 
follicle placodes also showed miR-214 expression during all stages of 
embryonic skin development (Fig. 3.1 c).  During more advanced stages of hair 
follicle morphogenesis (P0.5-P3.5), miR-214 expression predominated in the 
supra-basal epidermal layers and throughout the epithelium of stage 3-6 hair 
follicles (Fig. 3.1 e), while in fully developed hair follicles, miR-214 expression 
significantly increased in the developing hair matrix and individual cells of the 
outer root sheath (Fig. 3.1 f).  
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Figure 3.1.  Relative and spatio-temporal expression of miR-214 during 
hair follicle morphogenesis. (a) TaqMan qRT-PCR of miR-214 expression: 
low levels of miR-214 in embryonic skin at day 14.5 (E14.5), significant 
increase of miR-214 in the skin of newborn mice at postnatal day 0.5 (P0.5); 
(b) high expression of miR-214 in the anagen-like stage (P12), expression 
decreases during catagen (P16-17) and low levels of expression in telogen 
skin (P20-P22); (c-f) In-situ hybridisation of miR-214 during hair follicle 
morphogenesis: (c) in E14.5 skin, miR-214 is detected in the supra-basal 
layers of the epidermis (arrow); (d) miR-214 is expressed in the developing 
hair placodes at E17; (e) during more advanced stages of morphogenesis 
(P0.5), miR-214 is throughout the epithelium of stage 3-6 hair follicles 
(arrow); (f) miR-214 expression in the epidermis (arrowheads), and in the 
developing hair matrix (arrows) and individual cells of the outer root sheath 
(small arrows) in fully developed hair follicles (stage 8, P3.5), **P value<0.02, 
Unpaired students t-test; n=3. Scale bar 50μm.
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3.2 miR-214 shows discrete expression patterns in the epidermis and hair 
follicles during the hair cycle 
In order to produce a synchronised hair follicle cycle, the established method of 
depilating hair follicles from the dorsal skin of 7 week-old mice, when all hair 
follicles are in telogen, was utilised (Muller-Rover et al., 2001). Removing hair 
shafts immediately induces homogenous anagen development over the entire 
depilated region. Skin was initially harvested at the telogen stage 
(unmanipulated skin) followed by anagen II [3 days post depilation (dpd)], 
anagen IV (5 dpd), anagen VI (8-12 dpd) and catagen (17-19 dpd).  
qRT-PCR analysis revealed similar fluctuations in miR-214 levels in adult skin 
during depilation-induced hair cycle: miR-214 expression progressively 
increased during hair follicle transition from telogen to anagen and was maximal 
during late anagen stage of the hair cycle (day 12 post depilation) followed by 
rapid decrease during catagen (Fig. 3.2 a).  
In situ hybridisation showed that during the hair follicle cycle, miR-214 
expression was restricted to the secondary hair germ of the telogen follicles 
(Fig. 3.2 b), while during early anagen phase miR-214 expression appeared in 
the growing hair matrix, the outer root sheath and in the bulge area (Fig. 3.2 c). 
In fully developed anagen follicles, miR-214 was prominently expressed in the 
hair matrix, as well as in the distinct cells of the outer root sheath (Fig. 3.2 d). 
During catagen, miR-214 expression was seen in the regressing hair matrix, 
outer root sheath and in the epithelial strand of the mid-catagen hair follicle, 
whilst its expression disappeared from the epithelial strand at the advanced 
catagen stages (Fig. 3.2 e). These data suggest that miR-214 shows discrete 
expression patterns in the selected epithelial compartments of the skin.   
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Figure 3.2. Relative and spatio-temporal expression of miR-214 during 
hair follicle cycling. (a) TaqMan qRT-PCR of miR-214 during depilation-
induced hair cycle: expression of miR-214 increases during telogen-anagen 
transition and reaches maximal levels during late anagen (12 dpd), followed 
by a decrease during catagen (17 dpd); (b-e) In-situ hybridisation of miR-214 
during depilation-induced hair cycle: (b) miR-214 was detected in the 
secondary hair germ of telogen follicle (arrow); (c) In mid-anagen hair 
follicles, miR-214 is expressed in the matrix (arrow), the outer root sheath 
(small arrow) and the bulge (arrowhead); (d) In late anagen, prominent 
expression of miR-214 was detected in the hair matrix (arrows), in the outer 
root sheath (small arrows); (e) In catagen, miR-214 is expressed in the 
regressing hair matrix (arrow), the outer root sheath (small arrow) and in the 
epithelial strand of the mid-catagen hair follicle (arrowhead); in advanced 
catagen hair follicles, miR-214 expression disappears from the epithelial 
strand (asterisk), scale bar 50μm. Abbreviations: dpd - days post-depilation 
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In the epidermis, it is predominantly localised in the supra-basal epidermal 
layers, while considerably weaker expression is detectable in the basal 
epidermal layer. In the hair follicle, it is prominently expressed in the stem cells 
(secondary hair germ) and their lineage committed progenies in the outer root 
sheath and hair matrix.  
3.3 Generation of K14-rtTA/TRE-miR-214 transgenic mice  
To further elucidate the role of miR-214 in skin and hair follicle development, 
Krt14-driven over-expression in mice was used as a model. In order to amplify 
the miR-214 effects on epithelial progenitor cell population (basal epidermal 
layer, hair follicle outer root sheath), where miR-214 was relatively under-
expressed compared to more differentiated keratinocytes of suprabasal 
epidermal layer or hair follicle matrix (Fig. 3.1 c, d; Fig. 3.2 b, c, d), mice 
overexpressing miR-214 under the control of doxycyclin-inducible Krt14-
promoter (K14-rtTA/miR-214-TRE or double transgenic, DTG) were generated. 
Mice were genotyped using conventional PCR. The K14 and miR-214 primers 
were designed specifically for the promoter region that was integrated into the 
genome for transgenic mice. The primers were then used to characterise wild 
type and K14-rtTA/TRE-miR-214 transgenic mice. These primers only bind to 
specific regions used to generate transgenic mice; therefore samples that 
produced bands for both K14 and miR-214 indicated successful amplification of 
the miR-214 target sequence by the transgene promoter construct. Mice 
samples that produced no bands for both sequences were classed as wild type 
(Figure 3.3 a). To validate further, expression of transgene was determined by 
qRT-PCR and immunofluorescence. Induction of transgene by doxycycline 
(Dox) starting from day 10 of embryonic development (E10.5), which 
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corresponds to the onset of K14 expression in the developing epidermis (Byrne 
et al., 1994), caused a significant increase in the level of miR-214 in the skin of 
DTG mice, which was confirmed by qRT-PCR (Fig. 3.3 b). Transgene activation 
was also confirmed by the detection of a red fluorescent transgenic reporter 
mCherry, which was a part of the transgenic construct. mCherry fluorescence 
was seen in the basal epidermal layer of DTG mouse skin at E15.5, whilst it 
was undetectable in the epidermis of WT mice (Fig. 3.3 c).
3.4 K14-rtTA/TRE-miR-214 mice exhibited less visible hair shafts in 
comparison to WT littermates 
WT and DTG littermates were given doxycycline from embryonic day 10 and 
photographed at postnatal day 15 (P15) (Fig. 3.4 a).  DTG mice were viable, 
fertile and looked similar to their WT littermates at birth. However, as mice 
started to produce the visible hair shafts, DTG mice could be easily 
distinguished by the appearance of a “rough” fur coat, in contrast to WT mice 
producing a normal ‘smooth’ fur coat. (Fig. 3.4 b).
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Figure 3.3 Genotyping of wild type and K14-rtTA/TRE-miR-214 
transgenic mice. (a) Mice were genotyped using conventional PCR. 
Samples that produced bands for both K14 and miR-214 indicated successful 
amplification of the transgene promoter construct and were characterised as 
DTG. Samples that did not produce any bands were classed as WT. The gel 
also contains a negative control of FVB mice selected from a different litter of 
mice and a positive control from a previously identified K14-rtTA/TRE-
miR-214 mouse. DTG mice samples are circled; (b) TaqMan qRT-PCR: 
significant increase of miR-214 levels in the skin of DTG mice (**P<0.02, 
unpaired students t-test; n=3); (c) mCherry fluorescence in the epithelium of 
DTG mice indicating activation of miR-214. Abbreviations: WT –wild type, 
DTG – double transgenic mice 
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Figure 3.4. Photograph of wild-type and K14-rtTA/TRE-miR-214 mice at 
postnatal day 15. (a) Schematic illustration of the experimental design;    
(b) K14-rtTA/TRE-miR-214 (DTG) mice, exhibited a ‘rough’ fur coat, 
whereas wild-type mouse shows an appearance of a ‘smooth’ fur coat. 
a 
	


	
b

104 
3.5 K14 driven overexpression of miR-214 results in a thinner epidermis 
and reduced epidermal proliferation in DTG mice compared to WT 
littermates 
Histomorphological analysis of epidermal thickness during distinct 
developmental time points revealed that epidermis of DTG mice was 
significantly thinner during early stages of morphogenesis (E15.5 and P0.5) as 
well as upon a completion of  hair follicle morphogenesis (P8) (Fig. 3.5 a).  To 
assess whether it was due to the differences in proliferation and/or 
differentiation, expression of a marker of proliferation Ki-67 and the markers of 
epidermal differentiation Keratin 14, Keratin 10 and Loricrin was analysed. 
Ki-67 expression was visibly reduced in the epidermis of DTG mice (Fig. 3.5 b).  
Quantitative analysis of the number of Ki67 positive cells in the epidermis 
suggested a significant reduction in the number of Ki67 positive cells in DTG 
mice compared to WT controls at early embryonic developmental stages 
(E15.5) as well as at the latest points of postnatal development (P8.5) (Fig. 3.5 
c) 
The expression of K14 in basal and K10 and Loricrin in supra-basal epidermal 
layers in DTG mice were quite similar to WT epidermis (Fig. 3.5 d, e), 
suggesting that miR-214 over-expression does not alter epidermal 
differentiation. 
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Figure 3.5. Analysis of epidermal development in wild-type and K14-
rtTA/TRE-miR-214 mice. (a) Histomorphological analysis of epidermal 
thickness in WT and DTG mice; a significant reduction in thickness in DTG 
mice at E15.5, P0.5, P8.5; (b) Immunodetection of marker of proliferation 
Ki-67: visible decrease in the number of Ki-67+ cells in the epidermis of 
E14.5 skin; (c) Quantitative analysis of Ki-67+ cells in the epidermis of WT 
and DTG mice: significant reduction in Ki-67+ cells at E15.5 and P8.5 in the 
epidermis of DTG mice; (d-e) Immunodetection of markers of differentiation 
(K14, K10 and Loricrin) in E14.5 skin: no visible differences between 
expression of K14, K10 and Loricrin in WT and DTG mice at E15.5. (*P 
value<0.05, **P<0.02, unpaired students t-test; n=3). Scale bar 50μm. 
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3.6 Over-expression of miR-214 causes an inhibitory effect on hair follicle 
morphogenesis
Histomorphological analysis of dorsal skin of DTG mice revealed a visible 
reduction in the number and size of hair follicles during all developmental points 
(Fig. 3.6 a).  The overexpression of miR-214 caused a reduction of 
approximately 30% of hair follicle placodes in the back skin of DTG mice 
compared to WT littermates at embryonic day 15 (Fig. 3.6 b).The number of 
induced hair follicles was also significantly decreased in DTG mice at E17.5, 
P0.5 and P8 compared to WT controls (Fig. 3.6 c). This suggests that miR-214 
over-expression alters the process of induction in both primary and secondary 
hair follicles 
To analyse whether overexpression of miR-214 affected the rate of hair follicle 
development, stages of hair follicle  morphogenesis were quantified according 
to established morphological criteria (Paus et al., 1999) (Fig. 3.6 d). 
Quantification of hair follicle stages at embryonic day 19.5 during hair 
morphogenesis revealed the majority of hair follicles were in stages 2-4 in both 
WT and DTG mice (Fig. 3.6 d). Therefore, overexpression of miR-214 does not 
affect the rate of hair morphogenesis in DTG mice compared to WT littermates. 
At postnatal day 8 all hair follicles in DTG mice reached the first anagen-like 
phase similarly to WT controls (Fig. 3.6 a). In addition, a total skin thickness 
was significantly reduced in the skin of DTG mice to WT littermates (Fig. 3.6 e). 
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Figure 3.6. Overexpression of miR-214 exerts an inhibitory effect on 
hair follicle morphogenesis. (a) Microphotographs of histology of back 
skin; visible reduction in the number of hair placodes and hair follicles from 
embryonic day 15 to postnatal day 8; (b) quantitative analysis of the number 
of hair placodes at embryonic day 15 per mm of epidermal length; significant 
reduction in DTG mice compared to WT littermates; (c) quantitative analysis 
of the number of hair follicles per mm of skin from embryonic day 17.5 to 
postnatal day 8.5; significant reduction in the total number of hair follicles in 
DTG mice compared to WT littermates; (d) quantification  of hair follicle at 
the different stages of morphogenesis at embryonic day 19.5 in WT and DTG 
mice using established morphological criteria (Paus et al. 1999); no 
significant difference between WT and DTG mice; (e) analysis of total skin 
thickness at postnatal day 8. (*P value<0.05,**P<0.02,***P<0.001, unpaired 
students t-test.) 
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In contrast to WT hair follicles, epithelial portion of the fully developed anagen-
like hair follicle was significantly shorter in the skin of DTG mice at postnatal day 
8 (Fig. 3.7 a). 
To determine if reduced number of the hair follicles seen in the miR-214 
overexpressing  mice were due to the under developing of the specific hair 
follicle type, the proportion of  guard, awl, auchene and zigzag follicles was 
evaluated in DTG and WT mice. Hair shafts were plucked from WT and DTG 
mice at postnatal day 20 for analysis (Fig. 3.7 b). The plucked hair shafts were 
separated by different types and counted in order to determine the proportion of 
each hair type in WT and DTG mice. Analysis revealed the proportions of the 
guard, awl, auchene and zigzag hair shafts in DTG mice were similar to those in 
WT mice (Fig. 3.7 c). However analysis of hair shaft thickness revealed a 
significant decrease in the thickness of guard, awl, auchene and zigzag hairs in 
DTG mice compared to WT littermates (Fig. 3.7 d), whereas no significant 
difference in the shaft length between WT and DTG mice was detected (Fig. 3.7 
e).
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Figure 3.7 Analysis of different hair follicle types in wild-type and K14-
rtTA/TRE-miR-214 mice. (a) Analysis of hair follicle length at postnatal day 
8 in WT and DTG mice; significant reduction in the length of DTG hair 
follicles compared to WT; (b) microphotographs of hair shaft types (guard, 
awl, auchene and zigzag) plucked from mice at postnatal day 20; visible 
reduction of hair shaft thickness of all hair shaft types in DTG mice 
compared to WT; (c) quantification of hair shaft types in WT and DTG mice; 
no significant difference between WT and DTG mice; (d) morphometric 
analysis of hair shaft thickness plucked from mice at postnatal day 20; 
significant reduction of hair shaft thickness in all hair shaft types in DTG 
mice compared to WT; (e) morphometric analysis of hair shaft length at 
postnatal day 8; no significant difference between WT and DTG mice. 
(mean ± SD, **P value<0.02, ***P<0.001, unpaired Student’s t-test); 
Abbreviations: G-guard, Aw-awl, Ach-auchene, Z-zigzag
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3.7 Over-expression of miR-214 causes a reduction in the hair bulb size 
To assess the effect of miR-214 overexpression on proliferation of hair bulb 
keratinocytes during hair follicle morphogenesis, immunofluorescence  of pH3 
(Ser28) was performed at postnatal day 8 (Fig. 3.8 a, b). Quantification of pH3 
(Ser28) positive cells revealed a significant reduction in proliferating cells in the 
hair bulbs of DTG mice compared to WT littermates (Fig. 3.8 b).
To analyse effects of miR-214 overexpression on hair bulb size, the diameter of 
hair bulbs was measured across the widest area (critical line of Auber) in WT 
and DTG mice at postnatal day 8 (Fig 3.8 d). Analysis of hair bulb diameter 
revealed a significant reduction in the diameter of the hair bulbs of DTG mice 
compared to WT littermates (Fig. 3.8 d). 
Analysis was also carried out to determine whether miR-214 overexpression 
affects the dermal papilla of hair follicles. Quantification of the number of dermal 
papilla cells was performed in WT and DTG mice at postnatal day 8 (Fig. 3.8 e).
Quantitative analysis revealed a significant reduction in the number of dermal 
papilla cells in the hair follicles of DTG mice compared to WT littermates (Fig. 
3.8 e).  
To further analyse possible causes of decreased proliferative activity due to 
miR-214 overexpression, qRT-PCR analysis of Cdkn2d and Igf-1 was 
performed in postnatal day 8 skin (Fig 3.8 f, g). Cdkn2d (p19) is a cyclin-
dependent kinase inhibitor, which inhibits the activity of cyclins preventing 
progress of the cell cycle (Hirai et al., 1995). Igf-1 is crucial for proper hair shaft 
differentiation and was shown to have a mitogenic and morphogenetic function 
in pelage hair follicle (Weger and Schlake, 2005). qRT-PCR analysis of Cdkn2d 
revealed a significant increase in DTG mice compared to WT littermates (Fig 
111 
3.8 f).  qRT-PCR analysis of Igf-1 revealed a significant decrease in DTG mice 
compared to WT littermates (Fig 3.8 g).
To further investigate the possible effects of miR-214 overexpression on the 
dermal papilla, qRT-PCR analysis of Fgf7 and Fgf10 in skin of mice at postnatal 
day 8 was performed (Fig. 3.8 h). Fgf7 and Fgf10 are expressed in the dermal 
papilla and can stimulate the proliferation of adjacent epithelial cells of the hair 
follicle and are also required for hair shaft differentiation (Greco et al., 2009;
Schlake, 2005). qRT-PCR analysis revealed no significant difference in levels of 
transcripts of Fgf7 and Fgf10 in WT and DTG mice at postnatal day 8, 
suggesting that miR-214 overexpression does not alter the expression of these 
genes (Fig. 3.8 h). 
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Figure 3.8. Analysis of hair follicle size in wild-type and K14-rtTA/TRE-
miR-214 mice at postnatal day 8. (a-b) Immunofluorescence analysis of pH3 
(Ser28) to mark proliferating cells in the hair bulbs; visible reduction in pH3 
(Ser28)+ cells in the hair bulbs of DTG mice compared to WT littermates at 10X 
and 40X magnification (a-b), respectively; (c) quantitative analysis of 
pH3(Ser28)+ cells per hair follicle bulb: significant reduction in the number of 
pH3(Ser28)+ cells in DTG mice compared to WT; (d) measurement of hair bulb 
diameter: significant reduction in DTG mice compared to WT; (e) quantification 
of dermal papilla (DP) cells per hair bulb: significant reduction in the number of 
dermal papilla cells in the hair bulbs of DTG mice compared to WT; (f) qRT-PCR 
analysis of Cdkn2d: significant increase in Cdkn2d transcript levels in the skin of 
DTG mice compared to WT littermates; (g) qRT-PCR analysis of Igf-1: 
significant decrease in Igf-1 mRNA in the skin of DTG mice compared to WT 
littermates; (h) qRT-PCR analysis of Fgf7 and Fgf10; no significant difference in 
expression of Fgf7 and Fgf10 between WT and DTG mice (mean ± SD,***P 
value<0.001,**P<0.02 unpaired Student’s t-test; n=3). Scale bar 50μm. 
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3.8 Overexpression of miR-214 causes a reduction in the stem cell marker 
Lhx2 
To further elucidate the phenotypic properties of DTG mice, 
immunefluorescence analysis of the stem cell marker Lhx2 was performed at 
postnatal day 8 (Fig. 3.9). Lhx2 immunoreactivity was noticeably reduced in 
DTG hair follicles compared to WT hair follicles (Fig. 3.9). Fewer Lhx2 positive 
cells were seen in the bulge and the outer root sheath in the follicles of miR-214
overexpressing mice compared to the WT littermates (Fig. 3.9). These data 
indicate that overexpression of miR-214 may have a negative impact on stem 
cells and their activity. 
Taken together, the changes in visual coat appearance in K14-rtTA/TRE-miR-
214 DTG mice are the result of the reduced number of the hair follicles and the 
decreased hair shafts thickness, associated with the development of smaller 
follicles in size due to the inhibited proliferation and stem cell activity, 
Figure 3.9. Analysis of the stem cell marker Lhx2 in the hair follicles at 
postnatal day 8. Immunofluorescence analysis of Lhx2 (red): visible 
reduction of Lhx2 in the outer root sheath and bulge of DTG hair follicles 
compared to WT.  
Blue nuclear counterstaining with DAPI. Scale bar 50μm. 
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3.9 Gain of miR-214 activity in postnatal skin alters hair follicle cycling 
and hair follicle size 
To explore the effects of miR-214 on hair follicle cycling, DTG mice were treated 
with Doxycyclin during telogen phase followed by the induction of a 
synchronised hair cycle by depilation (Fig. 3.10 a). In order to analyse effects 
on the hair cycle, microphotographs of the histology of back skin of WT and 
DTG mice at days 3 (anagen II), 5 (anagen IV), 8 (anagen VI) and 12 (anagen 
VI) of depilation-induced hair cycle were taken (Fig. 3.10 b).
Hair follicles were quantified at different stages and sub-stages of the hair cycle 
according to established morphological criteria (Muller-Rover et al., 2001).
Although telogen-anagen transition was initiated in both WT and DTG mice, 
DTG mice showed a significant delay in early anagen development; at day 3 of 
depilation-induced hair cycle DTG mice had a significantly higher number of 
follicles were in anagen I and significantly less hair follicles in anagen II in DTG 
mice compared to WT littermate (Fig. 3.10 b, c). At day 5 of depilation-induced 
hair cycle, a significantly higher number of hair follicles were in anagen I in DTG 
mice compared to WT and a significantly higher number of hair follicles in 
anagen IV in WT mice compared to DTG littermates (Fig. 3.10 b, d). This 
suggests that miR-214 overexpression affects the rate of hair follicle growth 
during the hair cycle. 
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Figure 3.10. Overexpression of miR-214 inhibits hair cycle progression.  
(a) Schematic illustration of the experimental design; (b) microphotographs of 
histology of back skin of WT and DTG mice at days 3 (anagen II), 5 (anagen IV), 
8 (anagen VI) and 12 (anagen VI) after depilation; (c) quantitative 
histomorphometry of hair follicles at different anagen sub-stages at day 3 of 
depilation-induced hair cycle: significant increase in anagen I hair follicles and a 
significant decrease in anagen II hair follicles in DTG mice compared to WT 
littermates; (d) quantitative histomorphometry of hair follicles at different anagen 
sub-stages at day 5 of depilation-induced hair cycle: significantly higher number 
of anagen I hair follicles and significantly lower number of anagen IV hair follicles 
in DTG mice compared to WT littermates. (mean ± SD, *P value<0.05, **p<0.02 
unpaired students t-test). Scale bar 50μm.
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To further analyse the effects of miR-214 overexpression during the hair cycle, 
the diameter of hair bulbs and length of hair follicles were assessed. At both day 
5 of depilation-induced hair cycle when hair follicles are in anagen IV and day 
12 of depilation-induced hair cycle when hair follicles are in anagen VI, the 
diameter of hair bulbs in DTG mice were significantly reduced compared to the 
WT controls (Fig. 3.11 a). At day 5 of depilation-induced hair cycle when hair 
follicles are in anagen VI, hair follicles were significantly shorter in DTG mice 
compared to WT (Fig 3.11 b). Similar to the data obtained on hair follicle 
morphogenesis in which anagen-like hair follicles in DTG mice were shorter, 
anagen VI hair follicles at day 12 of depilation-induced hair cycle were 
significantly shorter in DTG mice compared to WT littermates (Fig.3.11 b).
To analyse the effects of miR-214 overexpression on hair shafts produced 
during depilation-induced hair cycle, hair shafts were plucked at day 26 after 
depilation. Hair shaft thickness was significantly reduced in DTG mice 
compared to the control (Fig. 3.11 c). However, no significant difference in hair 
shaft length was detected between WT and DTG (3.11 d). These findings are 
similar to the observations made for the hair shaft changes seen in miR-214 
overexpressing mice during hair follicle morphogenesis. 
To determine the possible causes of reduction in hair bulb size and hair follicle 
length, analysis of proliferation, differentiation and apoptosis was performed. 
Quantitative analysis of the number of pH3 (Ser28) positive cells revealed a 
significant reduction in proliferation in the hair follicles of DTG mice at days 3 
(anagen II), 5 (anagen IV) and 12 (anagen VI) of depilation-induced hair cycle, 
compared to WT littermates (Fig. 3.12 a-e).
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Figure 3.11. Morphometric analysis of hair follicles and shafts after 
depilation-induced hair cycle (a) Morphometric analysis of hair bulb 
diameter measured across the widest part (line of Auber) at days 5 (anagen 
IV) and 12 (anagen VI) after depilation: significant reduction of hair bulb
diameter in DTG mice compared to WT littermates; (b) analysis of hair 
follicle length at days 5 and 12 after depilation: significant reduction in the 
length of hair follicles in DTG mice compared to WT littermates; (c) analysis 
of hair shaft thickness: significant reduction of all hair shaft types (guard, 
awl, auchene and zigzag) in DTG mice compared to WT littermates; (d) 
analysis of hair shaft length: no significant difference in all hair shaft types 
(guard, awl, auchene and zigzag) between WT and DTG mice. (mean ± SD, 
*P value<0.05, **P value<0.02, unpaired Student’s t-test).
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Figure 3.12. Analysis of proliferation in the hair follicle during depilation-
induced hair cycle. (a) Immunofluorescence of pH3(Ser28) to mark 
proliferating cells at day 3 (anagen II) after depilation; (b-c) immunofluorescence 
of pH3(Ser28) at day 5 of depilation-induced hair cycle (anagen IV), 10x and  
40x magnification, respectively: visible reduction in the number of pH3(Ser28) 
positive cells in the hair bulb of DTG mice compared to WT; (d) 
immunofluorescence of pH3(Ser28)  at day 12 of depilation-induced hair cycle 
(anagen VI): a visible reduction in the number of pH3(Ser28) positive cells in the 
hair bulbs of DTG mice compared to WT; (e) quantification of pH3(Ser28) 
positive cells at days 3, 5 and 12 of depilation-induced hair cycle: significant 
reduction of pH3(Ser28)+ cells in the follicles of DTG compared to WT mice. 
(mean ± SD, *P value<0.05, ***P<0.002 unpaired Student’s t-test). Scale bar 
50μm. 
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Expression of Dlx3, a  transcription factor involved in the control of hair follicle 
keratinocyte differentiation (Hwang et al., 2008), was less pronounced in the 
inner root sheath of the  transgenic anagen VI hair follicles versus the controls 
in hair follicles (Fig. 3.13 a).
To explore the changes in apoptosis active form of Caspase-3 was used as it 
plays key effector roles in apoptosis (Riedl and Shi, 2004; Walsh et al., 2008).
No visible difference in the number of active Caspase-3 positive cells in the 
anagen VI hair follicles was seen between WT and DTG mice (Fig. 3.13 b). 
This data suggest that reduction in hair bulb size and follicle length seen in miR-
214 overexpressing mice is associated with the significantly decreased cell 
proliferation in the hair matrix, but not a cell death. In addition, miR-214 
negatively affects hair follicle differentiation during the hair cycle. 
Next, the changes in the morphology and activity of the dermal papilla in miR-
214 overexpressing mice were analysed. Sox2 immunofluorescence was 
performed in anagen VI hair follicles at day 12 of depilation-induced hair cycle 
as a marker of dermal papilla fibroblasts (Driskell et al., 2009; Rendl et al., 
2005) (Fig. 3. 14 a). Quantitative analysis revealed a significant reduction in the 
number of dermal papilla cells in transgenic hair follicles compared to WT 
littermates (Fig. 3.14 b).
qRT-PCR analysis of Fgf7 and Fgf10, which are known to be expressed in the 
dermal papilla and stimulate adjacent epithelial cells,  did not show significant 
difference in the levels of their transcripts in the anagen VI follicles between 
transgenic and WT mice (Fig. 3.14 c), which was consistent with observations 
during hair follicle morphogenesis.
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Figure 3.13 Analysis of differentiation and apoptosis in the hair follicles 
in anagen VI. (a) Immunofluorescence analysis of Dlx3 (green) in anagen VI 
follicles at day 12 of depilation-induced hair cycle: visible reduction in the 
expression of Dlx3 in the inner root sheath of DTG hair follicles compared to 
WT littermates; (b) immunofluorescence analysis of active Caspase 3 (red) in 
hair bulbs in anagen VI hair follicles at day 12 of depilation-induced hair 
cycle: no visible difference in expression  of active Caspase 3 between WT 
and DTG mice. 
Blue nuclear counterstain with DAPI.
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Figure. 3.15. Analysis of the dermal papilla of anagen IV hair follicles. 
(a) Immunofluorescence analysis of Sox2 in hair follicles at day 12 of 
depilation-induced hair cycle: no noticeable difference in expression of Sox2 
in the dermal papillae of WT and DTG mice; (b) quantification of dermal 
papilla cells in anagen VI hair follicles at day 12 of depilation-induced hair 
cycle: significant reduction in the number of dermal papilla cells in the hair 
follicles of DTG mice compared to WT; (c) qRT-PCR analysis of Fgf7 and 
Fgf10 expression in skin at day 12 of depilation-induced hair cycle: no 
significant differences in the transcript levels of Fgf7 and Fgf10 between WT 
and DTG mice (mean ± SD, ***P value<0.001, unpaired Student’s t-test), 
scale bar 50μm. 
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3.10 miR-214 overexpression induces complex changes in gene 
expression programs in keratinocytes 
To explore molecular mechanisms underlying the phenotype in miR-214 
transgenic mice and identify potential targets of miR-214 in the keratinocytes, 
global mRNA expression profiling was performed in the back skin epithelium of 
neonatal DTG mice (P2.5) which received doxycycline for 48 hours prior to skin 
collection (Fig. 3.15 a). The raw microarray expression profiles were 
background corrected and normalized with Bioconductor package limma (Smyth 
et al., 2005) and genes with more than two fold expression change in the 
epithelium of DTG mice compared to WT controls were identified as 
differentially expressed (Fig. 3.15 b). The in-house functional ontology 
database was used to categorise differentially expressed genes to the set of 12 
distinct functional categories (Lewis et al., 2014). Bioinformatic analysis of the 
microarray data revealed 2-fold and higher changes in expression of 1026 
genes in keratinocytes of DTG mice compared to WT controls (Fig. 3.15 b,
Supplementary Table 1). Differentially expressed genes which belong to “Cell 
Cycle” and “Signalling” categories were further validated by qRT-PCR. 
Microarray analysis revealed substantial decrease in the expression of cyclins 
and cyclin-dependent kinases in the epithelium of miR-214 overexpressing mice 
(Appen). By qRT-PCR it was confirmed that the transcript levels of Ccnb1, 
Ccnd1, Ccnd2 and Cdk1 (cyclin B1, cyclin D1, cyclin D2 and cyclin-dependent 
kinase 1) were significantly lower in DTG mice compared to the WT littermates 
(Fig. 3.16 a). These data suggest that miR-214 exerts inhibitory effects on cell 
proliferation, which were consistent with the epidermal and hair follicle 
phenotypes seen in DTG mice (Fig. 3.6).
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Interestingly, microarray analysis detected changes in the expression of the 
genes encoding the components of several signalling pathways which are 
crucial for hair follicle development and cycling, such as Wnt, Shh, Edar, and 
BMP (Blanpain and Fuchs, 2009; Botchkarev and Paus, 2003; Schmidt-Ullrich 
et al., 2006). qRT-PCR validation of the microarray results showed significant 
downregulation of β-catenin (Ctnnb1) (Fig. 3.16 b) and Lef-1 (Fig. 3. 16 c)
expression in the epithelium of DTG mice, suggesting a modulation of the 
activity of Wnt signalling pathway induced by miR-214. Overexpression of miR-
214 led to a significant decrease in the expression of Wnt inhibitor Sostdc1 in 
(Fig. 3.16 c) and Edar (Fig. 3.16 d) in DTG epithelium compared to WT. Also, 
expressions of several genes that belong to Hedgehog signalling such as Shh 
and its receptors Smo and Ptch2 were dramatically decreased in the epithelium 
of DTG versus wild type mice (Fig. 3.16 e).
These data provide the evidence that the effects of miR-214 on hair follicle 
development and cycling are mediated, at least in part, by the genes that 
control keratinocyte proliferation and modulate the activities of key signalling 
pathways (Wnt, Hedgehog, Bmp, Edar) that regulate skin development and hair 
growth. 
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Figure 3.15. Global gene expression profiling of the back skin epithelium 
of WT and K14-rtTA/TRE-miR-214 mice. (a) Schematic illustration of the 
experimental design; (b) microarray analysis of the global gene expression in 
the back skin epithelium of DTG versus WT: functional assignments of the 
gene with altered expression.  
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Figure. 3.16. Validation of microarray analysis by qRT-PCR;  
(a-e) qRT-PCR analysis of the selected genes involved in the cell cycle 
control and members of the Wnt, Hh and Eda signalling pathways in the 
epithelium of mice at postnatal day 2; (a) a significant reduction in the 
expression of Ccnb1, Ccnd1, Ccnd2 and Cdk1 in DTG mice compared to WT; 
(b) a significant reduction in the expression of β-catenin in DTG mice 
compared to WT; (c) significant reduction in the expression of Lef-1 and 
Sostdc1 in DTG mice compared to WT; (d) significant reduction in the 
expression of Shh, Smo and Ptch2 in DTG mice compared to WT; (e) 
significant reduction in the expression of Edar in DTG mice compared to WT 
(mean ± SD, *P value<0.05, **P<0.02, unpaired student’s t-test).
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3.11 miR-214 overexpression in epithelial progenitor cells alters 
expression of key regulators of the hair follicle development and cycling  
To further investigate the effects of gain of miR-214 functions on the activity of 
selected signalling pathways in skin, the pattern of expression of their different 
components in embryonic and postnatal skin of DTG and age-matched WT 
mice was determined via immunofluorescence analysis. 
Immunofluorescence  of β-Catenin, a key mediator of the Wnt pathway activity, 
showed decreased expression in the hair follicle placodes (stage 2 of hair 
morphogenesis) in skin of DTG mice in comparison to the WT littermates (Fig. 
3.17 a). The expression of β-catenin was also reduced in the epithelium of DTG 
hair follicles at stage 4 of morphogenesis compared to WT littermates (Fig. 3.17 
b). The expression of β-Catenin was also reduced in the hair matrix of fully 
developed anagen-like hair follicles in DTG mice compared to WT littermates at 
postnatal day 8 (Fig. 3.17 c).
Immunofluorescence  analysis of Lef-1,  the transcriptional cofactor of β-
catenin, also showed reduced expression in the epithelium and mesenchyme in 
hair follicle placodes (stage 2 of hair morphogenesis) of DTG mice compared to 
WT (Fig. 3.18 a). There was also a prominent reduction in Lef-1
immunoreactivity in the epithelium and dermal papilla in DTG hair follicles at 
stage 3 of hair morphogenesis compared to WT (Fig. 3.18 b). Expression of 
Lef-1 was also reduced in the hair matrix of DTG mice compared to WT 
littermates at postnatal day 8 (Fig. 3.18 c).
b 
Figure 3.17. Analysis of β-catenin expression during hair follicle 
morphogenesis by immunofluorescence (red). (a) decreased expression 
of β-catenin in the hair follicle placode (morphogenesis stage 2) in skin of 
DTG mice compared to WT littermates (arrows); (b) reduction in the 
expression of β-catenin (arrow) in the hair matrix of DTG follicles in stage 4 
of morphogenesis; (c) reduction in expression β-catenin in the hair matrix of 
fully developed anagen-like hair follicles of DTG mice compared to WT 
(arrows). Scale bar 50μm. 
Blue nuclear counterstaining with DAPI. 
a 
WT DTG 
       WT                    DTG 
WT DTG 
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Figure 3.18. Analysis of Lef-1 expression during hair follicle 
morphogenesis by immunofluorescence (red colour) 
(a) visible reduction in Lef-1 expression  in the epithelium (arrow) and 
mesenchyme (asterisk)  of hair placodes of DTG mice compared to WT 
littermates at embryonic day 17; (b) dramatic decrease in Lef-1 
immunofluorescence in the epithelium (arrows) and noticeable Lef-1 
reduction in the dermal papilla (arrowheads) in DTG hair follicles at stage 3 
of morphogenesis versus WT; (c) reduction in expression of Lef-1 in the hair 
matrix of DTG mice compared to WT littermates (arrows). Scale bar 50μm. 
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The downregulation of β-catenin and Lef-1, which are key mediators of the Wnt 
signalling pathway, indicates that miR-214 overexpression targets this pathway 
that contributes to the underlying phenotype in DTG mice seen during hair 
follicle morphogenesis. 
Analysis of Shh pathway, another key regulator of hair follicle growth, was also 
performed during hair follicle morphogenesis (Fig. 3.19). A reduction in 
expression of Shh was seen in hair follicle placodes (stage 2 of hair 
morphogenesis) in DTG mice compared to WT (Fig 3.19 a). In fully developed 
hair follicles (P8), expression of a transcription factor Gli-1, which mediates the 
activity of Shh, was also significantly decreased in DTG versus WT mice (Fig. 
3.19 c).
Consistent with the microarray data, expression of Edar appeared to be 
reduced in the epithelium of developing hair placodes (stage 2 of hair follicle 
morphogenesis) and in the matrix of more developed hair follicles in DTG mice 
compared to the corresponding control (Fig. 3.20 a, b).
In contrast, immunofluorescence  analysis of pSmad 1/5/8, as an indicator of 
Bmp signalling activity,  revealed more prominent expression of pSmad1/5/8 in 
the epithelium of hair follicle placodes (stage 2 of hair morphogenesis) in DTG 
mice compared to WT (Fig. 3.21 a).  Also, more prominent pSmad 1/5/8 
expression was seen in the inner root sheath and hair shaft of DTG hair follicles 
compared to WT at postnatal day 8 (Fig. 3.21 b). 
These findings suggest that inhibitory effects of miR-214 on hair follicle 
morphogenesis were associated with decreased activity of the Wnt, Shh and 
Edar signalling pathways and activation of BMP signalling, which all contribute 
to the phenotype seen in DTG mice during hair follicle morphogenesis. 
a 
Figure 3.19. Analysis of Shh pathway during hair  follicle 
morphogenesis. (a) Immunofluorescence analysis of Shh in hair follicle 
placodes in stage 2 of morphogenesis at embryonic day 17; reduction of 
Shh expression in hair follicle placodes of DTG mice compared to WT 
littermates; (b) qRT-PCR analysis of Gli-1 expression in skin at postnatal 
day 8: significant reduction in the level of Gli-1 transcripts in DTG mice 
compared to WT littermates (mean ± SD *P value<0.05, unpaired Student’s 
t-test). Scale bar 50μm. 
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Figure 3.20. Analysis of Edar expression during hair follicle 
morphogenesis by immunofluorescence (green colour).  
(a) Decreased expression of Edar in  the epithelium of hair follicle placodes 
of DTG mice compared to WT (stage 2 of morphogenesis, embryonic day 
17, arrows); (b) reduced immunofluorescence of Edar in the hair matrix of 
DTG follicles in stage 4 of morphogenesis. Scale bar 50μm. 
Blue nuclear counterstaining with DAPI 
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Figure 3.21. Analysis of pSmad 1/5/8 during hair follicle 
m o r p h o g e n e s i s b y i m m u n o f l u o r e s c e n c e ( r e d c o l o u r ) .                    
(a) increase in expression of pSmad 1/5/8 in  the epithelium of hair follicle 
placodes of DTG mice compared to WT littermates (stage 2 of hair 
morphogenesis, embryonic day 17, arrows);  (b) increase of pSmad 1/5/8 
(arrow) immunofluorescence in the inner root sheath and hair shaft of DTG 
hair follicles compared to WT littermates at postnatal day 8 at anagen-like 
stage (arrows). Scale bar 50μm. 
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3.12 Overexpression of miR-214 affects key hair follicle regulators during 
depilation-induced hair cycle 
To further validate microarray data, expression of the components of Wnt, Shh, 
and Bmp signalling pathways was analysed in the hair follicles during different 
anagen stages. 
A reduction in the expression of β-catenin was seen in the developing hair 
matrix of anagen II hair follicles (day 3 after depilation) and anagen IV hair 
follicles (day 5 after depilation) in DTG mice compared to WT (Fig.3.22 a). A 
reduction in β-catenin immunoreactivity was also seen in the hair matrix and 
dermal papilla in anagen VI hair follicles (day 12 after depilation) in DTG mice 
compared to WT (Fig.3.22 a). 
In anagen II hair follicles (day 3 after depilation), no visible difference in Lef-1
expression was seen between WT and DTG (Fig.3.22 b). Lef-1 expression was 
markedly reduced in the hair matrix and dermal papilla of anagen IV hair 
follicles (day 5 after depilation).  There was also a marked reduction of Lef-1
immunoreactivity in the hair matrix and dermal papillae of anagen VI (day 12 
after depilation) hair follicles in DTG mice compared to WT (Fig 3.22 b). 
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Figure 3.22. Expression of the mediators of Wnt signalling pathway during 
depilation-induced hair cycle. (a) Immunofluorescence analysis of β-catenin 
(red colour): reduced β-catenin expression in the hair matrix of anagen II follicles 
(day 3 after depilation, arrow) and anagen IV (day 5 after depilation, arrow) DTG 
hair follicles; decrease in β-catenin immunoreactivity  in the hair matrix (arrow) 
and dermal papilla (asterisk) in anagen VI hair follicles in DTG mice (day 12 after 
depilation); (b) immunodetection of Lef-1 (red colour): no noticeable difference in 
expression of Lef-1 anagen II hair follicles (day 3 after depilation); marked 
decrease in the expression of Lef-1 in the hair matrix (arrows) and dermal papilla 
(asterisk) in hair follicles of DTG mice in anagen IV and VI hair follicles (days 5 
and 12, respectively). Scale bar 50μm. 
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Consistent with data obtained above, activity of Shh pathway was reduced in 
the skin of DTG mice during hair cycle. Immunodetection of Shh in anagen II 
follicles (day 3 of after depilation) hair cycle showed no visible difference in 
expression between WT and DTG (Fig 3.23 a). However, qRT-PCR analysis 
confirmed a significant reduction of Gli-1 transcript levels in anagen II DTG skin 
(Fig 3.23 b).  The difference in Shh expression became visible in anagen IV 
transgenic hair follicles (day 5 after depilation) revealed a reduction in 
expression in the hair matrix of DTG hair follicles compared to WT (Fig. 3.23 c).
In anagen VI hair follicles, Shh expression was decreased at both protein and 
mRNA levels (Fig. 3.23 d-e), whilst no significant difference in Gli-1 expression 
between WT and DTG mice was detected at this time point (Fig. 3.23 d). 
Expression of pSmad 1/5/8 was increased in the transgenic hair follicles during 
the hair cycle (Fig 3.24). Increased immunoreactivity of pSmad 1/5/8 was seen 
in anagen II hair follicles (day 3 after depilation) (Fig 3.24 a) and anagen IV hair 
follicles (day 5 after depilation) (Fig 3.24 b) in DTG mice compared to WT. In 
anagen VI, the expression of pSmad 1/5/8 was further increased in the inner 
root sheath and hair shaft of transgenic follicles (day 12 after depilation) versus 
WT littermates (Fig. 3.24 c). 
Consistent with the microarray data, expression of Cyclin D1 was reduced in the 
hair matrix of anagen VI transgenic follicles (Fig 3.25 a).  In addition, significant 
increase in the transcript levels of cyclin-dependent kinase inhibitors Cdkn2a 
and Cdkn2d was detected in DTG skin at day 5 and at day 12 of depilation-
induced hair cycle (Fig 3.25 b, c). 
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Figure. 3.23 Analysis of Shh signalling during depilation-induced hair 
cycle. (a) immunofluorescence analysis of Shh in anagen II hair follicles at 
day 3 of depilation-induced hair cycle: no visible difference in Shh expression 
between WT and DTG (b) qRT-PCR analysis of Gli1 in skin at day 3 (anagen 
II) after depilation: significant decrease in Gli-1 mRNA in DTG mice compared
to WT; (c) reduced Shh immunoreactivity in the hair matrix (arrow) of anagen 
IV hair follicles (day 5 after depilation) in DTG mice compared to WT; (d) qRT-
PCR: significant decrease in Shh transcript levels, whilst no difference in 
expression of Gli1 in DTG mice compared to WT in skin at day 12 after 
depilation (anagen VI); (e) reduced Shh immunoreactivity in the hair matrix of 
anagen VI DTG hair follicles compared to WT mice (arrows, day 12 post 
depilation); (mean ± SD, *P value<0.05, unpaired Student’s t-test, n=3). Scale 
bar 50μm. 
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Figure. 3.24. Analysis of pSmad 1/5/8 during depilation-induced hair 
cycle by immunofluorescence (red colour). (a) increased pSmad 1/5/8 
immunoreactivity in anagen II hair follicles DTG mice compared to WT at 
day 3 after depilation (arrow); (b) increase in pSmad 1/5/8 in anagen IV hair 
follicles (day 5 post depilation; arrow) of DTG mice compared to WT 
littermates; (c) increased expression of pSmad 1/5/8 in the inner root sheath 
and hair shaft (arrow) in the anagen VI hair follicle of DTG mice compared 
to WT (day 12 after depilation). Scale bar 50μm. 
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Figure 3.25 Analysis of proliferation during depilation induced hair 
cycle. (a) Immunofluorescence of Cyclin D1 (red colour) in anagen VI hair 
follicles at day 12 of depilation-induced hair cycle: decreased expression of 
Cyclin D1 in the hair matrix of DTG follicles compared to WT littermates 
(arrow); (b) qRT-PCR analysis of Cdkn2a and Cdkn2d in anagen IV skin 
(day 5 after depilation): significant increase in the expression of Cdkn2a and 
Cdkn2d in DTG mice compared to WT littermates; (c) qRT-PCR analysis of 
Cdkn2a and Cdkn2d in anagen VI skin (day 12 post depilation): significant 
increase in Cdkn2a and Cdkn2d transcript levels in DTG mice compared to 
WT littermates (mean ± SD *P value<0.05, **P<0.02, unpaired Student’s t-
test). Scale bar 50μm. 
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To investigate the possible effects of miR-214 on the hair follicle stem cells 
during depilation-induced hair cycle, analysis of Sox9 expression was 
performed (Fig 3.26). A reduction in Sox9 expression in the developing outer 
root sheath of anagen II follicles (day 3 after depilation) (Fig 3.26 a) and anagen 
IV hair follicles (day 5 after depilation) (Fig 3.26 b) was observed in DTG mice 
compared to WT.  A visible decrease in the number of Sox9 positive cells was 
also seen in the outer root sheath of anagen VI hair follicles (day 12 after 
depilation) (Fig 3.26 c) in DTG mice compared to WT. Quantitative analysis of 
Sox9 positive cells in the outer root sheath of anagen VI hair follicles confirmed 
a significant reduction in the number of Sox9 positive cells in transgenic hair 
follicles compared to WT (Fig 3.26 d). This suggests that miR-214 
overexpression could inhibit a supply of progenitor cells from the bulge for the 
hair matrix. 
These data suggest that miR-214 exerts inhibitory effects on hair follicle cycling, 
at least in part, via regulating the activity of key signalling pathways (Wnt, 
Hedgehog, Bmp and Edar) in keratinocytes, as well as via modulation of the 
Wnt signalling in dermal papilla fibroblasts. 
Figure. 3.26 Analysis of the stem cell marker Sox9 during depilation-
induced hair cycle by immunofluorescence (red colour).  
(a-b) visible reduction in the number of Sox9 positive cells in the developing 
outer root sheath of anagen IV and VI hair follicles in DTG mice versus WT 
littermates (arrows, day 3 and 5 post depilation, respectively);                     (c-
d) significant decrease in the number of Sox9 positive cells in the outer root 
sheath of DTG anagen VI hair follicles compared to WT littermates (day 12 
after depilation). (mean ± SD, **P value<0.02, unpaired student’s t-test). 
Scale bar 50μm. 
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3.13 β-catenin is a direct target of miR-214 in keratinocytes
To identify the direct targets of miR-214 in keratinocytes, gene expression 
profiling results were linked with four databases for prediction of microRNA 
targets, including PITA, miRanda, miRDB, and TargetScan (Fig. 3.27 a). The 
largest number of possible miR-214 target genes was predicted by PITA and 
miRanda (192 and 78, respectively). TargetScan and miRDB showed only 18 
and 11 possible target genes, respectively. Intersections of PITA, miRanda, 
miRDB predictions identified 9 common genes that could possibly be direct 
targets of miR-214, which includes β-catenin and Shh (Table 3). However, 
overlapping of all four databases further revealed only 3 predicted target genes 
for miR-214, which expression was altered in DTG keratinocytes, including β-
catenin, but not Shh (Table  3).
PITA,
miRanda, miRDB
PITA, 
miRanda, 
miRDB, 
TargetScan
Ctnnb1 Ctnnb1
Dctd Lhx6
Idh1 Map6d1
Lhx6
Map6d1
Pcdh20
Ppp2r4
Sdf2l1
Shh
Table 3. Overlap of miR-214 predicted targets. Target prediction databases 
were linked to gene expression profiling to identify direct targets of miR-214 in 
keratinocytes. Overlap of 3 databases identified 9 common targets (genes of 
143 
interest in red highlight), whereas the overlap of all four databases further 
revealed only 3 predicted targets. 
To validate the results of bioinformatic analysis and explore whether β-catenin
and Shh 3’UTR carry functional binding sites for miR-214 (Fig. 3.27 b, d), 
luciferase reporter assay was performed. Co-transfection of HaCaT cells with 
miR-214 mimic and the β-catenin 3’UTR reporter construct caused significant 
reduction in luciferase activity, compared to the corresponding control, whilst 
this effect was not detected when β-catenin 3’UTR was mutated (Fig. 3.27 c), 
thus confirming that β-catenin is a direct target of miR-214. Luciferase reporter 
assay did not confirm the direct interactions between miR-214 and 3’UTR of 
Shh suggesting that decrease of its expression in the hair follicles after miR-214 
overexpression is mediated by other factors (Fig. 3.27 e).
To further validate miR-214-β-catenin interactions, the effect of miR-214 on the 
β-catenin/Tcf-dependent transcription activity was evaluated by using TOPflash 
reporter assay. A significant induction in TOPflash reporter activity, without any 
effect on FOPflash activity (negative control), was detected in HaCaT cells 
treated with a synthetic Wnt agonist 6-bromoindirubin-3’-oxime (BIO) (Sato et 
al., 2004; Tseng et al., 2006), whereas transfection of cells with miR-214 mimic 
significantly diminished TOPflash activity-induced by BIO (Fig. 3.27 f). This 
result suggested that miR-214 controls β-catenin expression by direct binding to 
its 3’UTR and that β-catenin represents a genuine target of miR-214. 
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Figure. 3.27. β-catenin is a direct target of miR-214 (a) A venn diagram 
depicting the overlap of four databases for prediction of microRNA targets 
(PITA, miRanda, miRDB and Targetscan) with gene expression profiling of the 
epithelium of neonatal DTG mice after 48 hours Doxycycline treatment. Only 
downregulated genes (<1.5 fold) were included; (b) predicted interactions 
between miR-214 and Ctnnb1: alignment of mouse and human sequences in 
the 3’-UTR of Ctnnb1 mRNA; (c) predicted interactions between miR-214 and 
Shh: alignment of mouse  sequences in the 3’-UTR of Shh; (d) significant 
reduction in luciferase activity due to co-transfection with miR-214 mimic and 
the Ctnnb1 3’UTR constructs encompassing putative miR-214 target site; no 
changes in luciferase activity was detected when the potential miRNA binding 
site was mutated (mut-3’UTR); (e) no changes in luciferase activity due to co-
transfection with miR-214 mimic and the Shh 3’UTR constructs encompassing 
putative miR-214 target site; (f) TOPflash reporter assay: significant induction 
in TOPflash reporter activity in HaCaTcells by BIO, which was diminished by 
miR-214 mimic. No changes in FOPflash activity in any experimental group 
(mean ± SD, *P value<0.05, **P<0.02, unpaired Student’s t-test) 
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3.14 Activation of Wnt signalling rescues skin phenotype in miR-214 
transgenic mice 
To explore the functional links between miR-214 and β-catenin in vivo, miR-214 
trangene was induced since embryonic day 10.5 followed by the subcutaneous 
injections of Wnt agonist BIO on five consecutive days after birth. 
Immunofluorescence analysis revealed that pharmacological activation of Wnt 
signalling resulted in restoration of β-catenin expression on postnatal day 5.5 
(P5.5) in DTG mice to the level seen in WT mice (Fig. 3.28 a).
Furthermore, BIO treatment lead to induction of new hair follicles in DTG mice 
postnatally, which resulted in appearance of hair follicles at early stages of 
morphogenesis (stages 2-3) in DTG mice followed by restoration of their total 
number to the levels seen in P5.5 WT controls (Fig. 3.28 b). To validate the 
visible difference, quantitative analysis was performed which revealed a 
significant reduction in the number of hair follicles in DTG compared to WT 
littermate at P5.5 (Fig. 3.28 c).  No such difference was found in the number of 
hair follicles between WT and DT after 5 days of BIO treatment In addition (Fig. 
3.28 d). Pharmacological Wnt activation resulted in an increase of the hair bulb 
diameter in the hair follicles at advanced stages (stages 6-7) of morphogenesis 
in DTG mice, while no increase of hair bulb size was seen in WT mice treated 
with BIO (Fig. 3.28 e). These observations demonstrate that activation of Wnt 
signalling in DTG mice rescues the effects of miR-214 overexpression in vivo 
confirming further that miR-214 indeed interfere with the Wnt pathway activity in 
the developing and postnatal skin. 


	




st 2-3 st 4-5 st 6-7 
%
 o
f H
Fs
 


WT+BIO 
B
ul
b 
si
ze
 (µ
m
) 
a
e




	
	
BIO -  BIO + 
N
 o
f H
Fs
 / 
m
m
 


dc
Figure. 3.28. Wnt agonist BIO rescues the phenotype caused by miR-214 
overexpression. (a) Immunofluorescence analysis of β-catenin in hair follicles 
at P5.5 after  treatment with Wnt agonist BIO; no difference in expression of β-
catenin between WT and DTG; (b) Representative microphotographs of 
histology of back skin of WT and DTG mice after 5 days of BIO treatment at 
P5.5, arrows show hair follicles at stages 2-3 of hair morphogenesis; (c) 
quantitative analysis revealed a significant reduction in the number of hair 
follicles in DTG compared to WT littermate at P5.5; no difference was found in 
the number of hair follicles between WT and DT after 5 days of BIO treatment; 
(d) Quantitative analysis of hair follicles at different stages of morphogenesis in 
skin of WT and DTG mice after 5 days of BIO treatment revealed a significantly 
increased number of the hair follicles at the stages 2-3 of morphogenesis in DTG 
skin versus WT littermates; (e) histomorphometric analysis of hair bulb diameter 
measured across the widest part (line of Auber) in stage 6-7 hair follicles: no 
difference between WT and DTG (mean ± SD, *P value<0.05, unpaired 
Student’s t-test). Scale bar 50μm.   
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4.0 DISCUSSION 
148 
4.1 miR-214 is expressed in distinct cell populations during hair follicle 
development and cycling 
Complex programmes of gene activation and silencing are involved in skin 
development and homeostasis. One of the most fascinating appendages of the 
skin is the hair follicle, which continually regenerates throughout a lifetime. In 
addition to transcription factor-mediated and epigenetic regulatory mechanisms, 
programmes of the gene activation and silencing governing hair follicle 
development and cycling are controlled by miRNAs (Botchkareva, 2012; Yi and 
Fuchs, 2011). MiRNA-dependent control of gene expression plays a 
fundamental role in the balancing and fine-tuning of lineage-specific 
differentiation programs in many organs including skin (Aberdam et al., 2008;
Andl et al., 2006; Flynt and Lai, 2008; Yi et al., 2006).
miR-214 is involved in numerous cellular processes such as proliferation, 
migration, differentiation and apoptosis (Yang et al., 2013; Yin et al., 2010;
Zhang et al., 2014) and has shown to be vital in determining cell fate in several 
cell types (Decembrini et al., 2009; Flynt et al., 2007; Juan et al., 2009). In 
zebrafish, miR-214 was shown to regulate muscle cell fate decision through 
regulation of Hh signalling (Flynt et al., 2007). The deletion of Dnm3os 
(Dynamin3-opposite strand), which contains the murine miR-214 locus leads to 
several developmental abnormalities (Watanabe et al., 2008). In mouse skeletal 
muscle, miR-214 targets Ezh2 (Enhancer of zest homologue 2), a Polycomb 
group protein, to regulate muscle cell differentiation (Juan et al., 2009). Ezh2 
performs the epigenetic modification of trimethylation of histone H3 at lysine 27 
(H3K27me3) and represses gene transcription. It has been shown that Ezh2 is 
regulated during myogenesis and prevents muscle differentiation by imposing 
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H3K27me3 on muscle-specific genes. In order for appropriate muscle gene 
activation, it is vital to remove Ezh2 and its associated methylation (Caretti et 
al., 2004). Hence, the repression of Ezh2 by miR-214 is essential for initiating 
muscle differentiation (Juan et al., 2009).The dynamic regulation of miRNA is 
exemplified in mouse skeletal muscle, where transcription of miR-214 is 
regulated by a double-negative feedback loop in which miR-214 is repressed by 
Ezh2 and activated by myoD/myogenin (Juan et al., 2009). The expression of 
the miR-214 gene is developmentally regulated by Twist-1, a key transcriptional 
factor controlling epithelial-mesenchymal transitions (Lee et al., 2009), which is 
crucial for normal development and tissue repair. It has also been demonstrated 
that miR-214 plays an important role in controlling the development of the 
nervous system, teeth, the pancreas, and bone formation (Chen et al., 2010; 
Joglekar et al., 2007; Sehic et al., 2011; Wang et al., 2013b) 
Yi et al showed that miR-214 is one of the most highly expressed miRNAs in the 
hair follicle during development (Yi et al., 2006), however, its role in the control 
of skin and hair follicle development and homeostasis is unknown. 
This project identified a novel role for miR-214 in the control of skin and hair 
follicle development and demonstrated that: i) miR-214 shows spatial-temporal 
changes of the expression patterns in the skin during hair follicle 
morphogenesis and cycling, ii) inducible overexpression of miR-214 in 
keratinocytes inhibits cell proliferation, results in a formation of fewer hair 
follicles with decreased size of the hair bulb, which produce thinner hairs, iii) 
miR-214 regulates the balance in the activities of multiple signalling pathways, 
including Wnt, Shh, Edar, and Bmp in developing and postnatal skin, and iv) β-
catenin serves as a direct miR-214 target in keratinocytes. 
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During skin development and postnatal growth, miR-214 expression 
predominates in differentiating populations of keratinocytes committed either to 
epidermal or hair follicle cell fates (suprabasal epidermal or hair matrix 
keratinocytes, respectively), while its expression in the progenitor cell 
populations of the basal epidermal layer or hair follicle outer root sheath 
appears to be considerably lower.  The difference in expression suggests that 
miR-214 may play a role in the differentiation of epidermal keratinocytes and 
possibly involved in determining cell fate during morphogenesis. The abundant 
expression of miR-214 in the growing hair matrix also suggests that miR-214 is 
essential for the control of keratinocyte proliferation and differentiation. 
 
In telogen hair follicles, miR-214 was highly expressed in the secondary hair 
germ. The telogen-anagen transition is promoted by Wnt and FGF signalling, 
which provide stimulatory signals to the hair follicle stem cells and/or their 
progeny residing in the hair follicle bulge and secondary hair germ, whereas 
Bmp signalling functions as an anagen inhibitor antagonising the activity of the 
FGF and Wnt pathways during telogen (Botchkarev et al., 2001a; Enshell-
Seijffers et al., 2010; Greco et al., 2009; Plikus et al., 2008). Thus miR-214 may 
be involved in regulating these signalling pathways during telogen quiescence 
and the transition from telogen to anagen. 
 
In mid- and late-anagen stages of the hair cycle, miR-214 was expressed in the 
bulge of hair follicles, the hair matrix and the inner and outer root sheath. The 
contrast in expression of miR-214 in differentiating keratinocytes and progenitor 
cell populations in the basal layer and outer root sheath suggests that miR-214 
may play a role in balancing the switch between proliferation and differentiation 
possibly by maintaining ‘stemness’ in keratinocytes. This is supported by the 
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low level miR-214 expression in stem cell rich areas such as the bulge in 
anagen hair follicle, in contrast to higher expression in the hair matrix. 
 
Therefore it was hypothesised that since the spatio-temporal expression of miR-
214 in distinct cell populations in the skin and hair follicle coincides with the 
components of several of the above mentioned signalling pathways, it may 
therefore function to regulate them.   
 
In this project a transgenic mouse model was employed to further elucidate the 
role of miR-214 in skin and hair follicle development and cycling.  
 
4.2 K14-driven overexpression of miR-214 negatively affects hair follicle 
induction 
 
K14-driven miR-214 overexpression in the progenitor cell populations of the 
epidermis and hair follicle resulted in DTG mice that exhibited a ‘rough’ fur coat 
in comparison to WT mice which showed an appearance of a ‘smooth’ fur coat. 
The overexpression of miR-214 led to approximately 30% fewer hair follicles 
forming in the dorsal skin of mice due to a reduction in the number of both 
primary and secondary hair follicles.  
 
Skin and hair follicle morphogenesis is controlled by coordinated activities of the 
Wnt, Hedgehog, Edar, Shh, Bmp, FGF, Notch and other signalling pathways. 
(Andl et al., 2002; Chiang et al., 1999; Eivers et al., 2008; Enshell-Seijffers et 
al., 2010; Huelsken et al., 2001; Jiang et al., 1999; Mikkola, 2011; Sick et al., 
2006; St-Jacques et al., 1998; Zhang et al., 2009; Zhou et al., 1995).   Among 
these pathways, Wnt signalling operates as the most powerful regulator of skin 
development and controls cell proliferation in epithelial cells of the epidermis 
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and hair follicle matrix as well as mesenchymal cells of the dermal papilla. In 
addition it regulates differentiation of hair matrix keratinocytes as well as the 
morphogen-producing activity of dermal papilla cells (Andl et al., 2002; Choi et 
al., 2013; Enshell-Seijffers et al., 2010; Fu and Hsu, 2013; Huelsken et al., 
2001; Jiang et al., 1999; Sick et al., 2006; Tsai et al., 2014; Zhou et al., 1995). 
The present study demonstrates that miR-214 contributes to regulation of the 
activity of Wnt signalling pathway in developing skin by targeting its key 
component β-catenin. Bioinformatic analysis validated by the reporter assays 
suggested that miR-214 directly targets β-catenin in keratinocytes. The 
immunofluorescence analysis of β-catenin and its transcriptional cofactor Lef-1, 
showed markedly decreased expression in the epidermis and hair follicle 
placodes during hair morphogenesis, indicating that miR-214 is involved in 
regulating the induction of hair follicles, at least in part through modulating Wnt 
signalling. In developing hair follicles, Wnt signalling pathway operates as 
activator of the placode formation, while BMP signalling inhibits this process 
and, together with Wnt inhibitors Dkk1/2/4 promotes the inter-placode cell fate 
in the epidermal progenitor cells (Andl et al., 2002; Botchkarev et al., 1999a; 
Jiang et al., 1999; Sick et al., 2006).
The reduced number of hair follicles in miR-214 overexpressing mice is 
consistent with a study by Huelsken et al, who showed that when β-catenin is 
absent during skin development, stem cells fail to differentiate into follicular 
keratinocytes but instead adopt an epidermal fate. Furthermore, the phenotypic 
properties seen in the skin of DTG  mice which included  a decrease of 
epidermal proliferation and epidermal thickness, a proportional decrease in 
number of all types of the hair follicles and retardation of their morphogenesis, 
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decrease of the size of hair bulbs and formation of thinner hair shafts compared 
to WT controls, is consistent with skin phenotype of mice with conditional 
ablation of β-catenin either in keratinocytes or in the dermal papilla fibroblasts 
(Enshell-Seijffers et al., 2010; Huelsken et al., 2001; Tsai et al., 2014).  
 
Tsai et al showed that Wnt signalling in dermal condensates is required for hair 
follicle formation (Tsai et al., 2014). The ablation of β-catenin led to the number 
of primary guard hair follicle becoming strongly reduced and by embryonic day 
18, most guard hair follicles were absent, suggesting that active Wnt signalling 
in dermal condensates is important for hair follicle formation to proceed after 
induction. Enshell-Seijffers et al showed that β-catenin activity in the dermal 
papilla regulates a number of other signalling pathways, including the FGF 
pathway that can mediate the inductive effects of the dermal papilla on the hair 
follicle epithelium (Enshell-Seijffers et al., 2010). In addition, the findings of the 
current study are in the line with the phenotypic properties seen in transgenic 
mice overexpressing β-catenin in skin keratinocytes, which produced extra hair 
follicles, a thicker fur coat, with uncontrolled proliferation eventually leading to 
the formation of tumours (Gat et al., 1998). 
 
As Edar is only expressed in the epidermis, studies have suggested that the 
Eda signalling pathway is important for placode patterning, affecting the 
induction of primary and zigzag hair follicles, but not necessary for initial 
placode formation (Botchkarev and Fessing, 2005; Schmidt-Ullrich et al., 2006; 
Zhang et al., 2009). However, Edar signalling promotes hair follicle placode 
formation via stimulation of expression of Shh (Pummila et al., 2007), which 
operates as a potent stimulator of keratinocyte proliferation in the developing 
hair follicle (Chiang et al., 1999; St-Jacques et al., 1998). Immunofluorescence 
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analysis of Edar and Shh showed reduced expression in hair follicle placodes of 
DTG mice. Given that Wnt signalling operates as upstream of Edar and 
Hedgehog pathways in the control of formation of the hair follicle placodes 
(Schmidt-Ullrich et al., 2006; Zhang et al., 2009) these data suggest that the 
decrease of Edar and Shh expression seen in the hair follicle placodes, is an 
indirect affect caused by downregulation of Wnt signalling. 
In addition to activators, the skin also contains inhibitors of hair follicle induction, 
in particular BMP signalling has shown to have an inhibitory effect on hair 
follicle induction (Botchkarev et al., 1999a). Expression of pSmad 1/5/8, an 
indicator of BMP activity, was increased in the hair follicle placodes and inter-
follicular epidermis of DTG mice, indicating that miR-214 overexpression results 
in activation of BMP signalling. As Edar pathway has been shown to promote 
the placode cell fate, at least in part, by inhibiting the activity of BMP signalling 
(Eivers et al., 2008; Plouhinec et al., 2011), the reduction of Edar expression 
and increase in BMP activity in DTG may also contribute to partially inihibited 
induction of hair follicle placodes and may promote inter-placode cell fate. 
The transcription factor Lhx2 has been shown to be crucial for hair follicle 
development (Rhee et al., 2006), however immunofluorescence analysis 
revealed no noticeable difference between WT and DTG littermates during hair 
follicle development. Thus, indicating that the phenotypic properties seen in 
DTG during hair follicle induction are independent of Lhx2 regulation. 
These data collectively indicate that miR-214 regulates the activity of epidermal 
keratinocytes and is involved in the induction of hair follicles through direct 
targeting of Wnt/β-catenin signalling, and indirectly targeting Edar, Shh and 
BMP pathways. 
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4.3. K14-driven overexpression of miR-214 modulates hair follicle 
morphogenesis 
Although the rate of hair follicle morphogenesis was not significantly affected 
and all hair follicles at postnatal day 8 reached anagen-like stage, they were 
significantly shorter and hair bulbs were significantly smaller in DTG mice.  In 
addition to changes seen in the hair follicle epithelium, the significant reduction 
in the number of dermal papilla cells was observed in DTG mice during 
postnatal growth. It is consistent with recently published data demonstrating that 
decrease of the hair bulb size is associated with reduced cellularity of the 
dermal papilla (Choi et al., 2013).  
Recent data suggest that activity of the Wnt signalling pathways considerably 
vary in distinct skin compartments: low levels of activity are required for 
maintenance of epidermal proliferation, medium level signalling is required for 
maintenance of epithelial-mesenchymal interactions in the hair bulb to promote 
active hair growth phase, while high activity promotes hair shaft differentiation 
(Choi et al., 2013). In addition to decreased expression of E-catenin and Lef-1 in 
the hair matrix, levels of these proteins were reduced in the dermal papilla of 
DTG hair follicles. This suggests that overexpression of miR-214 in the hair 
follicle keratinocytes has an effect on dermal papilla fibroblasts as a result of 
epithelial-mesenchymal interactions. Overexpression of miR-214 resulted in the 
decreased transcript levels of IGF-I expressed by the dermal papilla. IGF-I acts 
as a mitogen in the epidermis and hair follicle and is crucial for proper hair shaft 
differentiation (Weger and Schlake, 2005). The withdrawal of IGF-I from the 
medium of in vitro cultures of human hair follicles in the anagen phase induced 
premature entry into a catagen-like phase of the hair cycle (Philpott et al., 
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1994). Transgenic expression of IGF-I in the interfollicular epidermis causes 
epidermal hyperplasia (Bol et al., 1997). Reduced expression of IGF-1 in 
postnatal skin of DTG mice may additionally contribute to reduced keratinocyte
proliferation and altered hair shaft differentiation.
The changes in cellularity and gene expression in the dermal papilla of DTG 
mice suggest altered epithelial-mesenchymal interactions. Given that miRNAs 
are capable of exerting paracrine effects on distantly located cellular targets 
(Zhu and Fan, 2011), additional studies need to clarify whether miR-214 
overexpression in keratinocytes could directly influence cell number and gene 
expression in dermal papilla fibroblasts, or other paracrine factors released from 
keratinocytes affect traffic of connective tissue progenitor cells to populate 
dermal papilla and/or their activity in the hair follicles of DTG mice.
Wnt signalling pathway is a potent regulator of cell proliferation (Gat et al., 
1998; MacDonald et al., 2009; Van Mater et al., 2003) and many of the effects 
of miR-214 on skin and hair follicle development are most likely associated with 
interference with cell cycle regulation: in fact, short-term activation of miR-214 in 
the epidermis suppressed the expressions of several cyclins and cyclin 
dependent kinases, including cyclin B, cyclin D1, cyclin D2 and cdk1, in addition 
to significant downregulation of β-catenin. Consistent with these observations, 
substantial upregulation in cyclin-dependent kinase inhibitors Cdkn2a and
Cdkn2d was still detected in fully developed follicles (postnatal day 8) of the 
DTG mice, suggesting the activation of the anti-proliferative program in 
response to increased levels of miR-214 in the keratinocytes. These data are 
consistent with studies in which β-catenin has been shown to upregulate cyclin 
D1 expression (Shtutman et al., 1999; Tetsu and McCormick, 1999). This is 
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also in line with the results obtained in other models and demonstrating that 
miR-214 expression is substantially decreased in cutaneous squamous cell 
carcinoma (Yamane et al., 2013) and that the anti-proliferative effects of miR-
214 in myoblast cell line is achieved via targeting Nras (Liu et al., 2010). 
 
However, reduced proliferation seen in the epidermis and hair follicles in DTG 
mice could partly be a result of altered activity of Shh signalling. In fact, 
decreased expression of Shh and its signal tranducer Smo was found in the 
epithelium of DTG mice at postnatal day 2. Shh signalling is required for post 
hair placode initiation growth by promoting the proliferation of follicular epithelial 
cells by transcriptional activation of cyclin D1 and cyclin D2 in the developing 
hair follicles (Chiang et al., 1999; Mill et al., 2003; Schmidt-Ullrich et al., 2006; 
St-Jacques et al., 1998). This is also consistent with the downregulation of 
cyclin D and cyclin D2 in the epithelium of DTG mice. In addition, 
immunofluorescence analysis of Shh revealed a decrease in expression in the 
epithelium of DTG hair follicles during hair follicle morphogenesis. However, 
experimental validation of bioinformatic prediction analysis demonstrated that 
Shh does not serve as a direct miR-214 target in keratinocytes. Given that Wnt 
signalling operates as upstream of Edar and Hedgehog pathways these data 
suggest that the downregulation of the Edar and Shh expressions seen in the 
epithelium of DTG hair follicles during morphogenesis mice most likely 
represent the indirect effects linked to the miR-214-mediated decrease of the 
Wnt pathway activity in keratinocytes.   
 
The phenotypic properties of DTG mice were not only associated with 
downregulation of Wnt activity but also an upregulation of BMP activity. The 
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reduced proliferative activity, hair bulb diameter and hair follicle length of DTG 
hair follicles is consistent with a previous study by Sharov et al. who 
demonstrated that hair shaft diameter depends on size of the hair bulb and the 
proliferative activity of the matrix keratinocytes (Sharov et al., 2006). The 
inhibition of BMP activity led to the development of larger hair bulbs and thicker 
hair diameter (Sharov et al., 2006). This is consistent with the findings in this 
study, in which reduced bulb size and keratinocyte proliferation, was associated 
with an increase in BMP activity.  The expression levels of BMP inhibitor 
Sostdc1 was reduced in the epithelium of DTG mice in addition to increased 
immunoreactivity of pSmad 1/5/8  during hair follicle morphogenesis.  
 
The expression of Lef-1 was also decreased during hair follicle morphogenesis, 
and after short term activation of miR-214 in mouse epithelium. Lef-1, which is 
the transcriptional cofactor for β-catenin, is required for hair follicle growth. 
Elevation of Lef-1 expression in the keratinocytes of the hair matrix has been 
shown to be vital for commitment of keratinocytes for hair shaft differentiation 
(DasGupta and Fuchs, 1999).  Therefore, reduced hair shaft thickness could 
additionally be attributed to the reduction in the levels Lef-1. In addition Lef-1 
has been shown to be vital in determining hair follicle patterning (Zhou et al., 
1995), which could also partly contribute to the reduced number of hair follicle 
seen in DTG mice. These data demonstrate that the phenotypic property of hair 
follicles in DTG mice is also partly due to altered activity of Lef-1 as a 
downstream result of β-catenin downregulation. 
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These data collectively indicate that through the direct targeting of β-catenin, 
miR-214 directly affects Wnt signalling and indirectly affects Eda, Shh and BMP 
signalling, during hair follicle morphogenesis. 
The dorsal skin of mice produces four different types of hair follicles (guard, awl, 
auchene and zigzag) that produce hair shafts which vary in shape and structure 
(Schlake, 2007). In this study we found that the percentage of the different hair 
shafts produced was similar in WT and DTG mice after miR-214 
overexpression, although they were found to be significantly thinner in DTG 
mice in comparison to WT. Even though hair shafts were thinner in DTG mice 
they were not significantly shorter in length compared to WT. In addition, the 
expression of Sox2 was similar in the dermal papilla of WT and DTG mice 
during postnatal growth and during the hair cycle. The lack of difference in Sox2 
expression and hair follicle types between WT and DTG is consistent with a 
study by Driskell et al who demonstrated that Sox2 is involved in specifying hair 
follicle type in mammalian epidermis (Driskell et al., 2009).
Immunodetection of the stem cell marker Lhx2 showed decreased expression in 
the hair follicles of DTG mice at postnatal day 8, indicating that miR-214 affects 
the activity of hair follicle stem cells. Spatio-temporal expression of miR-214 
was seen in the stem cell rich regions; the bulge of fully developed hair follicles 
during postnatal growth and anagen hair follicles, the secondary hair germ in 
telogen hair follicles and also in the outer root sheath, where stem cell progeny 
migrate to the hair matrix. These data together, could lead one to speculate that 
by co-ordinately fine-tuning the expression of a large number of proteins, miR-
214 may be acting as a rheostat to regulate decisions involving the switch from 
stemness and commitment.
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In the hair lineage, quiescent bulge stem cells are known to be activated by 
external Wnt promoting and BMP inhibitory signals. As stem cell progeny move 
down along the outer root sheath, they are thought to progressively adjust their 
fate from that of stem cells to committed progenitors. Eventually, these cells 
pass a point of no return and end up as transiently-amplifying matrix cells (Hsu 
et al., 2011). This is consistent with the findings of this study in which β-catenin 
serves as a direct target of miR-214 and deregulates Wnt and BMP activity, 
together with reduced migration of stem cell progeny from the bulge to the 
matrix. However, the potential involvement of miR-214 in regulation of the 
activity of distinct hair follicle stem cell populations residing in the bulge and 
also secondary hair germ during hair cycle need to further investigated (Hsu et 
al., 2011; Huelsken et al., 2001; Rompolas and Greco, 2014). 
 
4.4 Overexpression of miR-214 modulates the expression of key signalling 
pathways during the hair cycle 
 
After transgene induction during the telogen phase, hair follicles were depilated 
to induce anagen. The progression of the hair cycle in DTG mice was 
significantly retarded, in addition to reduced proliferation, thinner hair bulbs and 
shorter hair follicles, similar to phenotypic properties seen during development. 
 
The activation of stem cells from a quiescent state leading to proliferation and 
differentiation is a complex process, which remains to be fully elucidated. 
Pathways which have been shown to be critical to these processes are the Wnt 
and BMP (Blanpain et al., 2004; DasGupta and Fuchs, 1999; Kobielak et al., 
2007)  Similar to postnatal hair follicle development, the overexpression of miR-
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214 results in decreased expression of the components of Wnt, Shh pathways 
and increased activity of BMP during the hair cycle.  
 
The immunoreactivity of β-catenin and Lef-1 was found to be reduced in the 
epithelium and also the dermal papilla of DTG anagen hair follicles. A recent 
study by Choi et al showed that β-catenin is required within bulge and 
secondary hair germ cells for anagen initiation, with the deletion of β-catenin in 
bulge and secondary hair germ cells preventing follicles from progressing 
through anagen (Choi et al., 2013). BMP signalling has also been shown to 
repress bulge cell proliferation and the loss of BMP signalling results in 
premature bulge cell activation (Blanpain et al., 2004; Kobielak et al., 2007).This 
is consistent with the delay in anagen progression seen in DTG mice, as miR-
214 is expressed in the secondary hair germ in telogen hair follicles, these data 
indicate that the downregulation of β-catenin by miR-214 and subsequently 
activation of BMP in the secondary hair germ causes a delay in anagen 
progression in DTG mice.  
As miR-214 is highly expressed in the hair bulb, it indicates that it is also 
involved in regulating hair differentiation and anagen progression by directly 
targeting β-catenin. This is consistent with previous studies which showed that 
Wnt/β-catenin signalling is also required for the differentiation of matrix 
keratinocytes in generating the hair shaft (DasGupta and Fuchs, 1999; Merrill et 
al., 2001).  
Shh promotes epidermal proliferation (Zhou et al., 2006) and in adult mice is 
essential for anagen onset and proper hair cycling (Sato et al., 1999; Wang et 
al., 2000). Although Shh expression was similar in early anagen, the expression 
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of Gli-1 which is an effector of Shh signalling was significantly downregulated, 
indicating that miR-214 indirectly affects several components of Shh signalling. 
In late anagen hair follicles, expression of Shh and its target gene Cyclin D1 
was reduced in DTG matrix, whereas transcript levels of Cdkn2a and Cdkn2d 
were increased. This indicates that reduced proliferation and small hair bulbs in 
DTG mice can be additionally attributed to decreased Shh activity. 
The data from this study suggests that decrease of hair follicle size in DTG mice 
could be associated with the decreased proliferation in the hair matrix, as well 
as with miR-214 effects on the migration of the progenitor cells from the bulge
alongside the outer root sheath towards hair matrix. In fact, hair follicles of DTG 
mice contained significantly fewer numbers of Sox9 positive cells in the outer 
root sheath. Sox9 is a transcriptional regulator which is expressed in the hair 
follicle stem cells and their outer root sheath progenies and is required for 
guiding stem cell progenies to the hair matrix (Vidal et al., 2005). Therefore, 
reduced number of Sox9 positive cells in the hair follicle of transgenic mice 
suggests the inhibitory action of miR-214 on stem cells and their progenies, 
contributes to the formation of the smaller hair bulbs. However, these effects 
could also be associated with decreased β−catenin expression, because 
β−catenin is an upstream regulator controlling Sox9 expression in the intestinal 
epithelium and neural crest cell (Blache et al., 2004; Liu et al., 2013).
In addition, Dlx3 which is involved in hair follicle differentiation and cycling 
(Hwang et al., 2008) showed decreased immunoreactivity in the hair follicles of 
DTG mice. This is consistent with the findings of this study as Dlx3 is positioned 
downstream of Wnt signalling in regulating hair follicle differentiation (Hwang et 
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al., 2008). This indicates another indirect effect of altered Wnt signalling caused 
by miR-214 overexpression in keratinocytes.  
 
4.5 Phenotype of DTG mice hair follicles is rescued by pharmacological 
activation of Wnt 
 
Importantly, key features of the skin phenotype in miR-214 overexpressing mice 
(decrease in the number of hair follicles and hair bulb size) were rescued by 
pharmacological activation of Wnt pathway in vivo. The induction of hair follicles 
during postnatal growth in DTG mice after pharmacological activation of Wnt 
pathway, in addition to similar hair bulb size of DTG and WT mice further 
supports the links between miR-214 and activity of Wnt pathway in the skin. 
These data are also consistent with data published previously and showing 
miR-214 targeting of β-catenin in hepatocellular carcinoma cells (Wang et al., 
2012b). This also supports the hypothesis that miR-214 serves as a rheostat 
rather than a master regulator; however further analysis would need to be 
carried out to see whether the phenotype of DTG mice is fully reversible and 
whether indirect targets are affected. 
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Figure 4.1. Effects of miR-214 on key signalling pathways in 
hair follicle growth 
The scheme illustrates the mechanisms of the effects of 
miR-214 overexpression in keratinocytes. The targeting of β-
catenin, the key component of Wnt signalling, by miR-214, leads 
to downstream effects on several signalling pathways that 
includes Bmp, Edar and Shh. 

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Conclusions 
In this project, a novel role for miR-214 in the control of skin and hair follicle 
development and postnatal physiological regeneration was determined. Based 
on the data obtained in this study the following conclusions can be made: 
(i) miR-214 exhibits discrete expression patterns in the epidermis and 
hair follicles in developing and postnatal skin. miR-214 is highly 
expressed in the epithelial stem cells and their lineage-committed 
progenies during hair follicle development and cycling: miR-214 is 
expressed in the compartment containing stem cells at predominantly 
quiescent state (secondary hair germ of telogen hair follicle), while it 
shows strong expression in highly proliferative compartments 
(epidermis, hair matrix of anagen hair follicle) during active hair 
growth. 
(ii) Keratinocyte specific overexpression of miR-214 during skin 
embryogenesis results in the partial inhibition of hair follicle induction 
and formation of the hair follicles reduced in size, which produce 
thinner hair. 
(iii) Keratinocyte specific overexpression of miR-214 in telogen skin 
causes retardation in the anagen progression and growth of smaller-
sized hair follicles. 
(iv) Inhibitory effects of miR-214 on hair follicle development and cycling 
are associated with supressed activity of stem cells, reduced 
proliferation in the hair matrix, and altered differentiation. 
(v) Overexpression of miR-214 induces complex changes in gene 
expression programs in keratinocytes, including inhibition of the 
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number of cyclins and cyclin dependent kinases and the essential 
components of Wnt, Edar, Shh and Bmp signalling pathways. 
(vi) miR-214 directly targets β-catenin in keratinocytes, therefore it 
directly regulates the activity of Wnt/E-catenin signalling pathways 
and cell-cycle-associated machinery in epithelial stem cells and their 
lineage-committed progenies. 
(vii)  miR-214 may act as one of the upstream effectors of the signalling 
cascades which governed hair follicle morphogenesis and cycling. 
Taken together, the data obtained in this project suggest that miR-214 operates 
as a key determinant that controls the activity of Wnt signalling pathway by 
targeting β-catenin expression in the developing and postnatal skin and hair 
follicles (Figure 4.1). As Wnt signalling plays a crucial role in the control of stem 
cell activity in many organs during development and regeneration, while its 
uncontrolled activation results in tumorigenesis (Chan et al., 1999; Malanchi et 
al., 2008), these data provide an important foundation for further analysis of the 
role of miR-214 as regulator of Wnt pathway activity in many areas of research 
including stem cell and cancer biology, regenerative medicine and ageing. 
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Future Work 
The following studies could be helpful to further unravel the role of miR-214 in 
controlling skin and hair follicle homeostasis: 
x Further explore the role of miR-214 during spontaneous and depilation-
induced hair cycle 
x Determine whether miR-214 has a direct effect on epithelial stem cells.
x To delineate the role of miR-214 in the control of injury-associated gene
expression programmes in epithelial stem cells and their progenies 
during wound healing. 
x To define how modulation of miR-214 levels in skin affects the initiation
and the progression of non-melanoma skin cancers such as basal cell 
carcinoma (BCC) and squamous cell carcinoma (SCC). 
x To explore the role for miR-214 in skin and hair follicle aging and whether
miR-214 contributes to the age-associated alterations in skin repair after 
injury. 
x Explore whether miR-214 antagonists could potentially be used as
therapeutic agents for hair disorders such as alopecia or hirsutism. 
x Investigate whether miR-214 is implicated in disorders caused by
abnormal Wnt signalling such as bowel cancer. 
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Appendix 
Genes that show 2-fold down-regulation in the keratinocytes of 
K14rtTA/TRE-miR-214 mice versus WT mice
Accession 
Number Gene Name Symbol
Fold 
Change
Adhesion/Extracellular matrix
NM_011302 retinoschisis (X-linked, juvenile) 1 Rs1 5.25
NM_178596 gap junction protein, delta 3 Gjd3 4.73
NM_010708
lectin, galactose binding, soluble 9, transcript 
variant 1 Lgals9 4.27
NM_010327
glycoprotein Ib, beta polypeptide, transcript 
variant 2 Gp1bb 3.93
NM_010577 integrin alpha 5 Itga5 3.73
NM_181277 collagen, type XIV, alpha 1 Col14a1 3.15
NM_001081249 versican, transcript variant 1 Vcan 2.90
NM_020486 basal cell adhesion molecule Bcam 2.77
NM_021334 integrin alpha X Itgax 2.72
NM_146007 collagen, type VI, alpha 2 Col6a2 2.68
NM_010386 histocompatibility 2, class II, locus DMa H2-DMa 2.64
NM_013565 integrin alpha 3 Itga3 2.58
NM_011150
lectin, galactoside-binding, soluble, 3 binding 
protein Lgals3bp 2.56
NM_023051 calsyntenin 1 Clstn1 2.50
NM_007992 fibulin 2, transcript variant 1 Fbln2 2.44
NM_178685 protocadherin 20 Pcdh20 2.43
NM_010181 fibrillin 2 Fbn2 2.35
NM_001082960 integrin alpha M, transcript variant 1 Itgam 2.32
NM_013552
hyaluronan mediated motility receptor 
(RHAMM) Hmmr 2.18
NM_010180 fibulin 1 Fbln1 2.01
Cell Cycle/Apoptosis
NM_018754 stratifin Sfn 3.34
NM_177372 DNA replication helicase 2 homolog Dna2 3.28
NM_007631 cyclin D1* Ccnd1 3.76
NM_008564
minichromosome maintenance deficient 2 
mitotin Mcm2 2.91
NM_028131 centromere protein N Cenpn 2.88
NM_010059
DMC1 dosage suppressor of mck1 homolog, 
meiosis-specific homologous recombination Dmc1 2.78
NM_028222 cyclin-dependent kinase inhibitor 3 Cdkn3 2.72
NM_008014
protein phosphatase 1G (formerly 2C), 
magnesium-dependent, gamma isoform Ppm1g 2.65
NM_027263 apoptosis-inducing, TAF9-like domain 1 Apitd1 2.60
NM_001012273
baculoviral IAP repeat-containing 5, transcript 
variant 3 Birc5 2.51
NM_198654
NSL1, MIND kinetochore complex component, 
homolog Nsl1 2.50
NM_011015
origin recognition complex, subunit 1, 
transcript variant A Orc1 2.43
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NM_027954
synaptonemal complex central element protein 
2, transcript variant 2 Syce2 2.42
NM_019499 MAD2 mitotic arrest deficient-like 1 Mad2l1 2.33
NM_022654 leucine-rich and death domain containing Lrdd 2.33
NM_008566
minichromosome maintenance deficient 5, cell 
division cycle 46 Mcm5 2.29
NM_026560 cell division cycle associated 8 Cdca8 2.28
NM_009828 cyclin A2 Ccna2 2.27
NM_198605
spindle and kinetochore associated complex 
subunit 3 Ska3 2.26
NM_001042421 kinetochore associated 1 Kntc1 2.25
NM_146235
excision repair cross-complementing rodent 
repair deficiency complementation group 6 like Ercc6l 2.23
NM_001159930 centromere protein L , transcript variant 1 Cenpl 2.19
NM_007900 ect2 oncogene, transcript variant 1 Ect2 2.18
NM_007659 cyclin-dependent kinase 1* Cdk1 2.64
NM_013929
SIVA1, apoptosis-inducing factor, transcript 
variant 1 Siva1 2.15
NM_011049 cyclin-dependent kinase 16 Cdk16 2.15
NM_172301 cyclin B1* Ccnb1 2.36
NM_001014976 extra spindle poles-like 1 Espl1 2.15
NM_025995 F-box protein 5 Fbxo5 2.14
NM_011799 cell division cycle 6, transcript variant 1 Cdc6 2.07
NM_027290 minichromosome maintenance deficient 10 Mcm10 2.05
NM_025866 cell division cycle associated 7 Cdca7 2.05
NM_016681 checkpoint kinase 2 Chek2 2.04
NM_175554 claspin Clspn 2.03
NM_008567 minichromosome maintenance deficient 6 Mcm6 2.03
NM_007630 cyclin B2 Ccnb2 2.02
NM_010790 maternal embryonic leucine zipper kinase Melk 2.01
NM_009829 Cyclin D2* 
Ccnd2 1.49
Chromatin remodelling
NM_178215 histone cluster 2, H3b Hist2h3b 4.50
NM_007928
MAP/microtubule affinity-regulating kinase 2, 
transcript variant 1 Mark2 4.42
NM_175654 histone cluster 1, H4d Hist1h4d 4.24
NM_178211 histone cluster 1, H4k Hist1h4k 4.04
NM_178210 histone cluster 1, H4j Hist1h4j 4.00
NM_178208 histone cluster 1, H4c Hist1h4c 3.91
NM_175652 histone cluster 4, H4 Hist4h4 3.84
NM_001080819 AT rich interactive domain 1A Arid1a 3.77
NM_030609 histone cluster 1, H1a Hist1h1a 3.51
NM_026785 ubiquitin-conjugating enzyme E2C Ube2c 3.39
NM_020034 histone cluster 1, H1b Hist1h1b 3.39
NM_015787 histone cluster 1, H1e Hist1h1e 3.28
NM_033596 histone cluster 2, H4 Hist2h4 3.17
NM_016957
high mobility group nucleosomal binding 
domain 2 Hmgn2 3.13
NM_001195421 histone cluster 1, H4m Hist1h4m 3.01
NM_013548 histone cluster 1, H3f Hist1h3f 2.90
NM_145073 histone cluster 1, H3g Hist1h3g 2.84
NM_010931
ubiquitin-like, containing PHD and RING finger 
domains, 1, transcript variant 1 Uhrf1 2.72
NM_175653 histone cluster 1, H3c Hist1h3c 2.66
NM_178856 GINS complex subunit 2 (Psf2 homolog) Gins2 2.66
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NM_012012 exonuclease 1  Exo1 2.62 
NM_001204973 bromodomain containing 2 , transcript variant 2 Brd2 2.56 
NM_021790 centromere protein K, transcript variant 1 Cenpk 2.55 
NM_175663 histone cluster 1, H2ba  Hist1h2ba 2.54 
NM_011234 RAD51 homolog  Rad51 2.53 
NM_020022 replication factor C (activator 1) 2  Rfc2 2.51 
NM_178183 histone cluster 1, H2ak Hist1h2ak 2.46 
NM_008210 H3 histone, family 3A  H3f3a 2.40 
NM_011623 topoisomerase (DNA) II alpha  Top2a 2.38 
NM_001163775 TAO kinase 2, transcript variant 2 Taok2 2.37 
NM_181586 
sirtuin 6 (silent mating type information 
regulation 2, homolog) 6 , transcript variant 1 Sirt6 2.35 
NM_198160 
SWI/SNF related, matrix associated, actin 
dependent regulator of chromatin, subfamily c, 
member 2, transcript variant 3 Smarcc2 2.35 
NM_024184 ASF1 anti-silencing function 1 homolog B Asf1b 2.33 
NM_028039 establishment of cohesion 1 homolog 2 Esco2 2.33 
NM_145946 Fanconi anemia, complementation group I  Fanci 2.31 
NM_178200 histone cluster 1, H2bm  Hist1h2bm 2.24 
NM_009030 retinoblastoma binding protein 4  Rbbp4 2.23 
NM_008894 
polymerase (DNA directed), delta 2, regulatory 
subunit Pold2 2.20 
NM_008228 histone deacetylase 1  Hdac1 2.20 
NM_013883 
sex comb on midleg homolog 1, transcript 
variant 1 Scmh1 2.18 
NM_020004 
K(lysine) acetyltransferase 2A, transcript 
variant 1 Kat2a 2.16 
NM_011121 polo-like kinase 1  Plk1 2.16 
NM_146208 nei like 3  Neil3 2.16 
NM_134083 
regulator of chromosome condensation and 
BTB (POZ) domain containing protein 2 , 
transcript variant 2 Rcbtb2 2.13 
NM_008892 polymerase (DNA directed), alpha 1 Pola1 2.11 
NM_029797 meiotic nuclear divisions 1 homolog  Mnd1 2.10 
NM_013550 histone cluster 1, H3a  Hist1h3a 2.10 
NM_010722 lamin B2 Lmnb2 2.09 
NM_026632 replication protein A3  Rpa3 2.08 
NM_153141 
coactivator-associated arginine 
methyltransferase 1, transcript variant 2 Carm1 2.07 
NM_023294 
NDC80 homolog, kinetochore complex 
component  Ndc80 2.05 
NM_172453 PIF1 5'-to-3' DNA helicase homolog Pif1 2.05 
NM_009013 RAD51 associated protein 1  Rad51ap1 2.03 
NM_008017 structural maintenance of chromosomes 2  Smc2 1.98 
Cytoskeleton 
NM_011072 profilin 1  Pfn1 3.96 
NM_010669 keratin 6B  Krt6b 3.94 
NM_009451 tubulin, beta 4A class IVA  Tubb4a 3.93 
NM_001163637 
janus kinase and microtubule interacting 
protein 2  Jakmip2 3.39 
NM_009449 tubulin, alpha 3B  Tuba3b 3.34 
NM_008445 kinesin family member 3C Kif3c 2.92 
NM_130857 keratin associated protein 19-3  Krtap19-3 2.92 
NM_183296 keratin associated protein 16-3  Krtap16-3 2.92 
NM_016879 keratin 85  Krt85 2.90 
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NM_011526 transgelin Tagln 2.88
NM_001163615 keratin associated protein 20-2 Krtap20-2 2.81
NM_130870 keratin associated protein 16-1 Krtap16-1 2.81
NM_175272 neuron navigator 2, transcript variant 1 Nav2 2.76
NM_001113406 keratin associated protein 11-1 Krtap11-1 2.70
NM_019445 formin 2 Fmn2 2.68
NM_148934 tubulin polyglutamylase complex subunit 1 Tpgs1 2.64
NM_010672 keratin associated protein 6-1 Krtap6-1 2.64
NM_028621 keratin associated protein 21-1 Krtap21-1 2.62
NM_019641 stathmin 1 Stmn1 2.60
NM_027771 keratin associated protein 7-1 Krtap7-1 2.58
NM_130873 keratin associated protein 19-4 Krtap19-4 2.57
NM_010626 kinesin family member 7 Kif7 2.50
NM_009931 collagen, type IV, alpha 1 Col4a1 2.42
NM_001024716
TRIO and F-actin binding protein, transcript 
variant 1 Triobp 2.41
NM_010662 keratin 13 Krt13 2.38
NM_026552
actin related protein 2/3 complex, subunit 4, 
transcript variant 1 Arpc4 2.37
NM_013928
schwannomin interacting protein 1, transcript 
variant 4 Schip1 2.34
NM_172946 keratin 222 Krt222 2.32
NM_011654 tubulin, alpha 1B Tuba1b 2.29
NM_001166157 keratin 81 Krt81 2.29
NM_017470 dynein, axonemal, light chain 4 Dnalc4 2.29
NM_027800 keratin associated protein 2-4 Krtap2-4 2.28
NM_010676 keratin associated protein 19-5 Krtap19-5 2.27
NM_212483 keratin 42 Krt42 2.26
NM_198599 MAP6 domain containing 1 Map6d1 2.25
NM_197945 ProSAPiP1 protein Prosapip1 2.24
NM_145575 caldesmon 1 Cald1 2.20
NM_017464
neural precursor cell expressed, 
developmentally down-regulated gene 9, 
transcript variant 2 Nedd9 2.19
NM_019670 diaphanous homolog 3 Diap3 2.18
NM_080728
myosin, heavy polypeptide 7, cardiac muscle, 
beta Myh7 2.16
NM_134471 kinesin family member 2C Kif2c 2.14
NM_009768 basigin, transcript variant 1 Bsg 2.14
NM_028390 anillin, actin binding protein Anln 2.13
NM_001191018 keratin associated protein 22-2 Krtap22-2 2.11
NM_133851
nucleolar and spindle associated protein 1, 
transcript variant 1 Nusap1 2.05
NM_178926
vimentin-type intermediate filament associated 
coiled-coil protein, transcript variant 1 Vmac 2.01
NM_010675 keratin associated protein 8-1 Krtap8-1 1.98
Metabolism
NM_016956 hemoglobin, beta adult minor chain Hbb-b2 14.97
NM_001080943 zinc finger, DHHC-type containing 22 Zdhhc22 13.25
NM_009653
aminolevulinic acid synthase 2, erythroid, 
transcript variant 1 Alas2 8.62
NM_008220 hemoglobin, beta adult major chain Hbb-b1 8.30
NM_008218 hemoglobin alpha, adult chain 1 Hba-a1 6.67
NM_139142
solute carrier family 6 (neurotransmitter 
transporter), member 20A Slc6a20a 5.09
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NM_018763 carbohydrate sulfotransferase 2  Chst2 4.81 
NM_001082975 
short chain dehydrogenase/reductase family 
39U, member 1 Sdr39u1 4.59 
NM_009464 
uncoupling protein 3 (mitochondrial, proton 
carrier)  Ucp3 4.46 
NM_001033270 
solute carrier family 4, sodium bicarbonate 
cotransporter, member 7 Slc4a7 4.43 
NM_011671 
uncoupling protein 2 (mitochondrial, proton 
carrier)  Ucp2 4.41 
NM_027093 
NADH dehydrogenase (ubiquinone) complex I, 
assembly factor 5 Ndufaf5 4.39 
NM_001104531 
cytochrome P450, family 2, subfamily d, 
polypeptide 11  Cyp2d11 4.17 
NM_019698 
aldehyde dehydrogenase 18 family, member 
A1, nuclear gene encoding mitochondrial 
protein, transcript variant 1 Aldh18a1 3.95 
NM_010066 
DNA methyltransferase (cytosine-5) 1 , 
transcript variant 2 Dnmt1 3.94 
NM_001083955 hemoglobin alpha, adult chain 2  Hba-a2 3.58 
NM_010596 
potassium voltage-gated channel, shaker-
related subfamily, member 7 Kcna7 3.47 
NM_007817 
cytochrome P450, family 2, subfamily f, 
polypeptide 2  Cyp2f2 3.46 
NM_010359 glutathione S-transferase, mu 3  Gstm3 3.37 
NM_175403 malectin Mlec 3.34 
NM_134118 
trans-2,3-enoyl-CoA reductase , transcript 
variant 1 Tecr 3.31 
NM_007807 cytochrome b-245, beta polypeptide  Cybb 3.31 
NM_177186 solute carrier family 35, member E2 Slc35e2 3.26 
NM_013784 
phosphatidylinositol glycan anchor 
biosynthesis, class N Pign 3.22 
NM_009034 retinol binding protein 2, cellular Rbp2 3.15 
NM_011371 
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-
galactosyl-1,3)-N-acetylgalactosaminide alpha-
2,6-sialyltransferase 1 St6galnac1 3.15 
NM_016966 3-phosphoglycerate dehydrogenase  Phgdh 3.09 
NM_009181 
ST8 alpha-N-acetyl-neuraminide alpha-2,8-
sialyltransferase 2  St8sia2 3.03 
NM_026969 Sec31 homolog A Sec31a 2.98 
NM_001243052 
branched chain aminotransferase 2, 
mitochondrial, transcript variant 2 Bcat2 2.94 
NM_027790 dehydrogenase/reductase member 2  Dhrs2 2.91 
NM_133189 
calcium channel, voltage-dependent, gamma 
subunit 7  Cacng7 2.85 
NM_144845 
UDP glycosyltransferases 3 family, polypeptide 
A2 Ugt3a2 2.84 
NM_008525 aminolevulinate, delta-, dehydratase  Alad 2.84 
NM_178788 dCMP deaminase (Dctd), transcript variant 1 Dctd 2.81 
NM_011961 
procollagen lysine, 2-oxoglutarate 5-
dioxygenase 2, transcript variant 2 Plod2 2.79 
NM_001033175 ceroid-lipofuscinosis, neuronal 6  Cln6 2.78 
NM_213733 aminopeptidase-like 1 Npepl1 2.76 
NM_030601 chloride channel calcium activated 2  Clca2 2.72 
NM_207161 
2'-deoxynucleoside 5'-phosphate N-hydrolase 
1  Dnph1 2.69 
NM_009437 thiosulfate sulfurtransferase, mitochondrial  Tst 2.68 
NM_009723 
ATPase, Ca++ transporting, plasma 
membrane 2, transcript variant 1 Atp2b2 2.67 
NM_019435 NADH dehydrogenase (ubiquinone) 1 beta Ndufb11 2.65 
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subcomplex, 11
NM_009374 transglutaminase 3 Tgm3 2.62
NM_146198
solute carrier family 5 (sodium/glucose 
cotransporter), member 11 Slc5a11 2.59
NM_025412 pyrroline-5-carboxylate reductase-like Pycrl 2.55
NM_033617
ATPase, H+ transporting, lysosomal V0 
subunit B Atp6v0b 2.53
NM_145603 carboxylesterase 2C Ces2c 2.51
NM_008631 metallothionein 4 Mt4 2.46
NM_009272 spermidine synthase Srm 2.41
NM_001044308
calcium channel, voltage-dependent, alpha 1I 
subunit Cacna1i 2.40
NM_009662 arachidonate 5-lipoxygenase Alox5 2.38
NM_009104 ribonucleotide reductase M2 Rrm2 2.38
NM_001163359 fidgetin-like 1, transcript variant 1 Fignl1 2.34
NM_009804 catalase Cat 2.32
NM_010497
isocitrate dehydrogenase 1 (NADP+), soluble, 
transcript variant 2 Idh1 2.32
NM_008826 phosphofructokinase, liver, B-type Pfkl 2.31
NM_009127 stearoyl-Coenzyme A desaturase 1 Scd1 2.28
NM_172371
solute carrier family 16 (monocarboxylic acid 
transporters), member 13 Slc16a13 2.28
NM_054094
acyl-CoA synthetase medium-chain family 
member 1 Acsm1 2.27
NM_025408 alkaline ceramidase 3 Acer3 2.26
NM_001271544
solute carrier family 4, sodium bicarbonate 
cotransporter, member 9, transcript variant 1 Slc4a9 2.26
NM_026764
glutathione S-transferase, mu 4 , transcript 
variant 1 Gstm4 2.25
NM_010274
glycerol phosphate dehydrogenase 2, 
mitochondrial (Gpd2), transcript variant 2 Gpd2 2.24
NM_010358 glutathione S-transferase, mu 1 Gstm1 2.22
NM_008278 hydroxyprostaglandin dehydrogenase 15 Hpgd 2.22
NM_020581 angiopoietin-like 4 Angptl4 2.21
NM_172117
ectonucleoside triphosphate 
diphosphohydrolase 6 Entpd6 2.15
NM_026678 biliverdin reductase A Blvra 2.15
NM_080440
solute carrier family 8 (sodium/calcium 
exchanger), member 3, transcript variant 2 Slc8a3 2.15
NM_030262 protein O-fucosyltransferase 2 Pofut2 2.13
NM_172773
solute carrier family 17 (anion/sugar 
transporter), member 5 Slc17a5 2.12
NM_178696
solute carrier family 25, member 44, transcript 
variant 1 Slc25a44 2.11
NM_001040699 myotubularin related protein 7 Mtmr7 2.11
NM_177382
cytochrome P450, family 2, subfamily r, 
polypeptide 1 Cyp2r1 2.11
NM_007838
dolichyl-di-phosphooligosaccharide-protein 
glycotransferase Ddost 2.10
NM_172609
translocase of outer mitochondrial membrane 
22 homolog Tomm22 2.08
NM_007621 carbonyl reductase 2 Cbr2 2.08
NM_013541 glutathione S-transferase, pi 1 Gstp1 2.07
NM_011962
procollagen-lysine, 2-oxoglutarate 5-
dioxygenase 3 Plod3 2.07
NM_016666 aryl-hydrocarbon receptor-interacting protein Aip 2.06
NM_007646 CD38 antigen Cd38 2.05
NM_028638 glutamate decarboxylase-like 1 Gadl1 2.05
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NM_007379 ATP-binding cassette, sub-family A, member 2 Abca2 2.04
NM_178086 fatty acid 2-hydroxylase Fa2h 2.02
NM_019501
prenyl (solanesyl) diphosphate synthase, 
subunit 1 Pdss1 2.01
NM_008212 hydroxyacyl-Coenzyme A dehydrogenase Hadh 2.01
NM_026947 enoyl-Coenzyme A delta isomerase 3 Eci3 2.00
NM_138665 sarcosine dehydrogenase Sardh 2.00
NM_011977
solute carrier family 27 (fatty acid transporter), 
member 1 Slc27a1 2.00
Others
NM_001201391 hemoglobin subunit beta-1-like Beta-s 29.45
NM_023900
pleckstrin homology domain containing, family 
J member 1 Plekhj1 5.60
NM_011174 proline rich protein HaeIII subfamily 1 Prh1 5.44
NM_021384
radical S-adenosyl methionine domain 
containing 2 Rsad2 4.67
NM_138602 PRA1 domain family 2 Praf2 4.14
NM_001042451 synuclein, alpha, transcript variant 1 Snca 4.05
NM_013877 calcium binding protein 5 Cabp5 3.98
NM_201518
fibronectin leucine rich transmembrane protein 
2 Flrt2 3.83
NM_177994 R3H domain containing 4 R3hdm4 3.80
NM_001205102
leucine-rich repeat, immunoglobulin-like and 
transmembrane domains 3 Lrit3 3.76
NM_018803 synaptotagmin X Syt10 3.74
NM_029000
GTPase, very large interferon inducible 1, 
transcript variant 1 Gvin1 3.73
NM_207105 histocompatibility 2, class II antigen A, beta 1 H2-Ab1 3.62
NM_080846 HIG1 domain family, member 1B Higd1b 3.60
NM_001033478
family with sequence similarity 47, member E, 
transcript variant 1 Fam47e 3.53
NM_001081418
glioma tumor suppressor candidate region 
gene 1 Gltscr1 3.53
NM_145981 phytanoyl-CoA hydroxylase interacting protein Phyhip 3.26
NM_021898 testis specific gene A8 Tsga8 3.11
NM_134122 nurim (nuclear envelope membrane protein) Nrm 3.06
NM_001163614 achaete-scute complex homolog 4 Ascl4 3.04
NM_020583
interferon-stimulated protein, transcript variant 
1 Isg20 2.98
NM_173862 family with sequence similarity 83, member A Fam83a 2.94
NM_175427 family with sequence similarity 163, member B Fam163b 2.91
NM_001082545 stefin A2 Stfa2 2.77
NM_183187 family with sequence similarity 107, member A Fam107a 2.76
NM_001142642 fibrosin-like 1, transcript variant 1 Fbrsl1 2.76
NM_001199631 FK506 binding protein 8, transcript variant 3 Fkbp8 2.75
NM_172756 ankyrin repeat and LEM domain containing 1 Ankle1 2.75
NM_133859 olfactomedin-like 3 Olfml3 2.72
NM_001025576 coiled-coil domain containing 141 Ccdc141 2.71
NM_025620 RAB15 effector protein Rep15 2.70
NM_010807 MARCKS-like 1 Marcksl1 2.63
NM_001081406 leucine rich repeat protein 1 Lrr1 2.51
NM_018884 PDZ domain containing RING finger 3 Pdzrn3 2.50
NM_183170 MPV17 mitochondrial membrane protein-like 2 Mpv17l2 2.44
NM_172116 Parkinson disease 7 domain containing 1 Pddc1 2.42
NM_133719 meteorin, glial cell differentiation regulator Metrn 2.41
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NM_030694 interferon induced transmembrane protein 2  Ifitm2 2.38 
NM_145361 BTB (POZ) domain containing 2  Btbd2 2.37 
NM_009185 Scl/Tal1 interrupting locus  Stil 2.37 
NM_016737 stress-induced phosphoprotein 1  Stip1 2.35 
NM_001163721 
small integral membrane protein 1 , transcript 
variant 1 Smim1 2.35 
NM_032543 ring finger protein 123  Rnf123 2.35 
NM_018771 
GIPC PDZ domain containing family, member 
1  Gipc1 2.34 
NM_025378 interferon induced transmembrane protein 3  Ifitm3 2.32 
NM_029377 lin-37 homolog  Lin37 2.30 
NM_001199337 apolipoprotein O, transcript variant 2 Apoo 2.29 
NM_133831 
glioma tumor suppressor candidate region 
gene 2  Gltscr2 2.27 
NM_010219 FK506 binding protein 4 Fkbp4 2.27 
NM_138682 leucine rich repeat containing 4  Lrrc4 2.26 
NM_026457 spermatid associated, transcript variant 2 Spert 2.25 
NM_013515 stomatin  Stom 2.24 
NM_053113 
eosinophil-associated, ribonuclease A family, 
member 11  Ear11 2.21 
NM_177028 O-acyltransferase like Oacyl 2.18 
NM_011627 trophoblast glycoprotein, transcript variant 1 Tpbg 2.17 
NM_146244 ribosomal protein S6 kinase-like 1  Rps6kl1 2.16 
NM_133187 family with sequence similarity 198, member B Fam198b 2.14 
NM_001025610 
membrane-spanning 4-domains, subfamily A, 
member 7, transcript variant 2 Ms4a7 2.13 
NM_172488 
laccase (multicopper oxidoreductase) domain 
containing 1 Lacc1 2.13 
NM_175118 dual specificity phosphatase 28  Dusp28 2.12 
NM_080595 EMI domain containing 1 Emid1 2.11 
NM_144556 leucine-rich repeat LGI family, member 4 Lgi4 2.11 
NM_019661 YKT6 homolog  Ykt6 2.10 
NM_021294 diazepam binding inhibitor-like 5  Dbil5 2.09 
NM_016663 synaptotagmin III, transcript variant 1 Syt3 2.08 
NM_178919 lipase maturation factor 2 Lmf2 2.08 
NM_011073 perforin 1 (pore forming protein)  Prf1 2.07 
NM_145390 
transportin 2 (importin 3, karyopherin beta 2b), 
transcript variant 1 Tnpo2 2.07 
NM_009538 pleiomorphic adenoma gene-like 1  Plagl1 2.05 
NM_026938 transmembrane protein 160  Tmem160 2.05 
NM_010129 
epithelial membrane protein 3, transcript 
variant 1 Emp3 2.04 
NM_010590 ajuba LIM protein  Ajuba 2.03 
NM_146156 
PDLIM1 interacting kinase 1 like, transcript 
variant 1 Pdik1l 2.03 
NM_001195088 
transmembrane channel-like gene family 8, 
transcript variant A Tmc8 2.03 
NM_183194 gasdermin C3 Gsdmc3 2.01 
NM_027984 epsin 3 Epn3 2.00 
Protein folding 
NM_024172 
HSPA (heat shock 70kDa) binding protein, 
cytoplasmic cochaperone 1 Hspbp1 2.47 
NM_175199 heat shock protein 12A  Hspa12a 2.03 
Proteolysis 
NM_023635 RAB27A, member RAS oncogene family Rab27a 5.79 
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NM_009126
serine (or cysteine) peptidase inhibitor, clade B 
(ovalbumin), member 3A Serpinb3a 5.55
NM_201363
serine (or cysteine) peptidase inhibitor, clade 
B, member 3C Serpinb3c 4.67
NM_001169153
CD300 antigen like family member F, transcript 
variant 1 Cd300lf 4.17
NM_145578
ubiquitin-conjugating enzyme E2M, transcript 
variant 1 Ube2m 3.50
NM_025312 sclerostin domain containing 1* Sostdc1 4.30
NM_025288 stefin A3 Stfa3 2.99
NM_173869 stefin A2 like 1 Stfa2l1 2.98
NM_001205070
Josephin domain containing 2, transcript 
variant 1 Josd2 2.94
NM_175188
membrane-associated ring finger (C3HC4) 1, 
transcript variant 3 March1 2.93
NM_010767
mannan-binding lectin serine peptidase 2, 
transcript variant 2 Masp2 2.91
NM_011187
proteasome (prosome, macropain) subunit, 
beta type 7 Psmb7 2.80
NM_145420 ubiquitin-conjugating enzyme E2D 1 Ube2d1 2.74
NM_008604 membrane metallo endopeptidase Mme 2.65
NM_178738 protease, serine, 35 Prss35 2.60
NM_007649 CD48 antigen Cd48 2.58
NM_019461 ubiquitin specific peptidase 27, X chromosome Usp27x 2.53
NM_198680
serine (or cysteine) peptidase inhibitor, clade B 
(ovalbumin), member 3B Serpinb3b 2.50
NM_010612 kinase insert domain protein receptor Kdr 2.49
NM_010418
hect (homologous to the E6-AP (UBE3A) 
carboxyl terminus) domain and RCC1 (CHC1)-
like domain (RLD) 2 Herc2 2.40
NM_015783 ISG15 ubiquitin-like modifier Isg15 2.35
NM_133354 SMT3 suppressor of mif two 3 homolog 2 Sumo2 2.26
NM_011595 tissue inhibitor of metalloproteinase 3 Timp3 2.21
NM_001001650 protease, serine, 48 Prss48 2.20
NM_001082543 stefin A1 Stfa1 2.20
NM_023386 receptor transporter protein Rtp4 2.15
NM_198028
serine (or cysteine) peptidase inhibitor, clade B 
(ovalbumin), member 10, transcript variant 1 Serpinb10 2.09
NM_008607 matrix metallopeptidase 13 Mmp13 2.09
NM_173754 ubiquitin specific peptidase 43 Usp43 2.04
NM_173052
serine (or cysteine) peptidase inhibitor, clade 
B, member 1b Serpinb1b 2.01
RNA processing
NM_013932 DEAD (Asp-Glu-Ala-Asp) box polypeptide 25 Ddx25 12.54
NM_012011
eukaryotic translation initiation factor 2, subunit 
3, structural gene Y-linked Eif2s3y 6.25
NM_012008
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-
linked Ddx3y 5.02
NM_153416
achalasia, adrenocortical insufficiency, 
alacrimia Aaas 3.31
NM_011358 serine/arginine-rich splicing factor 2 Srsf2 2.99
NM_025500 mitochondrial ribosomal protein L37 Mrpl37 2.94
NM_018799
eukaryotic translation initiation factor 3, subunit 
I Eif3i 2.70
NM_001008422 SR-related CTD-associated factor 1 Scaf1 2.54
NM_011431
elongation factor Tu GTP binding domain 
containing 2, transcript variant 1 Eftud2 2.42
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NM_001166589 
eukaryotic translation initiation factor 5A, 
transcript variant 1 Eif5a 2.41 
NM_175001 mitochondrial ribosomal protein L22 Mrpl22 2.35 
NM_026080 mitochondrial ribosomal protein S24 Mrps24 2.32 
NM_023133 ribosomal protein S19  Rps19 2.26 
NM_016805 heterogeneous nuclear ribonucleoprotein U Hnrnpu 2.24 
NM_175235 CUGBP, Elav-like family member 6 Celf6 2.22 
NM_177367 gem (nuclear organelle) associated protein 4  Gemin4 2.20 
NM_173757 mitochondrial ribosomal protein S27 Mrps27 2.19 
NM_019484 Aly/REF export factor 2  Alyref2 2.15 
NM_148917 
poly(A) binding protein, cytoplasmic 4, 
transcript variant 2 Pabpc4 2.14 
NM_009070 
ribonucleic acid binding protein S1, transcript 
variant 1 Rnps1 2.12 
NM_207523 ribosomal protein L23A Rpl23a 2.12 
NM_021288 thymidylate synthase, transcript variant 1 Tyms 2.09 
NM_022313 Era (G-protein)-like 1  Eral1 2.08 
NM_013507 
eukaryotic translation initiation factor 4, 
gamma 2, transcript variant 1 Eif4g2 2.01 
Signalling 
NM_010100 ectodysplasin-A receptor* Edar 58.69 
NM_009170 sonic hedgehog* Shh 45.41 
NM_176996 smoothened homolog (Drosophila) (Smo) Smo 36.25 
NM_008958 patched homolog 2 Ptch2 25.72 
NM_133249 peroxisome proliferative activated receptor, gamma, coactivator 1 beta Ppargc1b 16.21 
NM_009987 chemokine (C-X3-C) receptor 1 Cx3cr1 9.75 
ENSMUST00000
029611 lymphoid enhancer binding factor 1* Lef1 9.68 
NM_001033960 RAB GTPase activating protein 1, transcript variant 2 Rabgap1 8.53 
NM_007416 adrenergic receptor, alpha 1b  Adra1b 6.07 
NM_001042605 CD74 antigen, transcript variant 1 Cd74 5.86 
NM_199022 SHC (Src homology 2 domain containing) family, member 4 Shc4 4.08 
NM_026864 RAS-like, family 11, member A  Rasl11a 3.99 
NM_001272024 
sema domain, transmembrane domain (TM), 
and cytoplasmic domain, (semaphorin) 6C , 
transcript variant 1 
Sema6c 3.85 
NM_009835 chemokine (C-C motif) receptor 6, transcript variant 1 Ccr6 3.73 
NM_146862 olfactory receptor 763  Olfr763 3.59 
NM_001081105 ras homolog gene family, member H  Rhoh 3.57 
NM_022324 stromal cell-derived factor 2-like 1  Sdf2l1 3.57 
NM_008973 pleiotrophin  Ptn 3.52 
NM_011562 teratocarcinoma-derived growth factor 1 Tdgf1 3.47 
NM_027242 protein phosphatase 1, regulatory subunit 35 Ppp1r35 3.44 
NM_013834 secreted frizzled-related protein 1  Sfrp1 3.36 
NM_146457 olfactory receptor 282  Olfr282 3.04 
NM_011428 synaptosomal-associated protein 25  Snap25 2.85 
NM_028808 purinergic receptor P2Y, G-protein coupled 13 P2ry13 2.84 
NM_021885 tubby candidate gene Tub 2.75 
NM_007889 dishevelled 3, dsh homolog  Dvl3 2.71 
NM_010275 glial cell line derived neurotrophic factor  Gdnf 2.68 
NM_008975 protein tyrosine phosphatase 4a3, transcript variant 2 Ptp4a3 2.64 
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NM_008086 growth arrest specific 1  Gas1 2.61 
NM_029408 IQ motif containing D Iqcd 2.61 
NM_183315 cortexin 1  Ctxn1 2.6 
NM_207666 delta-like 2 homolog Dlk2 2.6 
NM_010733 leucine rich repeat protein 3, neuronal, transcript variant 2 Lrrn3 2.58 
NM_029057 TBC1 domain family, member 30 Tbc1d30 2.58 
NM_177740 RGM domain family, member A Rgma 2.58 
NM_013739 docking protein 3  Dok3 2.54 
NM_010517 insulin-like growth factor binding protein 4  Igfbp4 2.52 
NM_007479 ADP-ribosylation factor 4  Arf4 2.51 
NM_009708 Rho family GTPase 2 Rnd2 2.48 
NM_008342 insulin-like growth factor binding protein 2 Igfbp2 2.48 
NM_022657 fibroblast growth factor 23  Fgf23 2.46 
NM_028804 coiled-coil domain containing 3  Ccdc3 2.44 
NM_026814 protein phosphatase 1, regulatory subunit 27 Ppp1r27 2.43 
NM_198249 Rho guanine nucleotide exchange factor (GEF) 40 , transcript variant 1 Arhgef40 2.43 
NM_008356 interleukin 13 receptor, alpha 2  Il13ra2 2.41 
NM_011823 G protein-coupled receptor 34  Gpr34 2.41 
NM_010572 insulin receptor substrate 4 Irs4 2.38 
NM_145431 notchless homolog 1  Nle1 2.38 
NM_145373 secreted and transmembrane 1A Sectm1a 2.37 
NM_027280 naked cuticle 1 homolog, transcript variant 1 Nkd1 2.37 
NM_026840 platelet-derived growth factor receptor-like  Pdgfrl 2.34 
NM_007955 protein tyrosine phosphatase, receptor type, V Ptprv 2.31 
NM_009750 nerve growth factor receptor (TNFRSF16) associated protein 1, transcript variant 1 Ngfrap1 2.26 
NM_145379 MAS-related GPR, member F Mrgprf 2.26 
NM_016719 growth factor receptor bound protein 14  Grb14 2.25 
NM_016802 ras homolog gene family, member A  Rhoa 2.25 
NM_001033484 IQ motif containing GTPase activating protein 3 Iqgap3 2.25 
NM_009109 ryanodine receptor 1, skeletal muscle  Ryr1 2.22 
NM_008865 prolactin family 3, subfamily b, member 1  Prl3b1 2.22 
NM_146216 Vac14 homolog  Vac14 2.22 
NM_009314 tachykinin receptor 2 Tacr2 2.21 
NM_016891 protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), alpha isoform  Ppp2r1a 2.21 
NM_016971 interleukin 22  Il22 2.2 
NM_007486 Rho, GDP dissociation inhibitor (GDI) beta (Arhgdib) Arhgdib 2.19 
NM_021476 cysteinyl leukotriene receptor 1  Cysltr1 2.18 
NM_011915 Wnt inhibitory factor 1 Wif1 2.18 
NM_009216 somatostatin receptor 1  Sstr1 2.18 
NM_001011850 olfactory receptor 1505 Olfr1505 2.17 
NM_147030 olfactory receptor 1134 Olfr1134 2.14 
NM_009028 RAS-like, family 2, locus 9  Rasl2-9 2.13 
NM_026446 regulator of G-protein signaling 19 Rgs19 2.13 
NM_010273 guanosine diphosphate (GDP) dissociation inhibitor 1 Gdi1 2.11 
NM_146356 olfactory receptor 521  Olfr521 2.11 
NM_020257 C-type lectin domain family 2, member i  Clec2i 2.1 
NM_138748 protein phosphatase 2A, regulatory subunit B (PR 53)  Ppp2r4 2.09 
NM_206975 interferon, alpha 14  Ifna14 2.08 
209 
 
NM_023209 PDZ binding kinase Pbk 2.06 
NM_008728 natriuretic peptide receptor 3 Npr3 2.04 
NM_007865 delta-like 1  Dll1 2.04 
NM_017472 sorting nexin 3 Snx3 2.03 
NM_001198766 periostin, osteoblast specific factor, transcript variant 3 Postn 2.02 
NM_031875 otoferlin, transcript variant 2 Otof 2.02 
NM_175168 PTK7 protein tyrosine kinase 7 Ptk7 2.02 
NM_028416 kringle containing transmembrane protein 2 Kremen2 2.02 
NM_020259 Hedgehog-interacting protein  Hhip 2.01 
NM_008113 Rho GDP dissociation inhibitor (GDI) gamma  Arhgdig 2.01 
NM_001033851 copine VIII, transcript variant 2 Cpne8 2 
NM_001038018 G protein-coupled receptor kinase 6, transcript variant 1 Grk6 2 
NM_029646 interleukin 34, transcript variant 2 Il34 2 
NM_001164724 interleukin 33, transcript variant 1 Il33 2 
NM_001110320 CD72 antigen, transcript variant 1 Cd72 1.99 
NM_027571 purinergic receptor P2Y, G-protein coupled 12  P2ry12 1.99 
NM_001165902 beta-catenin* Ctnnb1 1.4 
Transcription 
NM_172495 
nuclear receptor coactivator 7, transcript 
variant 1 Ncoa7 11.61 
NM_027395 
brain abundant, membrane attached signal 
protein 1  Basp1 4.75 
NM_011640 
transformation related protein 53, transcript 
variant 1 Trp53 3.77 
NM_008709 
v-myc myelocytomatosis viral related 
oncogene, neuroblastoma derived Mycn 3.65 
NM_008688 nuclear factor I/C, transcript variant 1 Nfic 3.56 
NM_009236 SRY-box containing gene 18  Sox18 3.55 
NM_181319 T-box 22, transcript variant 2 Tbx22 3.54 
NM_016662 Max dimerization protein 3  Mxd3 3.37 
NM_010055 distal-less homeobox 3  Dlx3 3.30 
NM_025788 
nucleus accumbens associated 1, BEN and 
BTB (POZ) domain containing  Nacc1 3.02 
NM_028016 Nanog homeobox  Nanog 2.94 
NM_010466 homeobox C8  Hoxc8 2.87 
NM_009089 
polymerase (RNA) II (DNA directed) 
polypeptide A  Polr2a 2.81 
NM_009331 transcription factor 7, T cell specific Tcf7 2.76 
NM_170759 zinc finger protein 628 (Zfp628) Zfp628 2.73 
NM_178757 interferon regulatory factor 2 binding protein 1  Irf2bp1 2.68 
NM_026776 vacuolar protein sorting 25 Vps25 2.65 
NM_026532 nuclear transport factor 2 Nutf2 2.64 
NM_009235 SRY-box containing gene 15  Sox15 2.62 
NM_146040 cell division cycle associated 7 like  Cdca7l 2.62 
NM_008505 LIM domain only 2, transcript variant 1 Lmo2 2.58 
NM_001037914 multiciliate cell differentiation Mcin 2.50 
NM_026192 calcium binding and coiled coil domain 1  Calcoco1 2.49 
NM_011642 
transformation related protein 73, transcript 
variant 1 Trp73 2.46 
NM_001001980 
LIM and calponin homology domains 1, 
transcript variant 1 Limch1 2.39 
NM_010919 
NK2 transcription factor related, locus 2, 
transcript variant 1 Nkx2-2 2.37 
NM_178609 E2F transcription factor 7  E2f7 2.37 
NM_027946 DDB1 and CUL4 associated factor 7  Dcaf7 2.36 
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NM_001033813 zinc finger protein 872 Zfp872 2.35 
NM_011139 POU domain, class 2, transcription factor 3 Pou2f3 2.34 
NM_011869 mediator complex subunit 24  Med24 2.33 
NM_010835 homeobox, msh-like 1  Msx1 2.32 
NM_008269 homeobox B6  Hoxb6 2.24 
NM_026937 
activating signal cointegrator 1 complex 
subunit 1 ,  transcript variant 2 Ascc1 2.23 
NM_019574 
POZ (BTB) and AT hook containing zinc finger 
1, transcript variant 1 Patz1 2.22 
NM_001109743 SKI family transcriptional corepressor 2  Skor2 2.22 
NM_021501 protein inhibitor of activated STAT 4  Pias4 2.22 
NM_001163763 transcription factor 19, transcript variant 1 Tcf19 2.21 
NM_027658 
hexamethylene bis-acetamide inducible 2 ,  
transcript variant 1 Hexim2 2.17 
NM_001034900 zinc finger protein 345 Zfp345 2.15 
NM_019776 
staphylococcal nuclease and tudor domain 
containing 1  Snd1 2.12 
NM_029281 zinc finger protein 820 Zfp820 2.11 
NM_008627 Meis homeobox 3 Meis3 2.09 
NM_001168502 zinc finger protein 57, transcript variant 3 Zfp57 2.08 
NM_194350 
v-maf musculoaponeurotic fibrosarcoma 
oncogene family, protein A Mafa 2.06 
NM_145836 
interferon regulatory factor 2 binding protein-
like  Irf2bpl 2.06 
NM_011249 
retinoblastoma-like 1 (p107), transcript variant 
1 Rbl1 2.06 
NM_011377 single-minded homolog 2  Sim2 2.04 
NM_025945 
polymerase (RNA) III (DNA directed) 
polypeptide D, transcript variant 1 Polr3d 2.04 
NM_027434 
regulation of nuclear pre-mRNA domain 
containing 1B  Rprd1b 2.04 
NM_008321 inhibitor of DNA binding 3  Id3 2.02 
NM_010464 homeobox C13 Hoxc13 2.02 
NM_009056 
regulatory factor X, 2 (influences HLA class II 
expression), transcript variant 2 Rfx2 2.01 
NM_001013368 E2F transcription factor 8  E2f8 2.01 
NM_144799 LIM and cysteine-rich domains 1 Lmcd1 2.00 
NM_022435 trans-acting transcription factor 5  Sp5 2.00 
NM_008500 LIM homeobox protein 6, transcript variant 1 Lhx6 1.99 
NM_007531 prohibitin 2  Phb2 1.99 
Transport 
NM_012037 vesicle amine transport protein 1 homolog  Vat1 2.04 
NM_001164679 anoctamin 8  Ano8 2.23 
NM_008226 
hyperpolarization-activated, cyclic nucleotide-
gated K+ 2 Hcn2 3.05 
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Adhesion/Extracellular matrix 
NM_018857 mesothelin  Msln 43.81 
NM_009856 CD83 antigen Cd83 3.46 
NM_139200 cytohesin 1 interacting protein Cytip 3.39 
NM_027852 
retinoic acid receptor responder (tazarotene 
induced) 2  Rarres2 3.08 
NM_001243008 collagen, type VI, alpha 3, transcript variant 1 Col6a3 2.98 
NM_009903 claudin 4  Cldn4 2.96 
NM_022032 PERP, TP53 apoptosis effector  Perp 2.76 
NM_001008424 corneodesmosin Cdsn 2.67 
NM_010516 cysteine rich protein 61 Cyr61 2.56 
NM_008013 fibrinogen-like protein 2  Fgl2 2.5 
NM_053146 protocadherin beta 21  Pcdhb21 2.37 
NM_021893 CD274 antigen  Cd274 2.31 
NM_138672 stabilin 1  Stab1 2.3 
NM_145158 elastin microfibril interfacer 2  Emilin2 2.25 
NM_001093749 myelin protein zero-like 3, transcript variant 2 Mpzl3 2.19 
NM_027893 
poliovirus receptor-related 4 , transcript variant 
1 Pvrl4 2.19 
NM_033620 
par-3 (partitioning defective 3) homolog, 
transcript variant 3 Pard3 2.18 
NM_016919 collagen, type V, alpha 3  Col5a3 2.17 
NM_010814 myelin oligodendrocyte glycoprotein Mog 2.17 
NM_008127 gap junction protein, beta 4 Gjb4 2.16 
NM_010291 gap junction protein, beta 5  Gjb5 2.16 
NM_011016 orosomucoid 2  Orm2 2.16 
NM_001111058 CD33 antigen, transcript variant 1 Cd33 2.15 
NM_080437 
cadherin, EGF LAG seven-pass G-type 
receptor 3 (flamingo homolog, Drosophila)  Celsr3 2.13 
NM_133743 Ly6/Plaur domain containing 3 Lypd3 2.13 
NM_001113368 
carcinoembryonic antigen-related cell 
adhesion molecule 2, transcript variant 1 Ceacam2 2.1 
NM_008768 orosomucoid 1  Orm1 2.09 
NM_028523 discoidin, CUB and LCCL domain containing 2  Dcbld2 2.08 
NM_007993 fibrillin 1  Fbn1 2.08 
NM_023420 
collagen, type IV, alpha 3 binding protein, 
transcript variant 1 Col4a3bp 2.05 
NM_001081053 integrin, alpha 10  Itga10 2 
Cell Cycle/Apoptosis 
NM_009397 
tumor necrosis factor, alpha-induced protein 3, 
transcript variant 1 Tnfaip3 5.11 
NM_007570 B cell translocation gene 2, anti-proliferative Btg2 4.69 
NM_011540 titin-cap  Tcap 4.31 
NM_013642 dual specificity phosphatase 1  Dusp1 3.28 
NM_207677 
death effector domain-containing DNA binding 
protein 2 Dedd2 2.96 
NM_009871 
cyclin-dependent kinase 5, regulatory subunit 
1 (p35)  Cdk5r1 2.63 
NM_001162908 sestrin 1, transcript variant 1 Sesn1 2.61 
NM_001081156 TMF1-regulated nuclear protein 1  Trnp1 2.61 
NM_130886 
caspase recruitment domain family, member 
14 Card14 2.59 
NM_009760 BCL2/adenovirus E1B interacting protein 3 Bnip3 2.46 
NM_007609 
caspase 4, apoptosis-related cysteine 
peptidase Casp4 2.42 
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NM_008681 N-myc downstream regulated gene 1  Ndrg1 2.32 
NM_013469 annexin A11 Anxa11 2.25 
NM_025427 regulator of cell cycle  Rgcc 2.17 
NM_001103182 lin-9 homolog, transcript variant 1 Lin9 2.14 
NM_144899 ADAMTS-like 4 Adamtsl4 2.13 
NM_001003920 
BR serine/threonine kinase 1, transcript 
variant 1 Brsk1 2 
NM_008795 cyclin-dependent kinase 18  Cdk18 2 
Chromatin remodeling 
NM_001097979 histone cluster 1, H2bq  Hist1h2bq 59.61 
NM_178909 WD repeat domain 92 Wdr92 9.88 
NM_178196 histone cluster 1, H2bg  Hist1h2bg 5.99 
NM_015786 histone cluster 1, H1c  Hist1h1c 4.74 
NM_023422 histone cluster 1, H2bc Hist1h2bc 4.26 
BC015270 histone cluster 2, H3c2 Hist2h3c2 3.7 
BC059807 chromodomain helicase DNA binding protein 6 Chd6 3.64 
NM_199299 PHD finger protein 15  Phf15 3.61 
NM_013807 polo-like kinase 3  Plk3 3.51 
NM_025519 charged multivesicular body protein 4C  Chmp4c 3.27 
NM_001167884 
suppressor of variegation 4-20 homolog 1 
(Drosophila) , transcript variant 7 Suv420h1 2.69 
NM_030082 histone cluster 3, H2ba  Hist3h2ba 2.58 
NM_001081315 bromodomain and PHD finger containing, 3 Brpf3 2.49 
NM_178218 histone cluster 3, H2a  Hist3h2a 2.4 
NM_001109691 PHD finger protein 21A, transcript variant 3 Phf21a 2.34 
NM_001128151 
cat eye syndrome chromosome region, 
candidate 2  Cecr2 2.33 
NM_001081269 
Wolf-Hirschhorn syndrome candidate 1-like 1, 
transcript variant 2 Whsc1l1 2.24 
NM_153421 
polyhomeotic-like 3 (Drosophila) , transcript 
variant 2 Phc3 2.22 
NM_010434 
homeodomain interacting protein kinase 3, 
transcript variant 1 Hipk3 2.19 
NM_027892 
protein phosphatase 1, regulatory (inhibitor) 
subunit 12A  Ppp1r12a 2.16 
NM_026110 PAX3 and PAX7 binding protein 1  Paxbp1 2.14 
NM_001017426 KDM1 lysine (K)-specific demethylase 6B Kdm6b 2.04 
NM_001177374 
ubiquitin protein ligase E3 component n-
recognin 2, transcript variant 2 Ubr2 2.03 
NM_011235 RAD51 homolog D  Rad51d 2.02 
Cytoskeleton 
NM_008508 loricrin  Lor 8.18 
NM_025420 late cornified envelope 1M  Lce1m 5.51 
NM_027762 trichohyalin-like 1  Tchhl1 4.5 
NM_001099774 keratin associated protein 17-1 Krtap17-1 3.85 
NM_029667 late cornified envelope 1I Lce1i 3.83 
NM_212487 keratin 78 Krt78 3.81 
NM_027137 late cornified envelope 1D Lce1d 3.62 
NM_011472 small proline-rich protein 2F  Sprr2f 3.61 
NM_001005510 spectrin repeat containing, nuclear envelope 2  Syne2 3.5 
NM_013560 heat shock protein 1 Hspb1 3.49 
NM_026394 late cornified envelope 1F Lce1f 3.49 
NM_011470 small proline-rich protein 2D  Sprr2d 3.49 
NM_033373 keratin 23 Krt23 3.38 
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NM_011471 small proline-rich protein 2E  Sprr2e 3.23 
NM_011619 troponin T2, cardiac, transcript variant 9 Tnnt2 3.19 
NM_010664 keratin 18 Krt18 3.14 
NM_001252372 
myosin binding protein C, slow-type , 
transcript variant 1 Mybpc1 3.14 
NM_008473 keratin 1 Krt1 3.06 
NM_028622 late cornified envelope 1C (Lce1c) Lce1c 2.97 
NM_001039376 
phosphodiesterase 4D interacting protein 
(myomegalin), transcript variant 1 Pde4dip 2.88 
NM_026822 late cornified envelope 1B Lce1b 2.84 
NM_001271484 
CAP-GLY domain containing linker protein 
family, member 4, transcript variant 4 Clip4 2.79 
NM_028044 calponin 3, acidic Cnn3 2.75 
NM_007585 annexin A2 Anxa2 2.74 
NM_033175 late cornified envelope 3C  Lce3c 2.72 
NM_025501 late cornified envelope 3B Lce3b 2.64 
NM_001018079 late cornified envelope 3F Lce3f 2.59 
NM_026811 late cornified envelope 1E Lce1e 2.57 
NM_001270426 late cornified envelope 3D Lce3d 2.55 
NM_001039472 kinesin family member 21B Kif21b 2.4 
NM_018790 
activity regulated cytoskeletal-associated 
protein Arc 2.38 
NM_028721 
nephronophthisis 3 (adolescent), transcript 
variant 1 Nphp3 2.38 
NM_025413 late cornified envelope 1G Lce1g 2.33 
NM_030203 TSPY-like 4  Tspyl4 2.33 
NM_145070 huntingtin interacting protein 1 related Hip1r 2.26 
NM_010630 kinesin family member C2 Kifc2 2.24 
NM_025984 late cornified envelope 1A1 Lce1a1 2.24 
NM_019765 CAP-GLY domain containing linker protein 1 Clip1 2.19 
NM_001039594 late cornified envelope 3A Lce3a 2.18 
NM_146120 gelsolin, transcript variant 1 Gsn 2.17 
NM_001109657 growth arrest specific 7, transcript variant 2 Gas7 2.14 
NM_133357 keratin 75  Krt75 2.11 
NM_001254760 late cornified envelope 1K  Lce1k 2.11 
NM_019809 PDZ and LIM domain 5, transcript variant 2 Pdlim5 2.08 
NM_009450 tubulin, beta 2A class IIA  Tubb2a 2.07 
NM_010660 keratin 10 Krt10 2.06 
NM_175180 WD repeat domain 44 Wdr44 2.06 
NM_178593 
RCSD domain containing 1, transcript variant 
1 Rcsd1 2.04 
NM_198113 slingshot homolog 3  Ssh3 2.03 
NM_001163664 troponin T3, skeletal, fast , transcript variant 1 Tnnt3 2.01 
Metabolism 
NM_013743 
pyruvate dehydrogenase kinase, isoenzyme 4, 
nuclear gene encoding mitochondrial protein Pdk4 5.79 
NM_175650 ATPase type 13A5 Atp13a5 5.26 
NM_027299 
degenerative spermatocyte homolog 2 
(Drosophila), lipid desaturase, transcript 
variant 1 Degs2 5.02 
NM_011435 superoxide dismutase 3, extracellular  Sod3 4.95 
NM_146118 
solute carrier family 25 (mitochondrial carrier, 
phosphate carrier), member 25, transcript 
variant 1 Slc25a25 4.52 
NM_001111331 
Kv channel interacting protein 3, calsenilin , 
transcript variant 2 Kcnip3 4.38 
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NM_001199283 
solute carrier family 43, member 2, transcript 
variant 1 Slc43a2 4.33 
NM_007409 alcohol dehydrogenase 1 (class I)  Adh1 4.23 
NM_001164613 ATPase type 13A4, transcript variant 3 Atp13a4 4.18 
NM_001130194 bestrophin 2, transcript variant 1 Best2 4.18 
NM_009593 
ATP-binding cassette, sub-family G (WHITE), 
member 1 Abcg1 3.91 
NM_026945 alcohol dehydrogenase 6A (class V) Adh6a 3.68 
NM_001177753 
6-phosphofructo-2-kinase/fructose-2,6-
biphosphatase 3, transcript variant 2 Pfkfb3 3.61 
NM_194333 
solute carrier family 23 (nucleobase 
transporters), member 3  Slc23a3 3.52 
NM_001098789 
NADH dehydrogenase (ubiquinone) 1 alpha 
subcomplex, 4-like 2  Ndufa4l2 3.45 
NM_011031 
procollagen-proline, 2-oxoglutarate 4-
dioxygenase, alpha II polypeptide , transcript 
variant 2 P4ha2 3.45 
NM_030696 
solute carrier family 16 (monocarboxylic acid 
transporters), member 3 Slc16a3 3.28 
NM_001042591 arrestin domain containing 3 Arrdc3 3.27 
NM_028784 
coagulation factor XIII, A1 subunit, transcript 
variant 1 F13a1 3.24 
NM_028133 EGL nine homolog 3 (C. elegans)  Egln3 3.13 
NM_183161 solute carrier family 17, member 9 Slc17a9 3.01 
NM_033648 
FXYD domain-containing ion transport 
regulator 4, transcript variant 1 Fxyd4 2.99 
NM_001111111 autophagy related 16-like 2  Atg16l2 2.92 
NM_001114084 diacylglycerol O-acyltransferase 2-like 6  Dgat2l6 2.88 
NM_029415 
solute carrier family 10 (sodium/bile acid 
cotransporter family), member 6  Slc10a6 2.84 
NM_007421 adenylosuccinate synthetase like 1 Adssl1 2.74 
NM_172883 
major facilitator superfamily domain containing 
7A Mfsd7a 2.74 
NM_013455 acrosin prepropeptide, transcript variant 1 Acr 2.71 
NM_172837 lipase, family member K, transcript variant 2 Lipk 2.7 
NM_030558 carbonic anhydrase 15  Car15 2.68 
NM_153143 
potassium channel tetramerisation domain 
containing 11  Kctd11 2.67 
NM_001267707 
solute carrier organic anion transporter family, 
member 1a5, transcript variant 1 Slco1a5 2.67 
NM_007470 apolipoprotein D Apod 2.66 
NM_001195033 abhydrolase domain containing 12B  Abhd12b 2.65 
NM_001079865 carboxylesterase 2F Ces2f 2.65 
NM_011198 prostaglandin-endoperoxide synthase 2  Ptgs2 2.65 
NM_172524 NIPA-like domain containing 4  Nipal4 2.63 
NM_177243 solute carrier family 26, member 9  Slc26a9 2.62 
NM_153404 lipase, member H, transcript variant 2 Liph 2.58 
NM_019664 
potassium inwardly-rectifying channel, 
subfamily J, member 15 , transcript variant 2 Kcnj15 2.57 
NM_001160165 neuraminidase 2, transcript variant 3 Neu2 2.56 
NM_009695 apolipoprotein C-II  Apoc2 2.55 
NM_011786 arachidonate lipoxygenase 3  Aloxe3 2.53 
NM_001039176 
elongation of very long chain fatty acids 
(FEN1/Elo2, SUR4/Elo3, yeast)-like 1, 
transcript variant 1 Elovl1 2.49 
NM_175475 
cytochrome P450, family 26, subfamily b, 
polypeptide 1, transcript variant 1 Cyp26b1 2.46 
NM_001081349 solute carrier family 43, member 1, transcript Slc43a1 2.41 
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variant 1 
NM_134006 retinol dehydrogenase 5  Rdh5 2.4 
NM_001012434 
potassium channel tetramerisation domain 
containing 14, transcript variant 2 Kctd14 2.39 
NM_029688 sulfiredoxin 1 homolog  Srxn1 2.39 
NM_001042719 
DDHD domain containing 1, transcript variant 
3 Ddhd1 2.36 
NM_001081421 
UDP-N-acetyl-alpha-D-
galactosamine:polypeptide N-
acetylgalactosaminyltransferase-like 1 Galntl1 2.36 
NM_173785 
IBA57, iron-sulfur cluster assembly homolog, 
transcript variant 1 Iba57 2.35 
NM_027172 
solute carrier protein family 52, member 3 ,  
transcript variant 1 Slc52a3 2.35 
NM_009022 
aldehyde dehydrogenase family 1, subfamily 
A2  Aldh1a2 2.32 
NM_027868 
solute carrier family 41, member 3, transcript 
variant 1 Slc41a3 2.32 
NM_145828 xylosyltransferase II  Xylt2 2.32 
NM_021301 
solute carrier family 15 (H+/peptide 
transporter), member 2, transcript variant 1 Slc15a2 2.28 
BC047268 phospholipase D2 Pld2 2.27 
NM_183220 
1-aminocyclopropane-1-carboxylate synthase 
(non-functional) Accs 2.24 
NM_172692 glucosidase beta 2  Gba2 2.23 
NM_053079 
solute carrier family 15 (oligopeptide 
transporter), member 1 Slc15a1 2.23 
NM_018830 N-acylsphingosine amidohydrolase 2 Asah2 2.22 
NM_018881 flavin containing monooxygenase 2  Fmo2 2.22 
NM_013509 enolase 2, gamma neuronal  Eno2 2.21 
NM_001163689 
patatin-like phospholipase domain containing 
2, transcript variant 1 Pnpla2 2.21 
NM_026784 
phosphomevalonate kinase, transcript variant 
1 Pmvk 2.18 
NM_026644 
1-acylglycerol-3-phosphate O-acyltransferase 
4 (lysophosphatidic acid acyltransferase, 
delta)  Agpat4 2.17 
NM_010239 ferritin heavy chain 1, transcript variant 1 Fth1 2.17 
NM_008504 granzyme M (lymphocyte met-ase 1) Gzmm 2.17 
NM_145423 
solute carrier family 5 (iodide transporter), 
member 8 Slc5a8 2.17 
NM_052993 
core 1 synthase, glycoprotein-N-
acetylgalactosamine 3-beta-
galactosyltransferase, 1  C1galt1 2.16 
NM_019779 
cytochrome P450, family 11, subfamily a, 
polypeptide 1  Cyp11a1 2.16 
NM_175331 5'-nucleotidase domain containing 3  Nt5dc3 2.16 
NM_008131 
glutamate-ammonia ligase (glutamine 
synthetase)  Glul 2.15 
NM_009177 
ST3 beta-galactoside alpha-2,3-
sialyltransferase 1  St3gal1 2.15 
NM_001039710 coenzyme Q10 homolog B, transcript variant 1 Coq10b 2.14 
NM_027340 lipase, family member N Lipn 2.13 
NM_147219 
ATP-binding cassette, sub-family A , member 
5 Abca5 2.09 
NM_019807 
acid phosphatase, prostate , transcript variant 
2 Acpp 2.07 
NM_172607 
nicotinate phosphoribosyltransferase domain 
containing 1 Naprt1 2.07 
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NM_029810 
5'-nucleotidase, cytosolic II , transcript variant 
3 Nt5c2 2.07 
NM_027406 aldehyde dehydrogenase 1 family, member L1  Aldh1l1 2.06 
NM_153803 galactosidase, beta 1-like 2  Glb1l2 2.06 
NM_001159864 
potassium channel tetramerisation domain 
containing 18, transcript variant 1 Kctd18 2.05 
NM_001161767 
UDP-N-acetyl-alpha-D-
galactosamine:polypeptide N-
acetylgalactosaminyltransferase 6, transcript 
variant 1 Galnt6 2.04 
NM_145447 
major facilitator superfamily domain containing 
7C Mfsd7c 2.04 
NM_013820 hexokinase 2  Hk2 2.03 
NM_001161765 
flavin containing monooxygenase 5, transcript 
variant 1 Fmo5 2.02 
NM_025718 deoxyribonuclease 1-like 2  Dnase1l2 2.02 
NM_013850 ATP-binding cassette, sub-family A, member 7  Abca7 2.01 
NM_009721 
ATPase, Na+/K+ transporting, beta 1 
polypeptide Atp1b1 2.01 
Others 
NM_172051 
transmembrane and coiled coil domains 3, 
transcript variant 1 Tmcc3 7.29 
NM_001163502 
ELM2 and Myb/SANT-like domain containing 
1, transcript variant 1 Elmsan1 6.84 
NM_001166173 dermokine, transcript variant 3 Dmkn 5.26 
NM_001204959 resistin , transcript variant 2 Retn 5.11 
NM_175307 family with sequence similarity 46, member B  Fam46b 4.69 
NM_001199210 
eva-1 homolog C (C. elegans) , transcript 
variant 1 Eva1c 4.66 
NM_197986 transmembrane protein 140  Tmem140 4 
NM_172205 suprabasin, transcript variant 1 Sbsn 3.93 
NM_001190436 
Finkel-Biskis-Reilly murine sarcoma virus 
(FBR-MuSV) ubiquitously expressed, 
transcript variant 3 Fau 3.74 
NM_028798 cysteine-rich C-terminal 1 Crct1 3.73 
NM_001033411 predicted gene 826  Gm826 3.55 
BC090258 interferon induced transmembrane protein 1 Ifitm1 3.24 
NM_027511 histidine rich carboxyl terminus 1  Hrct1 3.19 
NM_013473 annexin A8 Anxa8 3.16 
NM_009778 complement component 3 C3 3.16 
NM_145535 syndecan binding protein (syntenin) 2  Sdcbp2 2.91 
NM_027585 cyclic nucleotide binding domain containing 2 Cnbd2 2.88 
NM_001013749 transmembrane protein 151B  Tmem151b 2.87 
NM_172801 otopetrin 2  Otop2 2.85 
NM_001033410 predicted gene 757 Gm757 2.79 
NM_181397 raftlin lipid raft linker 1  Rftn1 2.78 
NM_001163572 transmembrane protein 170B  Tmem170b 2.73 
NM_001025572 ankyrin repeat domain 12 Ankrd12 2.58 
NM_010220 FK506 binding protein 5  Fkbp5 2.57 
NM_173415 nyctalopin  Nyx 2.57 
NM_175407 
sine oculis-binding protein homolog 
(Drosophila)  Sobp 2.56 
NM_176860 
ubiquitin associated and SH3 domain 
containing, B Ubash3b 2.56 
NM_010732 leucine rich repeat protein 2, neuronal Lrrn2 2.52 
NM_031195 macrophage scavenger receptor 1, transcript Msr1 2.52 
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variant 1 
NM_020578 EH-domain containing 3  Ehd3 2.48 
NM_011573 testis expressed gene 264, transcript variant 1 Tex264 2.48 
NM_013562 interferon-related developmental regulator 1 Ifrd1 2.4 
NM_019576 
thrombospondin, type I, domain 1, transcript 
variant 1 Thsd1 2.39 
NM_170684 copine VII  Cpne7 2.38 
NM_029116 
kelch repeat and BTB (POZ) domain 
containing 11 Kbtbd11 2.38 
NM_010706 lectin, galactose binding, soluble 4  Lgals4 2.37 
NM_176834 ring finger protein 208  Rnf208 2.37 
NM_011029 ribosomal protein SA  Rpsa 2.36 
NM_026146 EPS8-like 1 Eps8l1 2.34 
NM_178884 obscurin-like 1  Obsl1 2.33 
NM_146008 t-complex 11 (mouse) like 2  Tcp11l2 2.32 
NM_026835 
membrane-spanning 4-domains, subfamily A, 
member 6D Ms4a6d 2.31 
NM_001085507 zinc finger and BTB domain containing 34  Zbtb34 2.31 
NM_133898 NEDD4 binding protein 2-like 1  N4bp2l1 2.3 
NM_001081652 NAC alpha domain containing Nacad 2.3 
NM_001162974 
leucine rich repeat containing 51, transcript 
variant 3 Lrrc51 2.29 
NM_001038592 glutaredoxin 2 , transcript variant 1 Glrx2 2.28 
NM_001205353 
GRAM domain containing 4, transcript variant 
2 Gramd4 2.28 
NM_144797 meteorin, glial cell differentiation regulator-like  Metrnl 2.28 
NM_001159577 ligand of numb-protein X 1, transcript variant 1 Lnx1 2.24 
NM_027898 GRAM domain containing 1A Gramd1a 2.23 
NM_001136259 target of myb1 homolog, transcript variant 2 Tom1 2.22 
NM_009150 selenium binding protein 1 Selenbp1 2.2 
NM_001164557 
PDZK1 interacting protein 1 , transcript variant 
1 Pdzk1ip1 2.18 
NM_145853 two pore channel 1  Tpcn1 2.17 
NM_053167 
tripartite motif-containing 9 , transcript variant 
1 Trim9 2.17 
NM_027166 yippee-like 5 Ypel5 2.17 
NM_011157 serglycin  Srgn 2.16 
NM_026588 syntaxin 19  Stx19 2.16 
NM_001168514 
mitogen-activated protein kinase 14, transcript 
variant 4 Mapk14 2.15 
NM_178242 
trinucleotide repeat containing 18, transcript 
variant B Tnrc18 2.14 
NM_009441 tetratricopeptide repeat domain 3  Ttc3 2.14 
NM_153507 copine II Cpne2 2.13 
NM_013532 
leukocyte immunoglobulin-like receptor, 
subfamily B, member 4 Lilrb4 2.13 
NM_001081235 meningioma 1  Mn1 2.13 
NM_001024134 
tripartite motif-containing 15, transcript variant 
2 Trim15 2.13 
NM_011123 proteolipid protein (myelin) 1  Plp1 2.12 
NM_053166 tripartite motif-containing 7  Trim7 2.12 
NM_181073 
pleckstrin homology domain containing, family 
H (with MyTH4 domain) member 1  Plekhh1 2.11 
NM_133774 
StAR-related lipid transfer (START) domain 
containing 4  Stard4 2.11 
NM_001146022 WD repeat and FYVE domain containing 4  Wdfy4 2.11 
NM_001008233 pleckstrin homology domain containing, family Plekhn1 2.1 
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N member 1  
NM_177775 extended synaptotagmin-like protein 3 Esyt3 2.07 
NM_026235 La ribonucleoprotein domain family, member 6 Larp6 2.07 
NM_019814 HIG1 domain family, member 1A  Higd1a 2.06 
NM_177185 ubinuclein 2  Ubn2 2.06 
NM_001256057 predicted gene 11570  Gm11570 2.05 
NM_172694 multiple EGF-like-domains 9 Megf9 2.05 
NM_177632 family with sequence similarity 43, member A  Fam43a 2.04 
NM_001146043 
G elongation factor, mitochondrial 2,  
transcript variant 2 Gfm2 2.04 
NM_027116 
NTPase, KAP family P-loop domain containing 
1  Nkpd1 2.04 
NM_028950 
NOL1/NOP2/Sun domain family member 6, 
transcript variant 2 Nsun6 2.04 
NM_001271727 tripartite motif-containing 2, transcript variant 3 Trim2 2.02 
NM_016714 nucleoporin 50  Nup50 2.01 
NM_001045483 
mitogen-activated protein kinase 1 interacting 
protein 1, transcript variant 1 Mapk1ip1 2 
Protein folding 
NM_028430 peptidylprolyl isomerase (cyclophilin)-like 6  Ppil6 2.25 
NM_018808 
DnaJ (Hsp40) homolog, subfamily B, member 
1 Dnajb1 2.23 
Proteolysis 
NM_013459 complement factor D (adipsin)  Cfd 11.31 
NM_177322 angiotensin II receptor, type 1a  Agtr1a 8.65 
NM_011414 secretory leukocyte peptidase inhibitor Slpi 7.4 
NM_008871 
serine (or cysteine) peptidase inhibitor, clade 
E, member 1  Serpine1 6.57 
NM_001252569 
serine (or cysteine) peptidase inhibitor, clade 
A, member 1A, transcript variant 2 Serpina1a 3.91 
NM_133753 ERBB receptor feedback inhibitor 1  Errfi1 3.83 
NM_001199940 
serine (or cysteine) peptidase inhibitor, clade 
A, member 3I  Serpina3i 3.72 
NM_015790 icos ligand  Icosl 3.69 
NM_010511 interferon gamma receptor 1 Ifngr1 3.56 
NM_009247 
serine (or cysteine) peptidase inhibitor, clade 
A, member 1E  Serpina1e 3.47 
NM_028660 kallikrein related-peptidase 9 Klk9 3.39 
NM_009245 
serine (or cysteine) peptidase inhibitor, clade 
A, member 1C  Serpina1c 3.31 
NM_024406 fatty acid binding protein 4, adipocyte  Fabp4 3.12 
NM_009776 
serine (or cysteine) peptidase inhibitor, clade 
G, member 1  Serping1 3.09 
NM_011113 plasminogen activator, urokinase receptor  Plaur 2.99 
NM_009543 ring finger protein 103  Rnf103 2.98 
NM_007796 
cytotoxic T lymphocyte-associated protein 2 
alpha, transcript variant 1 Ctla2a 2.87 
NM_009246 
serine (or cysteine) peptidase inhibitor, clade 
A, member 1D  Serpina1d 2.87 
NM_027997 
serine (or cysteine) peptidase inhibitor, clade 
A, member 9 Serpina9 2.83 
NM_007781 
colony stimulating factor 2 receptor, beta 2, 
low-affinity  Csf2rb2 2.79 
NM_178691 
YOD1 OTU deubiquitinating enzyme 1 
homologue Yod1 2.71 
NM_001025439 calcium/calmodulin-dependent protein kinase Camk2d 2.62 
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II, delta, transcript variant 1 
NM_016845 proacrosin binding protein, transcript variant 1 Acrbp 2.61 
NM_026414 aspartic peptidase, retroviral-like 1 Asprv1 2.61 
NM_019932 platelet factor 4  Pf4 2.47 
NM_001039042 kallikrein related-peptidase 13  Klk13 2.42 
NM_007797 
cytotoxic T lymphocyte-associated protein 2 
beta, transcript variant 1 Ctla2b 2.41 
NM_008906 cathepsin A , transcript variant 1 Ctsa 2.41 
NM_173749 
peptidase domain containing associated with 
muscle regeneration 1  Pamr1 2.4 
NM_001040106 AP2 associated kinase 1, transcript variant 1 Aak1 2.26 
NM_178730 transmembrane protease, serine 11f  Tmprss11f 2.23 
NM_028894 
LON peptidase N-terminal domain and ring 
finger 3  Lonrf3 2.21 
NM_011177 
kallikrein related-peptidase 6, transcript variant 
1 Klk6 2.2 
NM_183284 serine peptidase inhibitor, Kazal type 2  Spink2 2.17 
NM_001081115 
non-specific cytotoxic cell receptor protein 1 
homolog (zebrafish)  Nccrp1 2.13 
NM_052976 oligophrenin 1  Ophn1 2.12 
NM_178694 zyg-11 related, cell cycle regulator  Zer1 2.11 
NM_139147 Rab40b, member RAS oncogene family  Rab40b 2.06 
NM_007899 
extracellular matrix protein 1, transcript variant 
1 Ecm1 2.05 
NM_001001803 
serine peptidase inhibitor, Kazal type 7 
(putative)  Spink7 2.04 
RNA processing 
NM_011756 zinc finger protein 36  Zfp36 4.91 
NM_007475 ribosomal protein, large, P0 Rplp0 2.95 
BC096413 ribosomal protein L37a Rpl37a 2.82 
NM_001114079 poly(A) binding protein, cytoplasmic 1-like  Pabpc1l 2.8 
NM_133819 
protein phosphatase 1, regulatory (inhibitor) 
subunit 15b  Ppp1r15b 2.79 
NM_009095 ribosomal protein S5  Rps5 2.62 
NM_033541 2'-5' oligoadenylate synthetase 1C  Oas1c 2.43 
NM_025963 ribosomal protein S10  Rps10 2.42 
NM_026020 ribosomal protein, large P2  Rplp2 2.22 
NM_016680 
CLK4-associating serine/arginine rich protein, 
transcript variant L Clasrp 2.14 
NM_053255 elaC homolog 1 Elac1 2.1 
NM_025919 ribosomal protein L11  Rpl11 2.1 
NM_175937 
cytoplasmic polyadenylation element binding 
protein 2 , transcript variant 1 Cpeb2 2.09 
NM_175529 leukocyte receptor cluster (LRC) member 9 Leng9 2.07 
NM_011287 ribosomal protein L10A  Rpl10a 2.03 
NM_001024837 
adenosine deaminase, RNA-specific, B1, 
transcript variant 2 Adarb1 2.02 
Signalling 
NM_011314 serum amyloid A 2  Saa2 40.51 
NM_008176 chemokine (C-X-C motif) ligand 1 Cxcl1 23.24 
NM_009117 serum amyloid A 1  Saa1 12.21 
NM_011333 chemokine (C-C motif) ligand 2  Ccl2 9.04 
NM_008361 interleukin 1 beta  Il1b 8.5 
NM_009627 adrenomedullin Adm 7.04 
NM_007707 suppressor of cytokine signaling 3  Socs3 4.9 
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NM_007913 early growth response 1 Egr1 4.62 
NM_015811 regulator of G-protein signaling 1  Rgs1 4.39 
NM_011338 chemokine (C-C motif) ligand 9 Ccl9 4.29 
NM_177868 
forkhead-associated (FHA) phosphopeptide 
binding domain 1 Fhad1 3.93 
NM_013652 chemokine (C-C motif) ligand 4 Ccl4 3.8 
NM_015776 microfibrillar associated protein 5  Mfap5 3.58 
NM_026577 ADP-ribosylation factor-like 13B  Arl13b 3.55 
NM_029083 DNA-damage-inducible transcript 4 Ddit4 3.51 
NM_008344 insulin-like growth factor binding protein 6  Igfbp6 3.38 
NM_011817 
growth arrest and DNA-damage-inducible 45 
gamma  Gadd45g 3.37 
NM_009615 a disintegrin and metallopeptidase domain 17 Adam17 3.33 
NM_009061 regulator of G-protein signaling 2  Rgs2 3.28 
NM_017466 chemokine (C-C motif) receptor-like 2 Ccrl2 3.27 
NM_020622 family with sequence similarity 3, member B  Fam3b 3.19 
NM_009841 CD14 antigen  Cd14 3.17 
NM_146491 olfactory receptor 1410  Olfr1410 3.14 
NM_011905 toll-like receptor 2  Tlr2 3.14 
NM_177137 
guanine nucleotide binding protein, alpha 
stimulating, olfactory type, transcript variant 2 Gnal 3.07 
NM_145857 
nucleotide-binding oligomerization domain 
containing 2  Nod2 2.99 
NM_172718 
small G protein signaling modulator 1, 
transcript variant 1 Sgsm1 2.99 
NM_009017 retinoic acid early transcript beta  Raet1b 2.95 
NM_023463 lymphocyte antigen 6 complex, locus G6C Ly6g6c 2.84 
NM_001163262 c-Maf inducing protein, transcript variant 1 Cmip 2.8 
NM_027106 arginine vasopressin-induced 1 Avpi1 2.77 
NM_010276 GTP binding protein Gem 2.76 
NM_008855 protein kinase C, beta  Prkcb 2.62 
NM_021274 chemokine (C-X-C motif) ligand 10 Cxcl10 2.61 
NM_001163634 
wingless-related MMTV integration site 7B, 
transcript variant 2 Wnt7b 2.59 
NM_178256 
RALBP1 associated Eps domain containing 
protein 2  Reps2 2.58 
NM_007706 
suppressor of cytokine signaling 2, transcript 
variant 1 Socs2 2.57 
NM_013693 tumor necrosis factor  Tnf 2.52 
NM_025540 sarcolipin  Sln 2.46 
NM_001081155 
Rap1 GTPase-activating protein , transcript 
variant 1 Rap1gap 2.45 
NM_009184 PTK6 protein tyrosine kinase 6  Ptk6 2.44 
NM_010592 Jun proto-oncogene related gene d Jund 2.43 
NM_011058 
platelet derived growth factor receptor, alpha 
polypeptide , transcript variant 1 Pdgfra 2.42 
NM_010831 salt inducible kinase 1 Sik1 2.39 
NM_008773 purinergic receptor P2Y, G-protein coupled 2  P2ry2 2.37 
NM_025404 ADP-ribosylation factor-like 4D  Arl4d 2.36 
NM_022019 dual specificity phosphatase 10  Dusp10 2.36 
NM_008343 insulin-like growth factor binding protein 3 Igfbp3 2.33 
NM_001130409 
PTK2 protein tyrosine kinase 2, transcript 
variant 2 Ptk2 2.32 
NM_001081212 insulin receptor substrate 2 Irs2 2.31 
NM_178111 
transformation related protein 53 inducible 
nuclear protein 2  Trp53inp2 2.3 
NM_178258 interleukin 22 receptor, alpha 2  Il22ra2 2.28 
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NM_013584 
leukemia inhibitory factor receptor, transcript 
variant 1 Lifr 2.28 
NM_198703 
WNK lysine deficient protein kinase 1, 
transcript variant 1 Wnk1 2.28 
NM_001035533 
A kinase (PRKA) anchor protein 2, transcript 
variant 1 Akap2 2.25 
NM_018883 
calcium/calmodulin-dependent protein kinase 
kinase 1, alpha Camkk1 2.24 
NM_021306 endothelin converting enzyme-like 1 Ecel1 2.24 
NM_010559 interleukin 6 receptor, alpha Il6ra 2.22 
NM_175445 
Ras association (RalGDS/AF-6) domain family 
member 2  Rassf2 2.22 
NM_011530 
transporter 2, ATP-binding cassette, sub-
family B (MDR/TAP)  Tap2 2.16 
NM_139307 vasorin  Vasn 2.16 
NM_010950 numb-like  Numbl 2.15 
NM_133924 sorting nexin family member 21  Snx21 2.12 
NM_001025250 
vascular endothelial growth factor A, transcript 
variant 1 Vegfa 2.1 
NM_007557 bone morphogenetic protein 7 Bmp7 2.09 
NM_001002842 
PML-RAR alpha-regulated adaptor molecule 1 
(Pram1), transcript variant 1 Pram1 2.09 
BC122879 nebulette Nebl 2.05 
NM_080843 suppressor of cytokine signaling 4  Socs4 2.02 
NM_146322 olfactory receptor 187  Olfr187 2.01 
NM_178710 salt inducible kinase 2  Sik2 2.01 
NM_001081412 breakpoint cluster region Bcr 2 
Transcription 
NM_001077364 
TSC22 domain family, member 3, transcript 
variant 1 Tsc22d3 13.68 
NM_007498 activating transcription factor 3 Atf3 7.41 
NM_008036 FBJ osteosarcoma oncogene B  Fosb 7.34 
NM_010444 
nuclear receptor subfamily 4, group A, 
member 1  Nr4a1 7.12 
NM_010234 FBJ osteosarcoma oncogene  Fos 6.58 
NM_010828 
Cbp/p300-interacting transactivator, with 
Glu/Asp-rich carboxy-terminal domain, 2  Cited2 6.21 
NM_007679 
CCAAT/enhancer binding protein (C/EBP), 
delta  Cebpd 5.67 
NM_153287 cysteine-serine-rich nuclear protein 1 Csrnp1 4.92 
NM_001033324 zinc finger and BTB domain containing 16  Zbtb16 4.28 
NM_010591 Jun oncogene  Jun 4.23 
NM_016868 
hypoxia inducible factor 3, alpha subunit , 
transcript variant 2 Hif3a 4.01 
NM_007914 ets homologous factor  Ehf 3.86 
NM_008390 
interferon regulatory factor 1, transcript variant 
1 Irf1 3.81 
NM_001113333 
cryptochrome 2 (photolyase-like) , transcript 
variant 2 Cry2 3.67 
NM_010638 Kruppel-like factor 9 Klf9 3.46 
NM_010907 
nuclear factor of kappa light polypeptide gene 
enhancer in B cells inhibitor, alpha  Nfkbia 3.39 
NM_021897 
transformation related protein 53 inducible 
nuclear protein 1, transcript variant 1 Trp53inp1 3.39 
NM_010755 
v-maf musculoaponeurotic fibrosarcoma 
oncogene family, protein F Maff 3.33 
NM_008452 Kruppel-like factor 2 Klf2 3.14 
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NM_027477 zinc finger protein 398 , transcript variant 1 Zfp398 3.06 
NM_013874 D4, zinc and double PHD fingers family 1 Dpf1 3 
NM_010235 fos-like antigen 1  Fosl1 2.99 
NM_009821 
runt related transcription factor 1, transcript 
variant 4 Runx1 2.97 
NM_017373 nuclear factor, interleukin 3, regulated Nfil3 2.94 
NM_030612 
nuclear factor of kappa light polypeptide gene 
enhancer in B cells inhibitor, zeta , transcript 
variant 1 Nfkbiz 2.88 
NM_010056 distal-less homeobox 5, transcript variant 1 Dlx5 2.79 
NM_009565 zinc finger and BTB domain containing 7B Zbtb7b 2.71 
NM_011276 ring finger protein, LIM domain interacting  Rlim 2.7 
NM_010499 immediate early response 2 Ier2 2.63 
NM_023755 transcription factor CP2-like 1  Tfcp2l1 2.58 
NM_027947 
zinc finger and BTB domain containing 43, 
transcript variant 1 Zbtb43 2.57 
NM_011498 basic helix-loop-helix family, member e40 Bhlhe40 2.48 
NM_009637 AE binding protein 2, transcript variant 3 Aebp2 2.47 
NM_153599 cyclin-dependent kinase 8  Cdk8 2.47 
NM_020610 nuclear receptor interacting protein 3  Nrip3 2.46 
NM_023184 Kruppel-like factor 15 Klf15 2.42 
NM_183208 zinc finger, MIZ-type containing 1  Zmiz1 2.4 
NM_013519 forkhead box C2 Foxc2 2.39 
NM_001029929 zinc finger, MYND-type containing 15  Zmynd15 2.38 
NM_010137 endothelial PAS domain protein 1 Epas1 2.37 
NM_021397 zinc finger and BTB domain containing 32 Zbtb32 2.37 
NM_027264 zinc finger protein 715 Zfp715 2.34 
NM_011803 Kruppel-like factor 6  Klf6 2.3 
NM_175606 HOP homeobox, transcript variant 1 Hopx 2.29 
NM_011753 zinc finger protein 26 Zfp26 2.29 
NM_177993 
high mobility group box transcription factor 1, 
transcript variant 2 Hbp1 2.25 
NM_011066 period circadian clock 2  Per2 2.22 
NM_001100460 zinc finger and BTB domain containing 42 Zbtb42 2.22 
NM_009744 B cell leukemia/lymphoma 6  Bcl6 2.19 
NM_008554 
achaete-scute complex homolog 2 
(Drosophila) Ascl2 2.15 
NM_001025577 
avian musculoaponeurotic fibrosarcoma (v-
maf) AS42 oncogene homolog Maf 2.15 
NM_177660 zinc finger and BTB domain containing 10 Zbtb10 2.15 
NM_009884 
CCAAT/enhancer binding protein (C/EBP), 
gamma Cebpg 2.06 
NM_010658 
v-maf musculoaponeurotic fibrosarcoma 
oncogene family, protein B  Mafb 2.04 
NM_008270 homeobox B9 Hoxb9 2.03 
NM_001009935 
thioredoxin interacting protein, transcript 
variant 1 Txnip 2.03 
NM_177790 zinc finger protein 385C Zfp385c 2.01 
NM_001029838 
Pbx/knotted 1 homeobox 2 , transcript variant 
2 Pknox2 2.01 
NM_172643 
zinc finger and BTB domain containing 41 
homolog Zbtb41 2.01 
NM_031391 
general transcription factor II A, 1, transcript 
variant 1 Gtf2a1 2 
Transport 
NM_008432 potassium channel, subfamily U, member 1  Kcnu1 2.48 
223 
 
NM_020506 exportin 4  Xpo4 2.09 
NM_029491 
trafficking protein particle complex 8, transcript 
variant 2 Trappc8 2.04 
NM_011324 sodium channel, nonvoltage-gated 1 alpha  Scnn1a 2.03 
NM_172476 transmembrane channel-like gene family 7  Tmc7 2.01 
 
*genes validated by qPCR 
 
 
 
